Risk and special populations
Zeile 48: | Zeile 48: | ||
'''[[RSP - DIS Race]]''' | '''[[RSP - DIS Race]]''' | ||
+ | ===007=== rsp and secondary d | ||
+ | {{tp|p=32310612|t=2020. Cardiac Manifestations Of Coronavirus (COVID-19)|pdf=|usr=007}} | ||
+ | {{tp|p=32490972|t=2020. COVID-19 and the eye: how much do we really know? A best evidence review.|pdf=|usr=007}} | ||
+ | {{tp|p=32380787|t=2020. Acute Kidney Injury in SARS-CoV-2 Infection: Direct Effect of Virus on Kidney Proximal Tubule Cells.|pdf=|usr=007}} | ||
+ | {{tp|p=32486196|t=2020. Cerebrovascular and Neurological Dysfunction under the Threat of COVID-19: Is There a Comorbid Role for Smoking and Vaping?|pdf=|usr=007}} | ||
+ | {{tp|p=32455539|t=2020. Smoking-Mediated Upregulation of the Androgen Pathway Leads to Increased SARS-CoV-2 Susceptibility.|pdf=|usr=007}} | ||
+ | {{tp|p=32423094|t=2020. COVID-19 and Individual Genetic Susceptibility/Receptivity: Role of ACE1/ACE2 Genes, Immunity, Inflammation and Coagulation. Might the Double X-chromosome in Females Be Protective against SARS-CoV-2 Compared to the Single X-Chromosome in Males?|pdf=|usr=007}} | ||
+ | {{tp|p=32393136|t=2020. COVID-19 and the Cerebro-Cardiovascular Systems: What do we Know so Far?|pdf=|usr=007}} | ||
+ | {{tp|p=32472662|t=2020. COVID-19 and diabetes: Is there enough evidence?|pdf=|usr=007}} | ||
+ | {{tp|p=32397558|t=2020. Impact of COVID-19 on the Cardiovascular System: A Review.|pdf=|usr=007}} | ||
+ | {{tp|p=32392741|t=2020. Clotting Factors in COVID-19: Epidemiological Association and Prognostic Values in Different Clinical Presentations in an Italian Cohort.|pdf=|usr=007}} | ||
+ | {{tp|p=32443899|t=2020. Early Predictors of Clinical Deterioration in a Cohort of 239 Patients Hospitalized for Covid-19 Infection in Lombardy, Italy.|pdf=|usr=007}} | ||
+ | {{tp|p=32443834|t=2020. Specific EEG Encephalopathy Pattern in SARS-CoV-2 Patients.|pdf=|usr=007}} | ||
+ | {{tp|p=32403255|t=2020. COVID-19, MERS and SARS with Concomitant Liver Injury-Systematic Review of the Existing Literature.|pdf=|usr=007}} | ||
+ | {{tp|p=32503180|t=2020. Fatal Outcomes of COVID-19 in Patients with Severe Acute Kidney Injury.|pdf=|usr=007}} | ||
+ | {{tp|p=32498262|t=2020. Outcomes of COVID-19 among Patients on In-Center Hemodialysis: An Experience from the Epicenter in South Korea.|pdf=|usr=007}} | ||
+ | {{tp|p=32498230|t=2020. Acute Coronary Syndromes and Covid-19: Exploring the Uncertainties.|pdf=|usr=007}} | ||
+ | {{tp|p=32496205|t=2020. Why African Americans Are a Potential Target for COVID-19 Infection in the United States.|pdf=|usr=007}} | ||
+ | {{tp|p=32449782|t=2020. Long-term clinical outcomes in survivors of severe acute respiratory syndrome and Middle East respiratory syndrome coronavirus outbreaks after hospitalisation or ICU admission: A systematic review and meta-analysis.|pdf=|usr=007}} | ||
+ | {{tp|p=32271393|t=2020. Medical Rehabilitation in Pandemics: Towards a New Perspective.|pdf=|usr=007}} | ||
+ | {{tp|p=32482654|t=2020. Dr. Favalli, et al reply.|pdf=|usr=007}} | ||
+ | {{tp|p=32469410|t=2020. Venous Thrombosis Among Critically Ill Patients With Coronavirus Disease 2019 (COVID-19).|pdf=|usr=007}} | ||
+ | {{tp|p=32475878|t=2020. The first pediatric patients with coronavirus disease 2019 (COVID-19) in Japan; The risk of co-infection with other respiratory viruses.|pdf=|usr=007}} | ||
+ | {{tp|p=32475104|t=2020. Coronavirus Disease 2019 Presenting as Conjunctivitis.|pdf=|usr=007}} | ||
+ | {{tp|p=32314329|t=2020. ACE-2 och coronavirus - en fraga om balans och dynamik?|pdf=|usr=007}} | ||
+ | {{tp|p=32471831|t=2020. Reply to Siniorakis et al., "COVID-19 Interference with Renin-Angiotensin System in the Context of Heart Failure".|pdf=|usr=007}} | ||
+ | {{tp|p=32444383|t=2020. COVID-19 Interference with Renin-Angiotensin System in the Context of Heart Failure.|pdf=|usr=007}} | ||
+ | {{tp|p=32467553|t=2020. Smoking amidst the COVID-19 Pandemic - the invisible threat?|pdf=|usr=007}} | ||
+ | {{tp|p=32478706|t=2020. Severe COVID-19 Cases: Is Respiratory Distress Partially Explained by Central Nervous System Involvement?|pdf=|usr=007}} | ||
+ | {{tp|p=32442932|t=2020. Experiencia COVID-19 en un sanatorio privado de Buenos Aires durante el primer mes de la pandemia: 26 casos.|pdf=|usr=007}} | ||
+ | {{tp|p=32481381|t=2020. A case report with COVID-19 during perioperative period of lobectomy.|pdf=|usr=007}} | ||
+ | {{tp|p=32443345|t=2020. SARS-CoV-2 pneumonia with subcutaneous emphysema, mediastinal emphysema, and pneumothorax: A case report.|pdf=|usr=007}} | ||
+ | {{tp|p=32384516|t=2020. Novel coronavirus 2019 (COVID-19): A case report and review of treatments.|pdf=|usr=007}} | ||
+ | {{tp|p=32502054|t=2020. A 3-month-old child with COVID-19: A case report.|pdf=|usr=007}} | ||
+ | {{tp|p=32502034|t=2020. The epidemiological characteristics of 2019 novel coronavirus diseases (COVID-19) in Jingmen, Hubei, China.|pdf=|usr=007}} | ||
+ | {{tp|p=32397692|t=2020. A case of Covid19 infection manifesting itself with only abdominal symptoms.|pdf=|usr=007}} | ||
+ | {{tp|p=32408731|t=2020. Covid-19 infection in kidney transplant recipients: endocrine and metabolic issues.|pdf=|usr=007}} | ||
+ | {{tp|p=32380802|t=2020. Cardiovascular system and COVID-19: perspectives from a developing country.|pdf=|usr=007}} | ||
+ | {{tp|p=32449614|t=2020. Gender differences in patients with COVID-19: a narrative review.|pdf=|usr=007}} | ||
+ | {{tp|p=32447949|t=2020. Extrapolation of mortality in COVID-19: Exploring the role of age, sex, co-morbidities and health-care related occupation.|pdf=|usr=007}} | ||
+ | {{tp|p=32432433|t=2020. Severity of COVID-19: The importance of being hypertensive.|pdf=|usr=007}} | ||
+ | {{tp|p=32425013|t=2020. COVID-19 and coagulative axis: review of emerging aspects in a novel disease.|pdf=|usr=007}} | ||
+ | {{tp|p=32415003|t=2020. Do SARS-CoV2 viral proteins have neuromodulatory properties?|pdf=|usr=007}} | ||
+ | {{tp|p=32457227|t=2020. COVID-19-related acute necrotizing encephalopathy with brain stem involvement in a patient with aplastic anemia.|pdf=|usr=007}} | ||
+ | {{tp|p=32457226|t=2020. COVID-19 in MS: Initial observations from the Pacific Northwest.|pdf=|usr=007}} | ||
+ | {{tp|p=32482781|t=2020. Acute disseminated encephalomyelitis after SARS-CoV-2 infection.|pdf=|usr=007}} | ||
+ | {{tp|p=32461235|t=2020. Guillain-Barre syndrome related to SARS-CoV-2 infection.|pdf=|usr=007}} | ||
+ | {{tp|p=32444427|t=2020. COVID-19-White matter and globus pallidum lesions: Demyelination or small-vessel vasculitis?|pdf=|usr=007}} | ||
+ | {{tp|p=32414755|t=2020. COVID-19 and MS disease-modifying therapies.|pdf=|usr=007}} | ||
+ | {{tp|p=32432445|t=2020. The kidney in COVID-19: protagonist or figurant?|pdf=|usr=007}} | ||
+ | {{tp|p=32486188|t=2020. SARS-CoV-2 Infection and the Liver.|pdf=|usr=007}} | ||
+ | {{tp|p=32503140|t=2020. Human T leukaemia Type 1 and COVID-19.|pdf=|usr=007}} | ||
+ | {{tp|p=32384078|t=2020. Clinical findings of patients with coronavirus disease 2019 in Jiangsu province, China: A retrospective, multi-center study.|pdf=|usr=007}} | ||
+ | {{tp|p=32497090|t=2020. Maternal and neonatal outcomes associated with COVID-19 infection: A systematic review.|pdf=|usr=007}} | ||
+ | {{tp|p=32420710|t=2020. Clinical characteristics and short-term outcomes of patients with coronavirus disease 2019: a retrospective single-center experience of a designated hospital in Poland.|pdf=|usr=007}} | ||
+ | {{tp|p=32385979|t=2020. Diagnosis and recovery from severe acute respiratory syndrome coronavirus 2 infection is challenging in kidney patients: tests are an issue.|pdf=|usr=007}} | ||
+ | {{tp|p=32491298|t=2020. Gender differences in the frequency of gastrointestinal symptoms and olfactory or taste disorders among 1,942 non-hospitalized patients with COVID-19.|pdf=|usr=007}} | ||
+ | {{tp|p=32469263|t=2020. Nierensonomorphologie bei COVID-19 mit akuter Niereninsuffizienz.|pdf=|usr=007}} | ||
+ | {{tp|p=32458823|t=2020. Infeccion por coronavirus Covid-19 y lactancia materna: una revision exploratoria.|pdf=|usr=007}} | ||
+ | {{tp|p=32390132|t=2020. Trombosis venosa cerebral e infeccion por SARS-CoV-2.|pdf=|usr=007}} | ||
+ | {{tp|p=32491116|t=2020. A brief-review of the risk factors for covid-19 severity.|pdf=|usr=007}} | ||
+ | {{tp|p=32491091|t=2020. Adults at high-risk of severe coronavirus disease-2019 (Covid-19) in Brazil.|pdf=|usr=007}} | ||
+ | {{tp|p=32491053|t=2020. Diabetes and covid-19: more than the sum of two morbidities.|pdf=|usr=007}} | ||
+ | {{tp|p=32507709|t=2020. Sindrome de DRESS simulando enfermedad por coronavirus 2019-NcoV.|pdf=|usr=007}} | ||
+ | {{tp|p=32512263|t=2020. COVID-19 in rheumatic disease patients on immunosuppressive agents.|pdf=|usr=007}} | ||
+ | {{tp|p=32460453|t=2020. COVID-19 in Singapore - a case series from primary care.|pdf=|usr=007}} | ||
+ | {{tp|p=32466735|t=2020. Clinical Characteristics and Outcomes of COVID-19 Patients With a History of Stroke in Wuhan, China.|pdf=|usr=007}} | ||
+ | {{tp|p=32459857|t=2020. D-dimer and mortality in COVID-19: a self-fulfilling prophecy or a pathophysiological clue?|pdf=|usr=007}} | ||
+ | {{tp|p=32506344|t=2020. Acute intestinal ischemia in a patient with COVID-19.|pdf=|usr=007}} | ||
+ | {{tp|p=32463186|t=2020. Lungeembolisme ved covid-19.|pdf=|usr=007}} | ||
+ | {{tp|p=32460390|t=2020. Covid-19 in solid organ transplant recipients: A single center experience.|pdf=|usr=007}} | ||
+ | {{tp|p=32429038|t=2020. Prognosis of COVID-19 in Patients with Liver and Kidney Diseases: An Early Systematic Review and Meta-Analysis.|pdf=|usr=007}} | ||
+ | {{tp|p=32395790|t=2020. COVID-19 and Cardiovascular diseases. Scoping review study.|pdf=|usr=007}} | ||
+ | {{tp|p=32395788|t=2020. Features of patients with 2019 novel coronavirus admitted in a pneumology department: The first retrospective Tunisian case series.|pdf=|usr=007}} | ||
+ | {{tp|p=32395787|t=2020. First case of imported and confirmed COVID-19 in Tunisia.|pdf=|usr=007}} | ||
+ | {{tp|p=32394689|t=2020. COVID-19, Renin-angiotensin System and Hematopoiesis.|pdf=|usr=007}} | ||
+ | {{tp|p=32490641|t=2020. Characteristics of the initial patients hospitalized for COVID-19: a single-center report.|pdf=|usr=007}} | ||
+ | {{tp|p=32430957|t=2020. Effects of coronavirus disease 2019 (COVID-19) on maternal, perinatal and neonatal outcomes: a systematic review.|pdf=|usr=007}} | ||
+ | {{tp|p=32450787|t=2020. Liver injury in COVID-19: The current evidence.|pdf=|usr=007}} | ||
+ | {{tp|p=32450785|t=2020. COVID-19 and digestive health.|pdf=|usr=007}} | ||
+ | {{tp|p=32501145|t=2020. Venous thromboembolism in patients with COVID-19 (SARS-CoV-2 infection) - a position paper of the German Society of Angiology (DGA).|pdf=|usr=007}} | ||
+ | {{tp|p=32456286|t=2020. Antiviral Effects of Hydroxychloroquine and Type I Interferon on In Vitro Fatal Feline Coronavirus Infection.|pdf=|usr=007}} | ||
+ | {{tp|p=32403242|t=2020. Prognostic Value of Cardiovascular Biomarkers in COVID-19: A Review.|pdf=|usr=007}} | ||
+ | {{tp|p=32463395|t=2020. The involvement of the central nervous system in patients with COVID-19.|pdf=|usr=007}} | ||
+ | {{tp|p=32493200|t=2020. Prevention of COVID-19 infection in the medical population: a possible help from anosmia?.|pdf=|usr=007}} | ||
+ | {{tp|p=32386285|t=2020. Anosmia as a presenting symptom of SARS-CoV-2 infection in healthcare workers - A systematic review of the literature, case series, and recommendations for clinical assessment and management.|pdf=|usr=007}} | ||
+ | {{tp|p=32352450|t=2020. Sniffing out the evidence; It's now time for public health bodies recognize the link between COVID-19 and smell and taste disturbance.|pdf=|usr=007}} | ||
+ | {{tp|p=32396143|t=2020. Clinical and laboratory findings from patients with COVID-19 pneumonia in Babol North of Iran: a retrospective cohort study.|pdf=|usr=007}} | ||
+ | {{tp|p=32435811|t=2020. COVID-19 Infection May Cause Clozapine Intoxication: Case Report and Discussion.|pdf=|usr=007}} | ||
+ | {{tp|p=32355007|t=2020. The mystery of the pandemic's 'happy hypoxia'.|pdf=|usr=007}} | ||
+ | {{tp|p=32396963|t=2020. SARS-2 Coronavirus-Associated Hemostatic Lung Abnormality in COVID-19: Is It Pulmonary Thrombosis or Pulmonary Embolism?|pdf=|usr=007}} | ||
+ | {{tp|p=32512587|t=2020. Bleeding and Bleeding Risk in COVID-19.|pdf=|usr=007}} | ||
+ | {{tp|p=32512586|t=2020. Confronting COVID-19: Issues in Hemophilia and Congenital Bleeding Disorders.|pdf=|usr=007}} | ||
+ | {{tp|p=32447301|t=2020. Coexistent COVID-19 pneumonia and pulmonary embolism: challenges in identifying dual pathology.|pdf=|usr=007}} | ||
+ | {{tp|p=32455440|t=2020. Sars-CoV-2 Induced Coagulopathy and Prognosis in Hospitalized Patients: A Snapshot from Italy.|pdf=|usr=007}} | ||
+ | {{tp|p=32510876|t=2020. Differences in Clinical Characteristics of Covid-19 in Hispanic/Latino Population.|pdf=|usr=007}} | ||
+ | {{tp|p=32510771|t=2020. COVID-19 In Lung Transplant Recipients: A Case Series From Milan, Italy.|pdf=|usr=007}} | ||
+ | {{tp|p=32510756|t=2020. Hyponatremia: A Possible Immuno-Neuroendocrine Interface with COVID-19 in a Kidney Transplant Recipient.|pdf=|usr=007}} | ||
+ | {{tp|p=32500942|t=2020. Outcome of COVID-19 in liver transplant recipients: A preliminary report from Northwestern Italy.|pdf=|usr=007}} | ||
+ | {{tp|p=32500922|t=2020. Failed antibody response in a renal transplant recipient with SARS-CoV-2 infected.|pdf=|usr=007}} | ||
+ | {{tp|p=32500666|t=2020. Coronavirus Disease 2019 in an Orthotopic Liver Transplant Recipient Living with Human Immunodeficiency Virus.|pdf=|usr=007}} | ||
+ | {{tp|p=32492485|t=2020. Comparison of clinical and epidemiological characteristics of asymptomatic and symptomatic SARS-CoV-2 infection: A multi-center study in Sichuan Province, China.|pdf=|usr=007}} | ||
+ | {{tp|p=32400381|t=2020. [De forste kliniske data fra RASi-behandlede indlagte patienter med COVID-19 kommer nu, og vi skal ikke aendre medicinering].|pdf=|usr=007}} | ||
+ | {{tp|p=32400371|t=2020. [Anosmia and ageusia as primary symptoms of COVID-19].|pdf=|usr=007}} | ||
+ | {{tp|p=32286214|t=2020. [Possible unregistered SARS-CoV-2 infection in a young man with anosmia and ageusia].|pdf=|usr=007}} | ||
+ | {{tp|p=32462990|t=2020. COVID-19 complicated by pulmonary embolism treated with catheter directed thrombectomy.|pdf=|usr=007}} | ||
+ | {{tp|p=32314950|t=2020. Society for Vascular Medicine (SVM) Leaders Respond to the COVID-19 Crisis.|pdf=|usr=007}} | ||
+ | {{tp|p=32476394|t=2020. Otorinolaringologicheskie aspekty techeniya zabolevaniya u detei, infitsirovannykh virusom SARS-CoV-2.|pdf=|usr=007}} | ||
+ | {{tp|p=32223839|t=2020. [Epidemiology and clinical features of highly pathogenic human coronavirus infection in children].|pdf=|usr=007}} | ||
+ | {{tp|p=32065520|t=2020. [First case of neonate infected with novel coronavirus pneumonia in China].|pdf=|usr=007}} | ||
+ | {{tp|p=32294814|t=2020. [Recommendations for respiratory rehabilitation of coronavirus disease 2019 in adult].|pdf=|usr=007}} | ||
+ | {{tp|p=32447934|t=2020. [Clinical and coagulation characteristics in 7 patients with critical COVID-2019 pneumonia and acro-ischemia].|pdf=|usr=007}} | ||
+ | {{tp|p=32418377|t=2020. [Clinical analysis of kidney injury in patients with COVID-19].|pdf=|usr=007}} | ||
+ | {{tp|p=32496259|t=2020. COVID-19-Hospitalized Patients in Karnataka: Survival and Stay Characteristics.|pdf=|usr=007}} | ||
+ | {{tp|p=32393678|t=2020. COVID-19: Important Issues for Pediatricians.|pdf=|usr=007}} | ||
+ | {{tp|p=32412915|t=2020. Managing Children with Renal Diseases during COVID-19 Pandemic.|pdf=|usr=007}} | ||
+ | {{tp|p=32487797|t=2020. The seXY side of COVID-19: what is behind female protection?|pdf=|usr=007}} | ||
+ | {{tp|p=32487793|t=2020. Severe respiratory failure in an immunocompetent host with invasive pulmonary aspergillosis and H1N1 influenza.|pdf=|usr=007}} | ||
+ | {{tp|p=32487789|t=2020. Risk factors for mortality in patients with Coronavirus Disease 2019 (COVID-19) in Bolivia: An analysis of the first 107 confirmed cases.|pdf=|usr=007}} | ||
+ | {{tp|p=32468632|t=2020. Olfactory dysfunction in recovered COVID-19 patients.|pdf=|usr=007}} | ||
+ | {{tp|p=32449528|t=2020. Effects of COVID-19 on Parkinson's Disease Clinical Features: A Community-Based Case-Control Study.|pdf=|usr=007}} | ||
+ | {{tp|p=32470210|t=2020. Obesity is associated with worse outcomes in COVID-19: Analysis of Early Data From New York City.|pdf=|usr=007}} | ||
+ | {{tp|p=32463562|t=2020. Possible Role of Adipose Tissue and Endocannabinoid System in COVID-19 Pathogenesis: Can Rimonabant Return?|pdf=|usr=007}} | ||
+ | {{tp|p=32463545|t=2020. Obesity and COVID-19: an Italian snapshot.|pdf=|usr=007}} | ||
+ | {{tp|p=32445512|t=2020. Morbid Obesity as an Independent Risk Factor for COVID-19 Mortality in Hospitalized Patients Younger than 50.|pdf=|usr=007}} | ||
+ | {{tp|p=32445496|t=2020. Body Mass Index, Weight Discrimination, and Psychological, Behavioral, and Interpersonal Responses to the Coronavirus Pandemic.|pdf=|usr=007}} | ||
+ | {{tp|p=32428380|t=2020. Increased ACE2 Expression in the Bronchial Epithelium of COPD Patients who are Overweight.|pdf=|usr=007}} | ||
+ | {{tp|p=32505551|t=2020. Oral submucous fibrosis and COVID-19: Perspective on comorbidity.|pdf=|usr=007}} | ||
+ | {{tp|p=32507368|t=2020. SARS-COV-2 associated acute pancreatitis: Cause, consequence or epiphenomenon?|pdf=|usr=007}} | ||
+ | {{tp|p=32469426|t=2020. African American children are at higher risk of COVID-19 infection.|pdf=|usr=007}} | ||
+ | {{tp|p=32453902|t=2020. Chilblains-like lesions and COVID-19.|pdf=|usr=007}} | ||
+ | {{tp|p=32445583|t=2020. Erythema multiforme-like lesions in children and COVID-19.|pdf=|usr=007}} | ||
+ | {{tp|p=32437077|t=2020. Clinical characteristics of COVID-19 in children: Are they similar to those of SARS?|pdf=|usr=007}} | ||
+ | {{tp|p=32501190|t=2020. Angiotensin converting enzyme 2 (ACE2) and COVID-19: using antihypertensive medications, pharmacogenetic considerations.|pdf=|usr=007}} | ||
+ | {{tp|p=32461198|t=2020. COVID-19, hypertension and cardiovascular diseases: Should we change the therapy?|pdf=|usr=007}} | ||
+ | {{tp|p=32505834|t=2020. Would ACEIs/ARBs be beneficial for COVID-19 patients without hypertension?|pdf=|usr=007}} | ||
+ | {{tp|p=32512122|t=2020. Acute myocardial injury in patients hospitalized with COVID-19 infection: A review.|pdf=|usr=007}} | ||
+ | {{tp|p=32512352|t=2020. Affective psychosis after COVID-19 infection in a previously healthy patient: a case report.|pdf=|usr=007}} | ||
+ | {{tp|p=32454268|t=2020. D-dimer in patients infected with COVID-19 and suspected pulmonary embolism.|pdf=|usr=007}} | ||
+ | {{tp|p=32507399|t=2020. Tromboembolismo pulmonar y COVID-19: un cambio de paradigma.|pdf=|usr=007}} | ||
+ | {{tp|p=32463446|t=2020. Familial cluster of SARS-CoV-2 infection associated with a railway journey.|pdf=|usr=007}} | ||
+ | {{tp|p=32250460|t=2020. Impact of the COVID-19 Pandemic on Parkinson's Disease and Movement Disorders.|pdf=|usr=007}} | ||
+ | {{tp|p=32502296|t=2020. SARS-CoV2 as a potential trigger of neurodegenerative diseases.|pdf=|usr=007}} | ||
+ | {{tp|p=32502289|t=2020. SARS-CoV-2 as a trigger of neurodegeneration: thinking ahead.|pdf=|usr=007}} | ||
+ | {{tp|p=32484584|t=2020. COVID-19 in Parkinson's Disease Patients Living in Lombardy, Italy.|pdf=|usr=007}} | ||
+ | {{tp|p=32479103|t=2020. Special report: Prevalence of selected underlying health conditions among active component Army service members with coronavirus disease 2019, 11 February-6 April 2020.|pdf=|usr=007}} | ||
+ | {{tp|p=32467603|t=2020. Resistance of children to Covid-19. How?|pdf=|usr=007}} | ||
+ | {{tp|p=32463329|t=2020. Alemtuzumab in multiple sclerosis during the COVID-19 pandemic: A mild uncomplicated infection despite intense immunosuppression.|pdf=|usr=007}} | ||
+ | {{tp|p=32391998|t=2020. De eerste 29 COVID-19-patienten in de kliniek.|pdf=|usr=007}} | ||
+ | {{tp|p=32391997|t=2020. De eerste honderd opgenomen COVID-19-patienten in het Elisabeth-Tweesteden Ziekenhuis.|pdf=|usr=007}} | ||
+ | {{tp|p=32395964|t=2020. Do's-and-don'ts bij COVID-19-coagulopathie.|pdf=|usr=007}} | ||
+ | {{tp|p=32498065|t=2020. Neonates Hospitalized with Community-Acquired SARS-CoV-2 in a Colorado Neonatal Intensive Care Unit.|pdf=|usr=007}} | ||
+ | {{tp|p=32468450|t=2020. New clinical manifestation of COVID-19 related Guillain-Barre syndrome highly responsive to intravenous immunoglobulins: two Italian cases.|pdf=|usr=007}} | ||
+ | {{tp|p=32444493|t=2020. Clinical characteristics and outcomes of inpatients with neurologic disease and COVID-19 in Brescia, Lombardy, Italy.|pdf=|usr=007}} | ||
+ | {{tp|p=32444492|t=2020. Bilateral transient olfactory bulbs edema during COVID-19-related anosmia.|pdf=|usr=007}} | ||
+ | {{tp|p=32439822|t=2020. Pearls and Oy-sters: Facial nerve palsy as a neurological manifestation of Covid-19 infection.|pdf=|usr=007}} | ||
+ | {{tp|p=32439821|t=2020. Generalized myoclonus in COVID-19.|pdf=|usr=007}} | ||
+ | {{tp|p=32487714|t=2020. Cranial Neuropathies and COVID-19: Neurotropism and Autoimmunity.|pdf=|usr=007}} | ||
+ | {{tp|p=32482845|t=2020. Neurologic manifestations in hospitalized patients with COVID-19: The ALBACOVID registry.|pdf=|usr=007}} | ||
+ | {{tp|p=32424429|t=2020. Neurologically Devastating Intraparenchymal Hemorrhage in COVID-19 Patients on Extracorporeal Membrane Oxygenation: A Case Series.|pdf=|usr=007}} | ||
+ | {{tp|p=32496534|t=2020. Letter: Thrombotic Neurovascular Disease in COVID-19 Patients.|pdf=|usr=007}} | ||
+ | {{tp|p=32490520|t=2020. Letter: Hemorrhagic Conditions Affecting the Central Nervous System in COVID-19 Patients.|pdf=|usr=007}} | ||
+ | {{tp|p=32237206|t=2020. Obesity and its Implications for COVID-19 Mortality.|pdf=|usr=007}} | ||
+ | {{tp|p=32384387|t=2020. A Postpartum Death Due to Coronavirus Disease 2019 (COVID-19) in the United States.|pdf=|usr=007}} | ||
+ | {{tp|p=32384385|t=2020. Acute Respiratory Distress Syndrome in a Preterm Pregnant Patient With Coronavirus Disease 2019 (COVID-19).|pdf=|usr=007}} | ||
+ | {{tp|p=32459701|t=2020. Symptoms and Critical Illness Among Obstetric Patients With Coronavirus Disease 2019 (COVID-19) Infection.|pdf=|usr=007}} | ||
+ | {{tp|p=32433453|t=2020. Clinical Findings and Disease Severity in Hospitalized Pregnant Women With Coronavirus Disease 2019 (COVID-19).|pdf=|usr=007}} | ||
+ | {{tp|p=32433451|t=2020. Lymphopenia and Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection Among Hospitalized Obstetric Patients.|pdf=|usr=007}} | ||
+ | {{tp|p=32496337|t=2020. Prevalence and Severity of Coronavirus Disease 2019 (COVID-19) Illness in Symptomatic Pregnant and Postpartum Women Stratified by Hispanic Ethnicity.|pdf=|usr=007}} | ||
+ | {{tp|p=32510821|t=2020. Oral cavity lesions as a manifestation of the novel virus (COVID-19): a letter-to-editor.|pdf=|usr=007}} | ||
+ | {{tp|p=32506730|t=2020. Oral Manifestations in Coronavirus Disease 2019 (COVID-19).|pdf=|usr=007}} | ||
+ | {{tp|p=32506662|t=2020. Necrotizing periodontal disease: oral manifestation of COVID-19.|pdf=|usr=007}} | ||
+ | {{tp|p=32419568|t=2020. Orbital cellulitis, sinusitis and intracranial abnormalities in two adolescents with COVID-19.|pdf=|usr=007}} | ||
+ | {{tp|p=32453702|t=2020. Procoagulatio, hypercoagulatio es fibrinolysis "shut down" kimutatasa ClotPro(R) viszkoelasztikus tesztek segitsegevel COVID-19-betegekben.|pdf=|usr=007}} | ||
+ | {{tp|p=32423359|t=2020. Subjective Changes in Smell and Taste During the COVID-19 Pandemic: A National Survey-Preliminary Results.|pdf=|usr=007}} | ||
+ | {{tp|p=32423285|t=2020. Aggregate Prevalence of Chemosensory and Sinonasal Dysfunction in SARS-CoV-2 and Related Coronaviruses.|pdf=|usr=007}} | ||
+ | {{tp|p=32482123|t=2020. SARS-CoV-2 Infection in Health Care Workers: Cross-sectional Analysis of an Otolaryngology Unit.|pdf=|usr=007}} | ||
+ | {{tp|p=32501861|t=2020. Considering the potential for an increase in chronic pain following the COVID-19 pandemic.|pdf=|usr=007}} | ||
+ | {{tp|p=32413201|t=2020. Symptoms and immunoglobulin development in hospital staff exposed to a SARS-CoV-2 outbreak.|pdf=|usr=007}} | ||
+ | {{tp|p=32495391|t=2020. COVID-19 presenting with autoimmune hemolytic anemia in the setting of underlying immune dysregulation.|pdf=|usr=007}} | ||
+ | {{tp|p=32467457|t=2020. Severe SARS-CoV-2 Infection in Children With Suspected Acute Abdomen: A Case Series From a Tertiary Hospital in Spain.|pdf=|usr=007}} | ||
+ | {{tp|p=32467452|t=2020. ORCHIEPIDIDYMITIS IN A BOY WITH COVID-19.|pdf=|usr=007}} | ||
+ | {{tp|p=32404789|t=2020. Neonatal Early-Onset Infection With SARS-CoV-2 in a Newborn Presenting With Encephalitic Symptoms.|pdf=|usr=007}} | ||
+ | {{tp|p=32404786|t=2020. Clinical Analysis of 25 Novel Coronavirus Infections in Children.|pdf=|usr=007}} | ||
+ | {{tp|p=32502128|t=2020. COVID-19-Associated Myocarditis in an Adolescent.|pdf=|usr=007}} | ||
+ | {{tp|p=32398569|t=2020. COVID-19 in Children, Pregnancy and Neonates: A Review of Epidemiologic and Clinical Features.|pdf=|usr=007}} | ||
+ | {{tp|p=32433226|t=2020. The Role of Human Coronavirus Infection in Pediatric Acute Gastroenteritis.|pdf=|usr=007}} | ||
+ | {{tp|p=32433225|t=2020. Acute Inflammation and Elevated Cardiac Markers in a Two-Month-Old Infant with Severe Acute Respiratory Syndrome Coronavirus 2 Infection Presenting with Cardiac Symptoms.|pdf=|usr=007}} | ||
+ | {{tp|p=32427645|t=2020. Pediatric Life-Threatening Coronavirus Disease 2019 With Myocarditis.|pdf=|usr=007}} | ||
+ | {{tp|p=32404791|t=2020. COVID-19 in the Pediatric Population Admitted to a Tertiary Referral Hospital in Northern Italy: Preliminary Clinical Data.|pdf=|usr=007}} | ||
+ | {{tp|p=32404780|t=2020. First Case of Coronavirus Disease 2019 in Childhood Leukemia in China.|pdf=|usr=007}} | ||
+ | {{tp|p=32384398|t=2020. COVID-19 in Neonates and Infants: Progression and Recovery.|pdf=|usr=007}} | ||
+ | {{tp|p=32384397|t=2020. Children Hospitalized With Severe COVID-19 in Wuhan.|pdf=|usr=007}} | ||
+ | {{tp|p=32384396|t=2020. Hematuria Associated With SARS-CoV-2 Infection in a Child.|pdf=|usr=007}} | ||
+ | {{tp|p=32492251|t=2020. Clinical manifestations of children with COVID-19: A systematic review.|pdf=|usr=007}} | ||
+ | {{tp|p=32483934|t=2020. Overview: The history and pediatric perspectives of severe acute respiratory syndromes: Novel or just like SARS.|pdf=|usr=007}} | ||
+ | {{tp|p=32392382|t=2020. COVID-19: A message of hope from a young girl with severe cystic fibrosis.|pdf=|usr=007}} | ||
+ | {{tp|p=32439817|t=2020. Immune Thrombocytopenia (ITP) in a SARS-CoV-2 Positive Pediatric Patient.|pdf=|usr=007}} | ||
+ | {{tp|p=32409480|t=2020. Caring for Newborns Born to Mothers with COVID-19: More Questions than Answers.|pdf=|usr=007}} | ||
+ | {{tp|p=32404431|t=2020. A Case Series of the 2019 Novel Coronavirus (SARS-CoV-2) in Three Febrile Infants in New York.|pdf=|usr=007}} | ||
+ | {{tp|p=32380898|t=2020. The "venous perspective" in Lombardia (Italy) during the first weeks of the COVID-19 epidemic.|pdf=|usr=007}} | ||
+ | {{tp|p=32419564|t=2020. Consideration of prevention and management of long-term consequences of post-acute respiratory distress syndrome in patients with COVID-19.|pdf=|usr=007}} | ||
+ | {{tp|p=32449876|t=2020. COVID-19: an unprecedented pandemia with a potential arrhythmic undertone.|pdf=|usr=007}} | ||
+ | {{tp|p=32434874|t=2020. Elevated N-terminal pro-brain natriuretic peptide is associated with increased mortality in patients with COVID-19: systematic review and meta-analysis.|pdf=|usr=007}} | ||
+ | {{tp|p=32338566|t=2020. Experiences and Insights from the Early US COVID-19 Epicenter: A Rapid Assessment Procedure Informed Clinical Ethnography Case Series.|pdf=|usr=007}} | ||
+ | {{tp|p=32286091|t=2020. Mental health burden for the public affected by the COVID-19 outbreak in China: Who will be the high-risk group?|pdf=|usr=007}} | ||
+ | {{tp|p=32442308|t=2020. The Clinical Features and Outcomes of Discharged Coronavirus Disease 2019 PatientsA Prospective Cohort Study.|pdf=|usr=007}} | ||
+ | {{tp|p=32442268|t=2020. Stroke in a young COVID -19 patient.|pdf=|usr=007}} | ||
+ | {{tp|p=32437314|t=2020. COVID-19 -associated Diffuse Leukoencephalopathy and Microhemorrhages.|pdf=|usr=007}} | ||
+ | {{tp|p=32437313|t=2020. Imaging in Neurological Disease of Hospitalized COVID-19 Patients: An Italian Multicenter Retrospective Observational Study.|pdf=|usr=007}} | ||
+ | {{tp|p=32407258|t=2020. COVID-19-Associated Leukoencephalopathy.|pdf=|usr=007}} | ||
+ | {{tp|p=32391742|t=2020. Abdominal Imaging Findings in COVID-19: Preliminary Observations.|pdf=|usr=007}} | ||
+ | {{tp|p=32484418|t=2020. Focal Cerebral Arteriopathy in a COVID-19 Pediatric Patient.|pdf=|usr=007}} | ||
+ | {{tp|p=32374550|t=2020. Covid-19: la troublante decouverte des possibles vertus de la nicotine.|pdf=|usr=007}} | ||
+ | {{tp|p=32374540|t=2020. Prise en charge de l'asthme et de la BPCO en situation de pandemie de COVID-19.|pdf=|usr=007}} | ||
+ | {{tp|p=32374539|t=2020. Pandemie de COVID-19 : aspects cardiologiques.|pdf=|usr=007}} | ||
+ | {{tp|p=32462846|t=2020. COVID-19: differences de symptomatologie entre la Chine et l'Europe.|pdf=|usr=007}} | ||
+ | {{tp|p=32462841|t=2020. Obesite et risque de COVID-19 severe.|pdf=|usr=007}} | ||
+ | {{tp|p=32432429|t=2020. COVID-19: elements de connaissances concernant les enfants.|pdf=|usr=007}} | ||
+ | {{tp|p=32401442|t=2020. Les bloqueurs du systeme renine-angiotensine-aldosterone en temps de pandemie Covid-19 : amis ou ennemis ?|pdf=|usr=007}} | ||
+ | {{tp|p=32496707|t=2020. La rehabilitation: indispensable pour les survivants d'un COVID-19 severe.|pdf=|usr=007}} | ||
+ | {{tp|p=32348058|t=2020. Les complications cardiaques de la maladie COVID-19 sont-elles associees a une mortalite plus elevee ?|pdf=|usr=007}} | ||
+ | {{tp|p=32348051|t=2020. Anosmie et COVID-19.|pdf=|usr=007}} | ||
+ | {{tp|p=32348050|t=2020. Prise en charge des patients avec maladies digestives et hepatiques durant la pandemie COVID-19.|pdf=|usr=007}} | ||
+ | {{tp|p=32348048|t=2020. COVID-19 : impact pediatrique.|pdf=|usr=007}} | ||
+ | {{tp|p=32490966|t=2020. Neurological complications in patients with SARS-CoV-2 infection: a systematic review.|pdf=|usr=007}} | ||
+ | {{tp|p=32469246|t=2020. Psychophysical Olfactory Tests and Detection of COVID-19 in Patients With Sudden Onset Olfactory Dysfunction: A Prospective Study.|pdf=|usr=007}} | ||
+ | {{tp|p=32436441|t=2020. Anosmia Is a Key Symptom of COVID-19 Infection and Should Be Used as a Diagnostic Tool.|pdf=|usr=007}} | ||
+ | {{tp|p=32490886|t=2020. Is there a rationale for heparin use among severe COVID-19 patients?|pdf=|usr=007}} | ||
+ | {{tp|p=32453917|t=2020. SARS-CoV-2, bacterial co-infections, and AMR: the deadly trio in COVID-19?|pdf=|usr=007}} | ||
+ | {{tp|p=32453685|t=2020. Acute Cerebral Stroke with Multiple Infarctions and COVID-19, France, 2020.|pdf=|usr=007}} | ||
+ | {{tp|p=32441243|t=2020. Clostridioides difficile in COVID-19 Patients, Detroit, Michigan, USA, March-April 2020.|pdf=|usr=007}} | ||
+ | {{tp|p=32487282|t=2020. Encephalopathy and Encephalitis Associated with Cerebrospinal Fluid Cytokine Alterations and Coronavirus Disease, Atlanta, Georgia, USA, 2020.|pdf=|usr=007}} | ||
+ | {{tp|p=32458742|t=2020. Nurse infected with Covid-19 from a provisional dengue patient.|pdf=|usr=007}} | ||
+ | {{tp|p=32395943|t=2020. Pericarditis aguda secundaria a COVID-19.|pdf=|usr=007}} | ||
+ | {{tp|p=32392566|t=2020. The Hidden Face of Fear in the COVID-19 Era: The Amygdala Hijack.|pdf=|usr=007}} | ||
+ | {{tp|p=32467096|t=2020. Clinicopathological characteristics of 8697 patients with COVID-19 in China: meta-analysis.|pdf=|usr=007}} | ||
+ | {{tp|p=32429041|t=2020. COVID-19 and Gastrointestinal Symptoms-A Case Report.|pdf=|usr=007}} | ||
+ | {{tp|p=32474561|t=2020. Clinical Characteristics of Elderly Patients with COVID-19 in Hunan Province, China: A Multicenter, Retrospective Study.|pdf=|usr=007}} | ||
+ | {{tp|p=32482915|t=2020. Expression of Receptors for SARS-CoV-2 in the Gut of Patients with Inflammatory Bowel Disease.|pdf=|usr=007}} | ||
+ | {{tp|p=32436996|t=2020. The value of clinical parameters in predicting the severity of COVID-19.|pdf=|usr=007}} | ||
+ | {{tp|p=32427361|t=2020. Four cases: Human immunodeficiency virus and novel coronavirus 2019 Co-infection in patients from Long Island, New York.|pdf=|usr=007}} | ||
+ | {{tp|p=32427357|t=2020. Encephalopathy in patients with COVID-19: 'Causality or coincidence?'|pdf=|usr=007}} | ||
+ | {{tp|p=32418237|t=2020. Hypoxemia in COVID-19; Comment on: "The neuroinvasive potential of SARS - CoV2 may play a role in the respiratory failure of COVID-19 patients".|pdf=|usr=007}} | ||
+ | {{tp|p=32418216|t=2020. Children with coronavirus disease 2019: A review of demographic, clinical, laboratory, and imaging features in pediatric patients.|pdf=|usr=007}} | ||
+ | {{tp|p=32503883|t=2020. Defining causality in COVID-19 and neurological disorders.|pdf=|usr=007}} | ||
+ | {{tp|p=32507577|t=2020. COVID-19 and Cerebral Hemorrhage: Proposed Mechanisms.|pdf=|usr=007}} | ||
+ | {{tp|p=32510106|t=2020. Clinical Presentation of COVID19 in Dementia Patients.|pdf=|usr=007}} | ||
+ | {{tp|p=32418199|t=2020. Angiotensin-converting enzyme 2 (ACE2), SARS-CoV-2 and the pathophysiology of coronavirus disease 2019 (COVID-19).|pdf=|usr=007}} | ||
+ | {{tp|p=32470213|t=2020. All those D-dimers in COVID-19.|pdf=|usr=007}} | ||
+ | {{tp|p=32470207|t=2020. Frequency of lupus anticoagulant in Covid-19 patients.|pdf=|usr=007}} | ||
+ | {{tp|p=32470198|t=2020. Clinical differentiation of anticoagulant and non-anticoagulant properties of heparin.|pdf=|usr=007}} | ||
+ | {{tp|p=32470154|t=2020. Reply to 'Ibuprofen and thromboembolism in SARS-COV2'.|pdf=|usr=007}} | ||
+ | {{tp|p=32464707|t=2020. Macrothrombosis and stroke in patients with mild Covid-19 infection.|pdf=|usr=007}} | ||
+ | {{tp|p=32459046|t=2020. Scientific and Standardization Committee Communication: Clinical Guidance on the Diagnosis, Prevention and Treatment of Venous Thromboembolism in Hospitalized Patients with COVID-19.|pdf=|usr=007}} | ||
+ | {{tp|p=32426897|t=2020. Heparin - an old drug with multiple potential targets in Covid-19 therapy.|pdf=|usr=007}} | ||
+ | {{tp|p=32415902|t=2020. Ibuprofen and thromboembolism in SARS-COV2.|pdf=|usr=007}} | ||
+ | {{tp|p=32506364|t=2020. Hyperacute multi-organ thromboembolic storm in COVID-19: a case report.|pdf=|usr=007}} | ||
+ | {{tp|p=32504449|t=2020. Diagnosis of venous and arterial thromboembolic events in COVID-19 virus-infected patients.|pdf=|usr=007}} | ||
+ | {{tp|p=32492092|t=2020. Epidemiology, Clinical Features, and Disease Severity in Patients With Coronavirus Disease 2019 (COVID-19) in a Children's Hospital in New York City, New York.|pdf=|usr=007}} | ||
+ | {{tp|p=32505466|t=2020. Cyclosporine as preferred calcineurin inhibitor in renal allograft recipients with COVID-19 infection.|pdf=|usr=007}} | ||
+ | {{tp|p=32505222|t=2020. Early evidence of pronounced brain involvement in fatal COVID-19 outcomes.|pdf=|usr=007}} | ||
+ | {{tp|p=32436600|t=2020. SARS-CoV-2 as an extrahepatic precipitator of acute-on-chronic liver failure.|pdf=|usr=007}} | ||
+ | {{tp|p=32505846|t=2020. The use of ibuprofen to treat fever in COVID-19: A possible indirect association with worse outcome?|pdf=|usr=007}} | ||
+ | {{tp|p=32512494|t=2020. Could nutritional and functional status serve as prognostic factors for COVID-19 in the elderly?|pdf=|usr=007}} | ||
+ | {{tp|p=32441063|t=2020. Coronavirus disease 2019 (COVID-19): angiotensin-converting enzyme inhibitors, angiotensin II receptor blockers and cardiovascular disease.|pdf=|usr=007}} | ||
+ | {{tp|p=32507110|t=2020. Pattern of liver injury in adult patients with COVID-19: a retrospective analysis of 105 patients.|pdf=|usr=007}} | ||
+ | {{tp|p=32472989|t=2020. Relationship between ACE-inhibitors, ARBs and SARS-CoV-2 infection: where are we?|pdf=|usr=007}} | ||
+ | {{tp|p=32508078|t=2020. SARS-CoV-2 infection in pregnant women: are there long-term effects in offspring's brain development?|pdf=|usr=007}} | ||
+ | {{tp|p=32480326|t=2020. Are type 1 interferons treatment in Multiple Sclerosis as a potential therapy against COVID-19?|pdf=|usr=007}} | ||
+ | {{tp|p=32480327|t=2020. Benign course of COVID-19 in a multiple sclerosis patient treated with Ocrelizumab.|pdf=|usr=007}} | ||
+ | {{tp|p=32460086|t=2020. B-cell depleting therapies may affect susceptibility to acute respiratory illness among patients with multiple sclerosis during the early COVID-19 epidemic in Iran.|pdf=|usr=007}} | ||
+ | {{tp|p=32445201|t=2020. SARS-CoV-2-associated Guillain-Barre syndrome with dysautonomia.|pdf=|usr=007}} | ||
+ | {{tp|p=32510173|t=2020. Clinical characteristics and outcomes of COVID-19 patients with gastrointestinal symptoms admitted to Jianghan Fangcang Shelter Hospital in Wuhan, China.|pdf=|usr=007}} | ||
+ | {{tp|p=32497344|t=2020. COVID-19 presenting with immune thrombocytopenia: a case report and review of the literature.|pdf=|usr=007}} | ||
+ | {{tp|p=32497334|t=2020. A missing link between SARS-CoV-2 and the eye?: ACE2 expression on the ocular surface.|pdf=|usr=007}} | ||
+ | {{tp|p=32497298|t=2020. Pancreatic injury in the course of coronavirus disease 2019 (COVID-19): a not-so-rare occurrence.|pdf=|usr=007}} | ||
+ | {{tp|p=32497297|t=2020. Gendered effects on inflammation reaction and outcome of COVID-19 patients in Wuhan.|pdf=|usr=007}} | ||
+ | {{tp|p=32497290|t=2020. Epidemiological evidence for association between higher influenza vaccine uptake in the elderly and lower COVID-19 deaths in Italy.|pdf=|usr=007}} | ||
+ | {{tp|p=32497288|t=2020. COVID-19 polyradiculitis in 24 patients without SARS-CoV-2 in the cerebro-spinal fluid.|pdf=|usr=007}} | ||
+ | {{tp|p=32508329|t=2020. COVID-19 in Refractory Myasthenia Gravis- A Case Report of Successful Outcome.|pdf=|usr=007}} | ||
+ | {{tp|p=32500549|t=2020. Clinical update on COVID-19 in pregnancy: A review article.|pdf=|usr=007}} | ||
+ | {{tp|p=32423324|t=2020. Clinical course of COVID-19 infection in elderly patient with melanoma on nivolumab.|pdf=|usr=007}} | ||
+ | {{tp|p=32427809|t=2020. Inflammatory and Coagulative Considerations for the Management of Orthopaedic Trauma Patients with COVID-19: A Review of the Current Evidence and Our Surgical Experience.|pdf=|usr=007}} | ||
+ | {{tp|p=32390643|t=2020. COVID-19 and Parkinson's Disease: Are We Dealing with Short-term Impacts or Something Worse?|pdf=|usr=007}} | ||
+ | {{tp|p=32441753|t=2020. Clinical and Epidemiological Features of a Family Cluster of Symptomatic and Asymptomatic SARS-CoV-2 Infection.|pdf=|usr=007}} | ||
+ | {{tp|p=32441743|t=2020. A Case Report of Neonatal Acute Respiratory Failure Due to SARS-CoV-2.|pdf=|usr=007}} | ||
+ | {{tp|p=32504532|t=2020. Coronavirus Disease 2019 in Children Cared for at Texas Children's Hospital: Initial Clinical Characteristics and Outcomes.|pdf=|usr=007}} | ||
+ | {{tp|p=32479632|t=2020. Characteristics of Hospitalized Pediatric COVID-19 Cases - Chicago, Illinois, March - April 2020.|pdf=|usr=007}} | ||
+ | {{tp|p=32401228|t=2020. Are Covid-19-positive mothers dangerous for their term and well newborn babies? Is there an answer?|pdf=|usr=007}} | ||
+ | {{tp|p=32404798|t=2020. Long-term Pulmonary Consequences of Coronavirus Disease 2019 (COVID-19): What We Know and What to Expect.|pdf=|usr=007}} | ||
+ | {{tp|p=32495985|t=2020. The association between D-dimers in COVID-19 patients and mortality remains beset of uncertainties.|pdf=|usr=007}} | ||
+ | {{tp|p=32348627|t=2020. Hereditary Haemorrhagic Telangiectasia: a disease not to be forgotten during the COVID-19 pandemic.|pdf=|usr=007}} | ||
+ | {{tp|p=32432682|t=2020. Olfactory Dysfunction in COVID-19: Diagnosis and Management.|pdf=|usr=007}} | ||
+ | {{tp|p=32432681|t=2020. Nasal ACE2 Levels and COVID-19 in Children.|pdf=|usr=007}} | ||
+ | {{tp|p=32391864|t=2020. COVID-19 and Racial/Ethnic Disparities.|pdf=|usr=007}} | ||
+ | {{tp|p=32215579|t=2020. Can SARS-CoV-2 Infection Be Acquired In Utero?: More Definitive Evidence Is Needed.|pdf=|usr=007}} | ||
+ | {{tp|p=32511673|t=2020. Association Between Mode of Delivery Among Pregnant Women With COVID-19 and Maternal and Neonatal Outcomes in Spain.|pdf=|usr=007}} | ||
+ | {{tp|p=32250408|t=2020. Critical Illness in Patients With COVID-19: Mounting an Effective Clinical and Research Response.|pdf=|usr=007}} | ||
+ | {{tp|p=32293639|t=2020. COVID-19 and African Americans.|pdf=|usr=007}} | ||
+ | {{tp|p=32469387|t=2020. Neuropathogenesis and Neurologic Manifestations of the Coronaviruses in the Age of Coronavirus Disease 2019: A Review.|pdf=|usr=007}} | ||
+ | {{tp|p=32401283|t=2020. Low-Income Children and Coronavirus Disease 2019 (COVID-19) in the US.|pdf=|usr=007}} | ||
+ | {{tp|p=32392288|t=2020. Characteristics and Outcomes of Children With Coronavirus Disease 2019 (COVID-19) Infection Admitted to US and Canadian Pediatric Intensive Care Units.|pdf=|usr=007}} | ||
+ | {{tp|p=32511066|t=2020. Effect of Cancer on Clinical Outcomes of Patients With COVID-19: A Meta-Analysis of Patient Data.|pdf=|usr=007}} | ||
+ | {{tp|p=32369410|t=2020. Management of Febrile Neutropenia Associated With SARS-CoV-2 Infection in a Patient With Cancer.|pdf=|usr=007}} | ||
+ | {{tp|p=32394850|t=2020. [Role of age, comorbidity and renin- angiotensin-aldosterone system in COVID-19. Effects of ACE inhibitors and angiotensin receptor blockers].|pdf=|usr=007}} | ||
+ | {{tp|p=32392591|t=2020. SARS CoV-2 und Influenza A-Ko-Infektion bei einem padiatrischen Patienten in Deutschland.|pdf=|usr=007}} | ||
+ | {{tp|p=32471013|t=2020. Low prevalence and disease severity of COVID-19 in post liver transplant recipients - a single centre experience.|pdf=|usr=007}} | ||
+ | {{tp|p=32495496|t=2020. Abnormal liver tests in patients hospitalized with Coronavirus disease 2019: should we worry?|pdf=|usr=007}} | ||
+ | {{tp|p=32502316|t=2020. COVID-19 Infection in Early Post-Operative Period after Liver Transplantation.|pdf=|usr=007}} | ||
+ | {{tp|p=32485314|t=2020. Persistent SARS-CoV-2 infection and the risk for cancer.|pdf=|usr=007}} | ||
+ | {{tp|p=32512287|t=2020. Evaluation of COVID-19 infection in patients with Neuromyelitis optica spectrum disorder (NMOSD): A report from Iran.|pdf=|usr=007}} | ||
+ | {{tp|p=32497292|t=2020. Guillain-Barre Syndrome in a Patient with Minimal Symptoms of COVID-19 Infection.|pdf=|usr=007}} | ||
+ | {{tp|p=32320565|t=2020. First Case of Covid-19 in the United States. Reply.|pdf=|usr=007}} | ||
+ | {{tp|p=32320563|t=2020. First Case of Covid-19 in the United States.|pdf=|usr=007}} | ||
+ | {{tp|p=32320562|t=2020. First Case of Covid-19 in the United States.|pdf=|usr=007}} | ||
+ | {{tp|p=32320561|t=2020. First Case of Covid-19 in the United States.|pdf=|usr=007}} | ||
+ | {{tp|p=32320560|t=2020. First Case of Covid-19 in the United States.|pdf=|usr=007}} | ||
+ | {{tp|p=32320559|t=2020. First Case of Covid-19 in the United States.|pdf=|usr=007}} | ||
+ | {{tp|p=32220206|t=2020. Clinical Characteristics of Covid-19 in China. Reply.|pdf=|usr=007}} | ||
+ | {{tp|p=32220205|t=2020. Clinical Characteristics of Covid-19 in China.|pdf=|usr=007}} | ||
+ | {{tp|p=32220204|t=2020. Clinical Characteristics of Covid-19 in China.|pdf=|usr=007}} | ||
+ | {{tp|p=32220203|t=2020. Clinical Characteristics of Covid-19 in China.|pdf=|usr=007}} | ||
+ | {{tp|p=32220202|t=2020. Clinical Characteristics of Covid-19 in China.|pdf=|usr=007}} | ||
+ | {{tp|p=32402156|t=2020. Case 17-2020: A 68-Year-Old Man with Covid-19 and Acute Kidney Injury.|pdf=|usr=007}} | ||
+ | {{tp|p=32453517|t=2020. More on Neurologic Features in Severe SARS-CoV-2 Infection. Reply.|pdf=|usr=007}} | ||
+ | {{tp|p=32453516|t=2020. More on Neurologic Features in Severe SARS-CoV-2 Infection.|pdf=|usr=007}} | ||
+ | {{tp|p=32453515|t=2020. More on Neurologic Features in Severe SARS-CoV-2 Infection.|pdf=|usr=007}} | ||
+ | {{tp|p=32427431|t=2020. Renin-Angiotensin-Aldosterone System Inhibitors in Covid-19. Reply.|pdf=|usr=007}} | ||
+ | {{tp|p=32427430|t=2020. Renin-Angiotensin-Aldosterone System Inhibitors in Covid-19.|pdf=|usr=007}} | ||
+ | {{tp|p=32427429|t=2020. Renin-Angiotensin-Aldosterone System Inhibitors in Covid-19.|pdf=|usr=007}} | ||
+ | {{tp|p=32427428|t=2020. Renin-Angiotensin-Aldosterone System Inhibitors in Covid-19.|pdf=|usr=007}} | ||
+ | {{tp|p=32329974|t=2020. Mild or Moderate Covid-19.|pdf=|usr=007}} | ||
+ | {{tp|p=32427903|t=2020. How to address the coronavirus's outsized toll on people of colour.|pdf=|usr=007}} | ||
+ | {{tp|p=32393875|t=2020. Coronavirus blood-clot mystery intensifies.|pdf=|usr=007}} | ||
+ | {{tp|p=32265541|t=2020. Why measles deaths are surging - and coronavirus could make it worse.|pdf=|usr=007}} | ||
+ | {{tp|p=32395965|t=2020. Een man met dyspneu na een COVID-19-pneumonie.|pdf=|usr=007}} | ||
+ | {{tp|p=32503617|t=2020. Clinical characteristics of invasive pulmonary aspergillosis in patients with COVID-19 in Zhejiang, China: a retrospective case series.|pdf=|usr=007}} | ||
+ | {{tp|p=32403153|t=2020. COVID-19-assoziierte Pneumonie trotz persistierend negativen PCR-Tests aus oropharyngealen Abstrichen.|pdf=|usr=007}} | ||
+ | {{tp|p=32449179|t=2020. Mortality in Older Patients with COVID-19.|pdf=|usr=007}} | ||
+ | {{tp|p=32441771|t=2020. COVID-SAFER: Deprescribing Guidance for Hydroxychloroquine Drug Interactions in Older Adults.|pdf=|usr=007}} | ||
+ | {{tp|p=32445276|t=2020. Prosthetic aortic valve endocarditis complicated by COVID-19 and hemorrhage.|pdf=|usr=007}} | ||
+ | {{tp|p=32452050|t=2020. The outlook for diagnostic purposes of the 2019-novel coronavirus disease.|pdf=|usr=007}} | ||
+ | {{tp|p=32459882|t=2020. Comment on "Is the type of diabetes treatment relevant to outcome of COVID-19?"|pdf=|usr=007}} | ||
+ | {{tp|p=32455499|t=2020. Late onset of acral necrosis after SARS-CoV-2 infection resolution.|pdf=|usr=007}} | ||
+ | {{tp|p=32455485|t=2020. The COVID-19 outbreak in dermatologic surgery: resetting clinical priorities.|pdf=|usr=007}} | ||
+ | {{tp|p=32455475|t=2020. COVID-19 in a melanoma patient under treatment with checkpoint-inhibition.|pdf=|usr=007}} | ||
+ | {{tp|p=32453865|t=2020. Cutaneous small-vessel vasculitis associated with novel 2019 coronavirus SARS-CoV-2 infection (COVID-19).|pdf=|usr=007}} | ||
+ | {{tp|p=32452545|t=2020. Are chilblain-like acral skin lesions really indicative of COVID-19? A prospective study and literature review.|pdf=|usr=007}} | ||
+ | {{tp|p=32452542|t=2020. COVID-19 Presenting with Atypical Sweet's Syndrome.|pdf=|usr=007}} | ||
+ | {{tp|p=32441876|t=2020. Cutaneous small vessel vasculitis secondary to COVID-19 infection: A case report.|pdf=|usr=007}} | ||
+ | {{tp|p=32441830|t=2020. Diversity of clinical appearance of cutaneous manifestations in the course of COVID-19.|pdf=|usr=007}} | ||
+ | {{tp|p=32434277|t=2020. Acral purpuric lesions (erythema multiforme type) associated with thrombotic vasculopathy in a child during the COVID-19 pandemic.|pdf=|usr=007}} | ||
+ | {{tp|p=32428303|t=2020. COVID-19 and dermatology: a comprehensive guide for dermatologists.|pdf=|usr=007}} | ||
+ | {{tp|p=32428291|t=2020. Fever with Rash in COVID-19: Viral Exanthema or Secondary Lesions?|pdf=|usr=007}} | ||
+ | {{tp|p=32426877|t=2020. Metastatic melanoma treatment with checkpoint inhibitors in the COVID-19 era: experience from an Italian Skin Cancer Unit.|pdf=|usr=007}} | ||
+ | {{tp|p=32426864|t=2020. A clinicopathological study of 8 patients with COVID-19 pneumonia and a late-onset exanthema.|pdf=|usr=007}} | ||
+ | {{tp|p=32421877|t=2020. A late-onset widespread skin rash in a previous COVID-19-infected patient: viral or multidrug effect?|pdf=|usr=007}} | ||
+ | {{tp|p=32421876|t=2020. Chilblain acral lesions in the COVID-19 era. Are they marker of infection in asymptomatic patients?|pdf=|usr=007}} | ||
+ | {{tp|p=32450607|t=2020. Gastrointestinal: Bowel ischemia in a suspected coronavirus disease (COVID-19) patient.|pdf=|usr=007}} | ||
+ | {{tp|p=32436622|t=2020. Metabolic associated fatty liver disease increases coronavirus disease 2019 disease severity in nondiabetic patients.|pdf=|usr=007}} | ||
+ | {{tp|p=32512022|t=2020. Early administered antibiotics do not impact mortality in critically ill patients with COVID-19.|pdf=|usr=007}} | ||
+ | {{tp|p=32512021|t=2020. Anormal pulmonary function and residual CT abnormalities in rehabilitating COVID-19 patients after discharge.|pdf=|usr=007}} | ||
+ | {{tp|p=32504736|t=2020. Tumor biomarkers predict clinical outcome of COVID-19 patients.|pdf=|usr=007}} | ||
+ | {{tp|p=32458565|t=2020. Mortality of people with intellectual disabilities during the 2017/2018 influenza epidemic in the Netherlands: potential implications for the COVID-19 pandemic.|pdf=|usr=007}} | ||
+ | {{tp|p=32459372|t=2020. COVID-19 and renin-angiotensin system inhibition: role of angiotensin converting enzyme 2 (ACE2) - Is there any scientific evidence for controversy?|pdf=|usr=007}} | ||
+ | {{tp|p=32500773|t=2020. COVID-19 and Acute Lupus Pneumonitis: Diagnostic and Treatment Dilemma.|pdf=|usr=007}} | ||
+ | {{tp|p=32470212|t=2020. Letter to the Editor: Are severe COVID-19 patients more susceptible to conjunctivitis?|pdf=|usr=007}} | ||
+ | {{tp|p=32470211|t=2020. Are we now observing an increasing number of coinfections between SARS-CoV-2 and other respiratory pathogens?|pdf=|usr=007}} | ||
+ | {{tp|p=32470186|t=2020. Correlation between the variables collected at admission and progression to severe cases during hospitalization among patients with COVID-19 in Chongqing.|pdf=|usr=007}} | ||
+ | {{tp|p=32470174|t=2020. Higher prevalence of asymptomatic or mild COVID-19 in children, claims and clues.|pdf=|usr=007}} | ||
+ | {{tp|p=32470167|t=2020. Early risk factors of the exacerbation of Coronavirus disease 2019 pneumonia.|pdf=|usr=007}} | ||
+ | {{tp|p=32470156|t=2020. The novel coronavirus disease (COVID-19) complicated by pulmonary embolism and acute respiratory distress syndrome.|pdf=|usr=007}} | ||
+ | {{tp|p=32462695|t=2020. Coinfection with SARS-CoV-2 and other respiratory pathogens in COVID-19 patients in Guangzhou, China.|pdf=|usr=007}} | ||
+ | {{tp|p=32462689|t=2020. Features of enteric disease from human coronaviruses: Implications for COVID-19.|pdf=|usr=007}} | ||
+ | {{tp|p=32462663|t=2020. Clinical features and outcome of HIV/SARS-CoV-2 coinfected patients in The Bronx, New York city.|pdf=|usr=007}} | ||
+ | {{tp|p=32458578|t=2020. COVID-19 encephalopathy masquerading as substance withdrawal.|pdf=|usr=007}} | ||
+ | {{tp|p=32449972|t=2020. Presenting characteristics, comorbidities, and outcomes of patients coinfected with COVID-19 and Mycoplasma pneumoniae in the USA.|pdf=|usr=007}} | ||
+ | {{tp|p=32449792|t=2020. Severe SARS-CoV-2 pneumonia in a 58-year-old patient with HIV: a clinical case report from the Republic of Cyprus.|pdf=|usr=007}} | ||
+ | {{tp|p=32445489|t=2020. COVID-19 and Liver Dysfunction: a systematic review and meta-analysis of retrospective studies.|pdf=|usr=007}} | ||
+ | {{tp|p=32441816|t=2020. Systematic analysis of ACE2 and TMPRSS2 expression in salivary glands reveals underlying transmission mechanism caused by SARS-CoV-2.|pdf=|usr=007}} | ||
+ | {{tp|p=32441789|t=2020. Predictors of mortality in hospitalized COVID-19 patients: A systematic review and meta-analysis.|pdf=|usr=007}} | ||
+ | {{tp|p=32441787|t=2020. A Rare Case of Immune Thrombocytopenic Purpura Secondary to COVID-19.|pdf=|usr=007}} | ||
+ | {{tp|p=32441773|t=2020. COVID-19 in a patient with HIV infection.|pdf=|usr=007}} | ||
+ | {{tp|p=32437017|t=2020. Epidemiological and clinical characteristics of discharged patients infected with SARS-CoV-2 on the Qinghai plateau.|pdf=|usr=007}} | ||
+ | {{tp|p=32437016|t=2020. Obesity predisposes to the risk of higher mortality in young COVID-19 patients.|pdf=|usr=007}} | ||
+ | {{tp|p=32437004|t=2020. Hepatic complications of COVID-19 and its treatment.|pdf=|usr=007}} | ||
+ | {{tp|p=32437000|t=2020. HIV and SARS-CoV-2 coinfection: A case report from Uganda.|pdf=|usr=007}} | ||
+ | {{tp|p=32436998|t=2020. Lack of viral transmission to preterm newborn from a COVID-19 positive breastfeeding mother at 11 days postpartum.|pdf=|usr=007}} | ||
+ | {{tp|p=32505530|t=2020. Co-infection with an atypical pathogen of COVID-19 in a young.|pdf=|usr=007}} | ||
+ | {{tp|p=32505438|t=2020. The Association Between Symptom Onset and Length of Hospital Stay in 2019 Novel Coronavirus Pneumonia Cases Without Epidemiological Trace.|pdf=|usr=007}} | ||
+ | {{tp|p=32505908|t=2020. Immunologic characterization of a immunosuppressed multiple sclerosis patient that recovered from SARS-CoV-2 infection.|pdf=|usr=007}} | ||
+ | {{tp|p=32385130|t=2020. Clinical Characteristics of and Medical Interventions for COVID-19 in Hemodialysis Patients in Wuhan, China.|pdf=|usr=007}} | ||
+ | {{tp|p=32467113|t=2020. Presentation and Outcomes of Patients with ESKD and COVID-19.|pdf=|usr=007}} | ||
+ | {{tp|p=32484893|t=2020. Elevated Cardiac Troponin I Is Associated with Poor Outcomes in COVID-19 Patients at an Academic Medical Center in Midwestern USA.|pdf=|usr=007}} | ||
+ | {{tp|p=32448041|t=2020. Covid-19 induced superimposed bacterial infection.|pdf=|usr=007}} | ||
+ | {{tp|p=32453074|t=2020. Atrial Fibrillation in COVID-19: From epidemiological association to pharmacological implications.|pdf=|usr=007}} | ||
+ | {{tp|p=32510598|t=2020. Single-cell RNA analysis on ACE2 expression provides insights into SARS-CoV-2 potential entry into the bloodstream and heart injury.|pdf=|usr=007}} | ||
+ | {{tp|p=32433344|t=2020. Judicious Use of Sodium-Glucose Cotransporter 2 Inhibitors in Patients with Diabetes on Coronavirus-19 Pandemic.|pdf=|usr=007}} | ||
+ | {{tp|p=32433342|t=2020. Cardiovascular Manifestation and Treatment in COVID-19.|pdf=|usr=007}} | ||
+ | {{tp|p=32502117|t=2020. Coronavirus disease 2019 in children: Current status.|pdf=|usr=007}} | ||
+ | {{tp|p=32474598|t=2020. Predicting mortality due to SARS-CoV-2: A mechanistic score relating obesity and diabetes to COVID-19 outcomes in Mexico.|pdf=|usr=007}} | ||
+ | {{tp|p=32436948|t=2020. Subacute Thyroiditis After Sars-COV-2 Infection.|pdf=|usr=007}} | ||
+ | {{tp|p=32488958|t=2020. Analysis of clinical features and outcomes of 161 patients with severe and critical COVID-19: A multicenter descriptive study.|pdf=|usr=007}} | ||
+ | {{tp|p=32488888|t=2020. Elevated serum aspartate aminotransferase level identifies patients with coronavirus disease 2019 and predicts the length of hospital stay.|pdf=|usr=007}} | ||
+ | {{tp|p=32479133|t=2020. TMPRSS2 and ACE2 Coexpression in SARS-CoV-2 Salivary Glands Infection.|pdf=|usr=007}} | ||
+ | {{tp|p=32406283|t=2020. A survey of psoriasis patients on biologics during COVID-19: a single centre experience.|pdf=|usr=007}} | ||
+ | {{tp|p=32363967|t=2020. A challenging case of psoriasis flare-up after COVID-19 infection.|pdf=|usr=007}} | ||
+ | {{tp|p=32433220|t=2020. When life is put on hold, how do we hold on to life? - Challenges and Opportunities in Developmental and Behavioral Pediatrics during COVID-19.|pdf=|usr=007}} | ||
+ | {{tp|p=32394639|t=2020. COVID-19 and comorbidities: A role for dipeptidyl peptidase 4 (DPP4) in disease severity?|pdf=|usr=007}} | ||
+ | {{tp|p=32389027|t=2020. Glycemic Characteristics and Clinical Outcomes of COVID-19 Patients Hospitalized in the United States.|pdf=|usr=007}} | ||
+ | {{tp|p=32506937|t=2020. Why Do People With Diabetes Have a High Risk for Severe COVID-19 Disease?-A Dental Hypothesis and Possible Prevention Strategy.|pdf=|usr=007}} | ||
+ | {{tp|p=32484624|t=2020. COVID-19 Pandemic: Are There Unique Cutaneous Manifestations in Patients Infected With SARS-CoV-2?|pdf=|usr=007}} | ||
+ | {{tp|p=32468512|t=2020. COVID-19 may affect the endocrine pancreas by activating Na(+)/H(+) exchanger 2 and increasing lactate levels.|pdf=|usr=007}} | ||
+ | {{tp|p=32474947|t=2020. A clinical, histopathological and laboratory study of 19 consecutive Italian paediatric patients with chilblain-like lesions: lights and shadows on the relationship with COVID-19 infection.|pdf=|usr=007}} | ||
+ | {{tp|p=32510648|t=2020. Urticarial vasculitis in COVID-19 infection: a vasculopathy-related symptom?|pdf=|usr=007}} | ||
+ | {{tp|p=32500642|t=2020. Histology of skin lesions establishes that the vesicular rash associated with COVID-19 is not "varicella-like".|pdf=|usr=007}} | ||
+ | {{tp|p=32495400|t=2020. Exanthema and eosinophilia in Covid-19 patients: has viral infection a role in drug induced exanthemas?|pdf=|usr=007}} | ||
+ | {{tp|p=32495368|t=2020. Clinical and histological characterization of late appearance maculopapular eruptions in association with the coronavirus disease 2019. A case series of seven patients.|pdf=|usr=007}} | ||
+ | {{tp|p=32491234|t=2020. Retiform purpura as a dermatological sign of covid-19 coagulopathy.|pdf=|usr=007}} | ||
+ | {{tp|p=32491223|t=2020. COVID-19: how it can look on the skin. Clinical and pathological features in twenty COVID-19 patients observed in Bologna, northeastern Italy.|pdf=|usr=007}} | ||
+ | {{tp|p=32488946|t=2020. No antibody response in acral cutaneous manifestations associated with COVID-19 ?|pdf=|usr=007}} | ||
+ | {{tp|p=32488910|t=2020. Acro-ischemia and COVID-19 infection: clinical and histopathological features.|pdf=|usr=007}} | ||
+ | {{tp|p=32506122|t=2020. Clinical Characteristics of Hospitalized Individuals Dying with COVID-19 by Age Group in Italy.|pdf=|usr=007}} | ||
+ | {{tp|p=32490807|t=2020. Clinical Progress Note: Point-of-Care Ultrasound Applications in COVID-19.|pdf=|usr=007}} | ||
+ | {{tp|p=32502097|t=2020. Angiotensin-converting enzyme inhibitors, angiotensin II type 1 receptor blockers and risk of COVID 19: information from Bartter's and Gitelman's syndromes patients.|pdf=|usr=007}} | ||
+ | {{tp|p=32502096|t=2020. Are COVID-19 patients with hypertension at higher risk in China?|pdf=|usr=007}} | ||
+ | {{tp|p=32504747|t=2020. Cardiovascular complications in COVID-19: A systematic review and meta-analysis.|pdf=|usr=007}} | ||
+ | {{tp|p=32504746|t=2020. SARS-CoV-2 RNA detection in tears and conjunctival secretions of COVID-19 patients with conjunctivitis.|pdf=|usr=007}} | ||
+ | {{tp|p=32504741|t=2020. Does type of immunosupression influence the course of Covid-19 infection?|pdf=|usr=007}} | ||
+ | {{tp|p=32490559|t=2020. Supporting individuals with intellectual and developmental disability during the first 100 days of the COVID-19 outbreak in the USA.|pdf=|usr=007}} | ||
+ | {{tp|p=32462792|t=2020. Sex-based dimorphism in the SARS-CoV2 virulence.|pdf=|usr=007}} | ||
+ | {{tp|p=32452046|t=2020. Racial disparities in COVID-19 deaths reveal harsh truths about structural inequality in America.|pdf=|usr=007}} | ||
+ | {{tp|p=32498135|t=2020. Older age and comorbidity are independent mortality predictors in a large cohort of 1305 COVID-19 patients in Michigan, United States.|pdf=|usr=007}} | ||
+ | {{tp|p=32406374|t=2020. Olfactory dysfunction in the COVID-19 outbreak.|pdf=|usr=007}} | ||
+ | {{tp|p=32498581|t=2020. Relationship between pregnancy and coronavirus: what we know.|pdf=|usr=007}} | ||
+ | {{tp|p=32223477|t=2020. Pregnant women in the exposure to COVID-19 infection outbreak: the unseen risk factors and preventive healthcare patterns.|pdf=|usr=007}} | ||
+ | {{tp|p=32369209|t=2020. Clinical characteristics and outcomes of cancer patients with COVID-19.|pdf=|usr=007}} | ||
+ | {{tp|p=32497287|t=2020. Anticardiolipin antibodies and COVID-19-A case report from America.|pdf=|usr=007}} | ||
+ | {{tp|p=32497283|t=2020. Influenza and COVID-19 Co-infection: Report of 6 cases and review of the Literature.|pdf=|usr=007}} | ||
+ | {{tp|p=32492209|t=2020. ''Determining Host Factors Contributing to Disease Severity in a Family Cluster of 29 Hospitalized SARS-CoV-2 Patients: Could Genetic Factors Be Relevant in the Clinical Course of COVID-19?''.|pdf=|usr=007}} | ||
+ | {{tp|p=32492199|t=2020. Direct endothelial damage and vasculitis due to SARS-CoV-2 in small bowel submucosa of CoViD-19 patient with diarrhea.|pdf=|usr=007}} | ||
+ | {{tp|p=32492193|t=2020. Potential Neuroinvasive Pathways of SARS-CoV-2: Deciphering the Spectrum of Neurological Deficit Seen in Coronavirus Disease 2019 (COVID-19).|pdf=|usr=007}} | ||
+ | {{tp|p=32492188|t=2020. A case of SARS-CoV-2 infection in an untreated HIV patient in Tokyo, Japan.|pdf=|usr=007}} | ||
+ | {{tp|p=32484990|t=2020. First Case of Focal Epilepsy Associated with SARS-Coronavirus-2.|pdf=|usr=007}} | ||
+ | {{tp|p=32484975|t=2020. Myocardial injury characterized by elevated cardiac troponin and in-hospital mortality of COVID-19: an insight from a meta-analysis.|pdf=|usr=007}} | ||
+ | {{tp|p=32314808|t=2020. Comment on Li et al: COVID-19 patients' clinical characteristics, discharge rate, and fatality rate of meta-analysis.|pdf=|usr=007}} | ||
+ | {{tp|p=32335609|t=2020. Clinical Profile of Cases of COVID-19 in Far Western Province of Nepal.|pdf=|usr=007}} | ||
+ | {{tp|p=32451359|t=2020. Stroke and mechanical thrombectomy in patients with COVID-19: technical observations and patient characteristics.|pdf=|usr=007}} | ||
+ | {{tp|p=32409442|t=2020. Skin manifestations of COVID-19.|pdf=|usr=007}} | ||
+ | {{tp|p=32409440|t=2020. The role of cardiac imaging in hospitalized COVID-19-positive patients.|pdf=|usr=007}} | ||
+ | {{tp|p=32409438|t=2020. Treating acute anxiety in patients with COVID-19.|pdf=|usr=007}} | ||
+ | {{tp|p=32409436|t=2020. Patients with interstitial lung disease and pulmonary sarcoidosis are at high risk for severe illness related to COVID-19.|pdf=|usr=007}} | ||
+ | {{tp|p=32409434|t=2020. Renin-angiotensin system inhibitors in COVID-19.|pdf=|usr=007}} | ||
+ | {{tp|p=32393596|t=2020. COVID-19 and pulmonary hypertension.|pdf=|usr=007}} | ||
+ | {{tp|p=32393593|t=2020. Recognition and management of respiratory coinfection and secondary bacterial pneumonia in patients with COVID-19.|pdf=|usr=007}} | ||
+ | {{tp|p=32409435|t=2020. Coagulopathy in COVID-19.|pdf=|usr=007}} | ||
+ | {{tp|p=32452350|t=2020. Understanding immune effects of oestrogens to explain the reduced morbidity and mortality in female versus male COVID-19 patients. Comparisons with autoimmunity and vaccination.|pdf=|usr=007}} | ||
+ | {{tp|p=32461326|t=2020. Baseline characteristics and outcomes of patients with COVID-19 admitted to intensive care units in Vancouver, Canada: a case series.|pdf=|usr=007}} | ||
+ | {{tp|p=32461325|t=2020. Anosmia and dysgeusia associated with SARS-CoV-2 infection: an age-matched case-control study.|pdf=|usr=007}} | ||
+ | {{tp|p=32409520|t=2020. Probable congenital SARS-CoV-2 infection in a neonate born to a woman with active SARS-CoV-2 infection.|pdf=|usr=007}} | ||
+ | {{tp|p=32504100|t=2020. Ocular manifestations of coronavirus disease 2019.|pdf=|usr=007}} | ||
+ | {{tp|p=32437033|t=2020. Objective olfactory evaluation of self-reported loss of smell in a case series of 86 COVID-19 patients.|pdf=|usr=007}} | ||
+ | {{tp|p=32437022|t=2020. Olfactory and gustatory function impairment in COVID-19 patients: Italian objective multicenter-study.|pdf=|usr=007}} | ||
+ | {{tp|p=32507468|t=2020. Measuring grip strength in COVID-19: A simple way to predict overall frailty/impairment.|pdf=|usr=007}} | ||
+ | {{tp|p=32456720|t=2020. COVID-19 infections among HCWs exposed to a patient with a delayed diagnosis of COVID-19.|pdf=|usr=007}} | ||
+ | {{tp|p=32460395|t=2020. Focus on kidney disease among the coronavirus disease 2019 patients: A comparative perspective between China, Italy and the United States.|pdf=|usr=007}} | ||
+ | {{tp|p=32447761|t=2020. Dermatological findings in COVID-19 patients: Mexican experience.|pdf=|usr=007}} | ||
+ | {{tp|p=32505878|t=2020. Patients with COVID-19 and neurological manifestations show undetectable SARS-CoV-2 RNA levels in the cerebrospinal fluid.|pdf=|usr=007}} | ||
+ | {{tp|p=32505779|t=2020. Could antiphospholipid antibodies contribute to coagulopathy in COVID-19?|pdf=|usr=007}} | ||
+ | {{tp|p=32505431|t=2020. Neuroimmune correlates of the nervous system involvement of COVID-19: A commentary.|pdf=|usr=007}} | ||
+ | {{tp|p=32505432|t=2020. Does COVID-19 cause axonal GBS?|pdf=|usr=007}} | ||
+ | {{tp|p=32449224|t=2020. Analysis of the clinical characteristics, drug treatments and prognoses of 136 patients with coronavirus disease 2019.|pdf=|usr=007}} | ||
+ | {{tp|p=32398625|t=2020. Coincidence of COVID-19 Infection and Smell: Taste Perception Disorders.|pdf=|usr=007}} | ||
+ | {{tp|p=32512349|t=2020. Clinically significant anticardiolipin antibodies associated with COVID-19.|pdf=|usr=007}} | ||
+ | {{tp|p=32242895|t=2020. Experiences and lesson strategies for cardiology from the COVID-19 outbreak in Wuhan, China, by 'on the scene' cardiologists.|pdf=|usr=007}} | ||
+ | {{tp|p=32498078|t=2020. Renin-angiotensin system inhibitors in the COVID-19 pandemic: consequences of antihypertensive drugs.|pdf=|usr=007}} | ||
+ | {{tp|p=32423251|t=2020. Comparison of cardiovascular metabolic characteristics and impact on COVID-19 and MERS.|pdf=|usr=007}} | ||
+ | {{tp|p=32423249|t=2020. Physical activity/inactivity and COVID-19.|pdf=|usr=007}} | ||
+ | {{tp|p=32397803|t=2020. Les liaisons dangereuses and the danger of deductions: The interplay between cardiovascular disease and COVID-19.|pdf=|usr=007}} | ||
+ | {{tp|p=32475157|t=2020. Exercise in the Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) era: A Question and Answer session with the experts Endorsed by the section of Sports Cardiology & Exercise of the European Association of Preventive Cardiology (EAPC).|pdf=|usr=007}} | ||
+ | {{tp|p=32270698|t=2020. Physical inactivity and cardiovascular disease at the time of coronavirus disease 2019 (COVID-19).|pdf=|usr=007}} | ||
+ | {{tp|p=32233671|t=2020. Have a heart during the COVID-19 crisis: Making the case for cardiac rehabilitation in the face of an ongoing pandemic.|pdf=|usr=007}} | ||
+ | {{tp|p=32495914|t=2020. No infectious risk of COVID-19 patients with long-term fecal 2019-nCoV nucleic acid positive.|pdf=|usr=007}} | ||
+ | {{tp|p=32495913|t=2020. Severe acute dried gangrene in COVID-19 infection: a case report.|pdf=|usr=007}} | ||
+ | {{tp|p=32495849|t=2020. Gender differences in COVID-19 infection. The estrogen effect on upper and lower airways. Can it help to figure out a treatment?|pdf=|usr=007}} | ||
+ | {{tp|p=32441761|t=2020. COVID-19 and QT interval prolongation: more than just drug toxicity?|pdf=|usr=007}} | ||
+ | {{tp|p=32441223|t=2020. COVID-19 and obesity: links and risks.|pdf=|usr=007}} | ||
+ | {{tp|p=32511033|t=2020. COVID-19 and diabetes mellitus: implications for prognosis and clinical management.|pdf=|usr=007}} | ||
+ | {{tp|p=32425184|t=2020. Sindrome Takotsubo in corso di polmonite da SARS-CoV-2: una possibile complicanza cardiovascolare.|pdf=|usr=007}} | ||
+ | {{tp|p=32412510|t=2020. Neurological manifestations of COVID-19.|pdf=|usr=007}} | ||
+ | {{tp|p=32420884|t=2020. Pathologies cardiovasculaires et Covid-19 : particularites chez les personnes agees.|pdf=|usr=007}} | ||
+ | {{tp|p=32434831|t=2020. Clinical course and risk factors for mortality of COVID-19 patients with pre-existing cirrhosis: a multicentre cohort study.|pdf=|usr=007}} | ||
+ | {{tp|p=32430348|t=2020. Comparative study of the clinical characteristics and epidemiological trend of 244 COVID-19 infected children with or without GI symptoms.|pdf=|usr=007}} | ||
+ | {{tp|p=32414813|t=2020. Risk of severe illness from COVID-19 in patients with metabolic dysfunction-associated fatty liver disease and increased fibrosis scores.|pdf=|usr=007}} | ||
+ | {{tp|p=32493828|t=2020. Prevalence, risk factors and clinical outcomes of COVID-19 in patients with a history of pancreatitis in Northern California.|pdf=|usr=007}} | ||
+ | {{tp|p=32464676|t=2020. Haemostasis in Times of COVID-19.|pdf=|usr=007}} | ||
+ | {{tp|p=32498097|t=2020. Coagulopathy in COVID-19 and Its Implication for Safe and Efficacious Thromboprophylaxis.|pdf=|usr=007}} | ||
+ | {{tp|p=32431118|t=2020. [CURRENT KNOWLEDGE ON COVID-19 IN CHILDREN - CAUTIOUS OPTIMISM].|pdf=|usr=007}} | ||
+ | {{tp|p=32437224|t=2020. Disparities In Outcomes Among COVID-19 Patients In A Large Health Care System In California.|pdf=|usr=007}} | ||
+ | {{tp|p=32461330|t=2020. Impact of cardiovascular disease and cardiac injury on in-hospital mortality in patients with COVID-19: a systematic review and meta-analysis.|pdf=|usr=007}} | ||
+ | {{tp|p=32461328|t=2020. Getting to the heart of the matter of COVID-19.|pdf=|usr=007}} | ||
+ | {{tp|p=32451360|t=2020. Cardiovascular disease and COVID-19: implications for prevention, surveillance and treatment.|pdf=|usr=007}} | ||
+ | {{tp|p=32499236|t=2020. COVID-19 pandemic and troponin: indirect myocardial injury, myocardial inflammation or myocarditis?|pdf=|usr=007}} | ||
+ | {{tp|p=32364920|t=2020. A Case of Postoperative Covid-19 Infection After Cardiac Surgery: Lessons Learned.|pdf=|usr=007}} | ||
+ | {{tp|p=32473607|t=2020. Acute Liver Injury in COVID-19: Prevalence and Association with Clinical Outcomes in a Large US Cohort.|pdf=|usr=007}} | ||
+ | {{tp|p=32415860|t=2020. Liver Biochemistries in Hospitalized Patients With COVID-19.|pdf=|usr=007}} | ||
+ | {{tp|p=32512611|t=2020. Endocrine Conditions and COVID-19.|pdf=|usr=007}} | ||
+ | {{tp|p=32429774|t=2020. Anti-coagulant and anti-platelet therapy in the COVID-19 patient: a best practices quality initiative across a large health system.|pdf=|usr=007}} | ||
+ | {{tp|p=32456489|t=2020. Complications and outcomes of SARS-CoV-2 in pregnancy: where and what is the evidence?|pdf=|usr=007}} | ||
+ | {{tp|p=32383626|t=2020. RAAs inhibitors and outcome in patients with SARS-CoV-2 pneumonia. A case series study.|pdf=|usr=007}} | ||
+ | {{tp|p=32383624|t=2020. Controversial Relationship between Renin-Angiotensin System Inhibitors and Severity of COVID-19: Announcing a Large Multicentre Case-Control Study in Italy.|pdf=|usr=007}} | ||
+ | {{tp|p=32458694|t=2020. Decreased Mortality of COVID-19 with Renin-Angiotensin-Aldosterone System Inhibitors Therapy in Patients with Hypertension: A Meta-Analysis.|pdf=|usr=007}} | ||
+ | {{tp|p=32493070|t=2020. Comparative impacts of angiotensin converting enzyme inhibitors versus angiotensin II receptor blockers on the risk of COVID-19 mortality.|pdf=|usr=007}} | ||
+ | {{tp|p=32476472|t=2020. COVID-19: ACE2centric infective disease?|pdf=|usr=007}} | ||
+ | {{tp|p=32503820|t=2020. Ocular Manifestations of COVID-19 (SARS-CoV-2): A Critical Review of Current Literature.|pdf=|usr=007}} | ||
+ | {{tp|p=32389131|t=2020. A case of COVID-19 with an ultralong incubation period.|pdf=|usr=007}} | ||
+ | {{tp|p=32427018|t=2020. Several neonates reported positive for COVID-19.|pdf=|usr=007}} | ||
+ | {{tp|p=32476551|t=2020. Challenges in COVID-19: is pulmonary thromboembolism related to overall severity?|pdf=|usr=007}} | ||
+ | {{tp|p=32476537|t=2020. Early experience with COVID-19 patients at academic hospital in Southwestern United States.|pdf=|usr=007}} | ||
+ | {{tp|p=32436835|t=2020. Isolated Anosmia as a Presentation of COVID-19: An Experience in a Referral Hospital.|pdf=|usr=007}} | ||
+ | {{tp|p=32418532|t=2020. Counter-regulatory 'Renin-Angiotensin' System-based Candidate Drugs to Treat COVID-19 Diseases in SARS-CoV-2-infected patients.|pdf=|usr=007}} | ||
+ | {{tp|p=32389117|t=2020. A Viewpoint on Angiotensin-Converting Enzyme 2, Anti-Hypertensives and Coronavirus Disease 2019 (COVID-19).|pdf=|usr=007}} | ||
+ | {{tp|p=32348232|t=2020. A Patient with COVID-19 Disease in a Referral Hospital in Iran: A Typical Case.|pdf=|usr=007}} | ||
+ | {{tp|p=32440692|t=2020. Temporal Correlation Between Neurological and Gastrointestinal Symptoms of SARS-CoV-2.|pdf=|usr=007}} | ||
+ | {{tp|p=32497397|t=2020. Psychophysical olfactory testing in COVID-19: is smell function really impaired in nearly all patients?|pdf=|usr=007}} | ||
+ | {{tp|p=32496658|t=2020. Reply to: Psychophysical olfactory testing in COVID-19: Is smell function really impaired in nearly all patients?|pdf=|usr=007}} | ||
+ | {{tp|p=32505331|t=2020. COVID-19 and cardiovascular injury: A role for oxidative stress and antioxidant treatment?|pdf=|usr=007}} | ||
+ | {{tp|p=32506768|t=2020. Clinical features and outcomes of COVID-19 patients with benign prostatic hyperplasia in aging male: A retrospective study of 18 cases.|pdf=|usr=007}} | ||
+ | {{tp|p=32506743|t=2020. No current evidence supporting risk of using Ibuprofen in patients with COVID-19.|pdf=|usr=007}} | ||
+ | {{tp|p=32496583|t=2020. Chilblain-like lesions during the COVID-19 pandemic: should we really worry?|pdf=|usr=007}} | ||
+ | {{tp|p=32496578|t=2020. Chilblains-like dermatologic manifestation of COVID-19 diagnosed by serology via multidisciplinary virtual care.|pdf=|usr=007}} | ||
+ | {{tp|p=32363628|t=2020. Management of older people during the COVID-19 outbreak: Recommendations from an Italian experience.|pdf=|usr=007}} | ||
+ | {{tp|p=32473603|t=2020. Maternal mortality from COVID-19 in Mexico.|pdf=|usr=007}} | ||
+ | {{tp|p=32438521|t=2020. Update on clinical outcomes of women with COVID-19 during pregnancy.|pdf=|usr=007}} | ||
+ | {{tp|p=32428290|t=2020. Severe COVID-19 in a pregnant patient admitted to hospital in Wuhan.|pdf=|usr=007}} | ||
+ | {{tp|p=32510581|t=2020. Clinical characteristics and laboratory results of pregnant women with COVID-19 in Wuhan, China.|pdf=|usr=007}} | ||
+ | {{tp|p=32330289|t=2020. Be aware of misdiagnosis-Influenza A H1N1 in a pregnant patient with suspected COVID-19.|pdf=|usr=007}} | ||
+ | {{tp|p=32510283|t=2020. EXPRESS: COVID-19 and stroke in Iran; a case series, and effects on stroke admissions.|pdf=|usr=007}} | ||
+ | {{tp|p=32501751|t=2020. EXPRESS: Brain ischemic and hemorrhagic complications of COVID-19.|pdf=|usr=007}} | ||
+ | {{tp|p=32468166|t=2020. Acute kidney injury associated with COVID-19: another extrapulmonary manifestation.|pdf=|usr=007}} | ||
+ | {{tp|p=32408926|t=2020. Fallout from the Covid-19 pandemic - should we prepare for a tsunami of post viral depression?|pdf=|usr=007}} | ||
+ | {{tp|p=32267662|t=2020. Pregnancy and Sars-Cov-2: A Novel Virus in a Unique Population|pdf=|usr=007}} | ||
+ | {{tp|p=32483000|t=2020. COVID-19 pneumonia in patients with HIV - A Case Series.|pdf=|usr=007}} | ||
+ | {{tp|p=32404716|t=2020. A case of HIV and SARS-CoV-2 co-infection in Singapore.|pdf=|usr=007}} | ||
+ | {{tp|p=32418475|t=2020. Who are the Most At-Risk Older Adults in the COVID-19 Era? It's Not Just Those in Nursing Homes.|pdf=|usr=007}} | ||
+ | {{tp|p=32250655|t=2020. Call to Action: Announcing the Traditional, Complementary and Integrative Health and Medicine COVID-19 Support Registry.|pdf=|usr=007}} | ||
+ | {{tp|p=32497704|t=2020. Comment on: "Characterization of acute acro-ischemic lesions in non-hospitalized patients: a case series of 132 patients during the COVID-19 outbreak".|pdf=|usr=007}} | ||
+ | {{tp|p=32482887|t=2020. Haemorrhagic enteritis and COVID-19: causality or coincidence.|pdf=|usr=007}} | ||
+ | {{tp|p=32511148|t=2020. COVID-19 and Its Potential Effect on Patients With Rheumatic Diseases in Latin America.|pdf=|usr=007}} | ||
+ | {{tp|p=32364930|t=2020. Circadian rhythm sleep-wake disorders and the COVID-19 pandemic.|pdf=|usr=007}} | ||
+ | {{tp|p=32364928|t=2020. Dental sleep medicine perspectives post-COVID-19: interprofessional adaptation and directions.|pdf=|usr=007}} | ||
+ | {{tp|p=32441248|t=2020. The impact of SARS-CoV-2 on sleep.|pdf=|usr=007}} | ||
+ | {{tp|p=32441246|t=2020. Does obstructive sleep apnea lead to increased risk of COVID-19 infection and severity?|pdf=|usr=007}} | ||
+ | {{tp|p=32356516|t=2020. Potential influences of obstructive sleep apnea and obesity on COVID-19 severity.|pdf=|usr=007}} | ||
+ | {{tp|p=32484776|t=2020. COVID-19 and obstructive sleep apnea.|pdf=|usr=007}} | ||
+ | {{tp|p=32347205|t=2020. Narcolepsy and COVID-19: sleeping on an opportunity?|pdf=|usr=007}} | ||
+ | {{tp|p=32449619|t=2020. Preliminary Data Suggests That Biologics in Dermatology Are Not Associated With Adverse COVID-19 Outcomes.|pdf=|usr=007}} | ||
+ | {{tp|p=32436736|t=2020. Visual Dermatology: Acral Erythemato-purpuric Lesions During COVID-19 Pandemic.|pdf=|usr=007}} | ||
+ | {{tp|p=32391713|t=2020. Cutaneous Manifestations of Coronavirus Disease 2019 (COVID-19) Infection-What Do We Know So Far?|pdf=|usr=007}} | ||
+ | |||
+ | {{tp|p=32464084|t=2020. The first two months of COVID-19 pandemic in Bosnia and Herzegovina: Single-center experience.|pdf=|usr=007}} | ||
+ | {{tp|p=32415815|t=2020. Lessons Learned from COVID-19 Pandemic in Italy.|pdf=|usr=007}} | ||
+ | {{tp|p=32468942|t=2020. A matter of time: duration and choice of venous thromboprophylaxis in patients diagnosed with COVID-19.|pdf=|usr=007}} | ||
+ | {{tp|p=32454503|t=2020. Stroke in COVID-19 and SARS-CoV-1.|pdf=|usr=007}} | ||
+ | {{tp|p=32438476|t=2020. Reply to "Clinical and histological characterization of vesicular COVID-19 rashes: a prospective study in a tertiary care hospital": Pseudoherpetic Grover disease seems to appear in patients with COVID-19 infection.|pdf=|usr=007}} | ||
+ | {{tp|p=32421857|t=2020. Novel outbreak of acral lesions in times of COVID-19: A description of 74 cases from a tertiary university hospital in Spain.|pdf=|usr=007}} | ||
+ | {{tp|p=32505730|t=2020. Uncommon presentation of COVID-19: Gastrointestinal bleeding.|pdf=|usr=007}} | ||
+ | {{tp|p=32508062|t=2020. COVID-19 critical illness pathophysiology driven by diffuse pulmonary thrombi and pulmonary endothelial dysfunction responsive to thrombolysis.|pdf=|usr=007}} | ||
+ | {{tp|p=32508037|t=2020. Mental health status and related influencing factors of COVID-19 survivors in Wuhan, China.|pdf=|usr=007}} | ||
+ | {{tp|p=32508034|t=2020. Predicted value of coagulation function for prognosis and admission time to negative RT-PCR detection in non-critical COVID-19 patients.|pdf=|usr=007}} | ||
+ | {{tp|p=32508024|t=2020. Clinical characteristics and risk factors for mortality among inpatients with COVID-19 in Wuhan, China.|pdf=|usr=007}} | ||
+ | {{tp|p=32508041|t=2020. Significance of clinical phenomes of patients with COVID-19 infection: A learning from 3795 patients in 80 reports.|pdf=|usr=007}} | ||
+ | {{tp|p=32507407|t=2020. COVID 19-An eye on the virus.|pdf=|usr=007}} | ||
+ | {{tp|p=32505211|t=2020. Lung ventilation function characteristics of survivors from severe COVID-19: a prospective study.|pdf=|usr=007}} | ||
+ | {{tp|p=32467423|t=2020. Potential mechanisms of cardiac injury and common pathways of inflammation in patients with COVID-19.|pdf=|usr=007}} | ||
+ | {{tp|p=32458546|t=2020. Cutaneous manifestations of COVID-19: A review of the published literature.|pdf=|usr=007}} | ||
+ | {{tp|p=32447798|t=2020. Are erythema multiforme and urticaria related to a better outcome of COVID-19?|pdf=|usr=007}} | ||
+ | {{tp|p=32505652|t=2020. Detrimental effects of metabolic dysfunction-associated fatty liver disease and increased neutrophil-to-lymphocyte ratio on severity of COVID-19.|pdf=|usr=007}} | ||
+ | {{tp|p=32505980|t=2020. Relationship between COVID-19 and obesity.|pdf=|usr=007}} | ||
+ | {{tp|p=32469464|t=2020. Newly diagnosed diabetes is associated with a higher risk of mortality than known diabetes in hospitalized patients with COVID-19.|pdf=|usr=007}} | ||
+ | {{tp|p=32463179|t=2020. Exposure to DPP-4 inhibitors and COVID-19 among people with type 2 diabetes. A case-control study.|pdf=|usr=007}} | ||
+ | {{tp|p=32463166|t=2020. Why is hyperglycemia worsening COVID-19 and its prognosis?|pdf=|usr=007}} | ||
+ | {{tp|p=32451317|t=2020. The contribution of diabetic micro-angiopathy to adverse outcomes in COVID-19.|pdf=|usr=007}} | ||
+ | {{tp|p=32506222|t=2020. COVID-19: Impact of and on Diabetes.|pdf=|usr=007}} | ||
+ | {{tp|p=32507692|t=2020. Clinical characteristics of coronavirus disease (COVID-19) patients with gastrointestinal symptoms: A report of 164 cases.|pdf=|usr=007}} | ||
+ | {{tp|p=32463538|t=2020. Excess out-of-hospital deaths during COVID-19 outbreak: evidence of pulmonary embolism as a main determinant.|pdf=|usr=007}} | ||
+ | {{tp|p=32438449|t=2020. The Dilemma of Renin Angiotensin System Blockers in Coronavirus Disease (Covid-19): Insights on the Lung Fluid Handling and Gas Exchange in Heart Failure Patients.|pdf=|usr=007}} | ||
+ | {{tp|p=32430971|t=2020. SARS-CoV2-related myocarditis-like syndroms: Shakespeare s question: What s in a name?|pdf=|usr=007}} | ||
+ | {{tp|p=32507518|t=2020. Does active smoking worsen Covid-19?|pdf=|usr=007}} | ||
+ | {{tp|p=32460417|t=2020. COVID-19 - neurologists stay aware!|pdf=|usr=007}} | ||
+ | {{tp|p=32460415|t=2020. Dysphagia in COVID-19 -multilevel damage to the swallowing network?|pdf=|usr=007}} | ||
+ | {{tp|p=32449247|t=2020. Reply to letter: Acute-onset smell and taste disorders in the context of Covid-19: a pilot multicenter PCR-based case-control study.|pdf=|usr=007}} | ||
+ | {{tp|p=32449248|t=2020. COVID-19 and herpes zoster co-infection presenting with trigeminal neuropathy.|pdf=|usr=007}} | ||
+ | {{tp|p=32443166|t=2020. Letter to the Editor about the Beltran-Corbellini et al. publication :"Acute-onset smell and taste disorders in the context of Covid-19: a pilot multicenter PCR-based case-control study" (Eur J Neurol. 2020. doi: 10.1111/ene.14273.).|pdf=|usr=007}} | ||
+ | {{tp|p=32416028|t=2020. Neurological manifestations and neuro-invasive mechanisms of the severe acute respiratory syndrome coronavirus type 2.|pdf=|usr=007}} | ||
+ | {{tp|p=32505514|t=2020. COVID-19 infection during the third trimester of pregnancy: Current clinical dilemmas.|pdf=|usr=007}} | ||
+ | {{tp|p=32504135|t=2020. Point-of-care lung ultrasound in three neonates with COVID-19.|pdf=|usr=007}} | ||
+ | {{tp|p=32339038|t=2020. ST-Segment-Elevation Myocardial Infarction Care and COVID-19: The Value Proposition of Fibrinolytic Therapy and the Pharmacoinvasive Strategy.|pdf=|usr=007}} | ||
+ | {{tp|p=32500721|t=2020. Approach to Acute Cardiovascular Complications in COVID-19 Infection.|pdf=|usr=007}} | ||
+ | {{tp|p=32482087|t=2020. Incidence of New-Onset and Worsening Heart Failure Before and After the COVID-19 Epidemic Lockdown in Denmark: A Nationwide Cohort Study.|pdf=|usr=007}} | ||
+ | {{tp|p=32508261|t=2020. Hypoalbuminemia, Coagulopathy and Vascular Disease in Covid-19.|pdf=|usr=007}} | ||
+ | {{tp|p=32469253|t=2020. The Spectrum of Cardiac Manifestations in Coronavirus Disease 2019 (COVID-19) - a Systematic Echocardiographic Study.|pdf=|usr=007}} | ||
+ | {{tp|p=32421381|t=2020. Deep Vein Thrombosis in Hospitalized Patients with Coronavirus Disease 2019 (COVID-19) in Wuhan, China: Prevalence, Risk Factors, and Outcome.|pdf=|usr=007}} | ||
+ | {{tp|p=32412320|t=2020. Extremely High Incidence of Lower Extremity Deep Venous Thrombosis in 48 Patients with Severe COVID-19 in Wuhan.|pdf=|usr=007}} | ||
+ | {{tp|p=32507123|t=2020. Self-reported anosmia and dysgeusia as key symptoms of COVID-19.|pdf=|usr=007}} | ||
+ | {{tp|p=32386189|t=2020. ACE Ins/Del genetic polymorphism and epidemiological findings in COVID-19.|pdf=|usr=007}} | ||
+ | {{tp|p=32386188|t=2020. No significant correlation between ACE Ins/Del genetic polymorphism and COVID-19 infection.|pdf=|usr=007}} | ||
+ | {{tp|p=32432563|t=2020. Reporting of D-dimer data in COVID-19: some confusion and potential for misinformation.|pdf=|usr=007}} | ||
+ | {{tp|p=32406381|t=2020. COVID-19: progression of disease and intravascular coagulation - present status and future perspectives.|pdf=|usr=007}} | ||
+ | {{tp|p=32423908|t=2020. Early Outcomes of Outpatient Management of Kidney Transplant Recipients with Coronavirus Disease 2019.|pdf=|usr=007}} | ||
+ | {{tp|p=32390405|t=2020. COVID-19 Viral Load of an Infected Family in China.|pdf=|usr=007}} | ||
+ | {{tp|p=32423903|t=2020. Thrombotic risk in COVID-19: a case series and case-control study.|pdf=|usr=007}} | ||
+ | {{tp|p=32414711|t=2020. The renin-angiotensin system - a therapeutic target in COVID-19?|pdf=|usr=007}} | ||
+ | {{tp|p=32503799|t=2020. Abrupt deterioration and pulmonary embolism in COVID-19: a case report.|pdf=|usr=007}} | ||
+ | {{tp|p=32452757|t=2020. Vascular injury and COVID-19-related mortality: What lies below the tip of the iceberg?|pdf=|usr=007}} | ||
+ | {{tp|p=32512408|t=2020. The choice of intravenous thrombolysis for Acute Ischemic Stroke under COVID-19 infection.|pdf=|usr=007}} | ||
+ | {{tp|p=32462940|t=2020. Characteristics of Children With Reactivation of SARS-CoV-2 Infection After Hospital Discharge.|pdf=|usr=007}} | ||
+ | {{tp|p=32468411|t=2020. COVID-19 and Asthma: Reflection During the Pandemic.|pdf=|usr=007}} | ||
+ | {{tp|p=32507883|t=2020. Covid-19: the renin-angiotensin system imbalance hypothesis.|pdf=|usr=007}} | ||
+ | {{tp|p=32459672|t=2020. Routine Venous Thromboembolism Prophylaxis May Be Inadequate in the Hypercoagulable State of Severe Coronavirus Disease 2019.|pdf=|usr=007}} | ||
+ | {{tp|p=32463005|t=2020. The COVID-19 Pandemic: A Challenge for the Cardiovascular Health.|pdf=|usr=007}} | ||
+ | {{tp|p=32442082|t=2020. Severe acute respiratory syndrome coronavirus 2 is penetrating to dementia research.|pdf=|usr=007}} | ||
+ | {{tp|p=32448405|t=2020. Characteristics of patients with COVID-19 pneumonia at Hvidovre Hospital, March-April 2020.|pdf=|usr=007}} | ||
+ | {{tp|p=32475056|t=2020. Psoriasis, COVID-19 and acute respiratory distress syndrome: focusing on the risk of concomitant biological treatment.|pdf=|usr=007}} | ||
+ | {{tp|p=32475035|t=2020. Contributions of dermatologists to COVID-19 research: a brief systematic review.|pdf=|usr=007}} | ||
+ | {{tp|p=32474988|t=2020. Non-complicated evolution of COVID-19 infection in a patient with psoriasis and psoriatic arthritis during treatment with adalimumab.|pdf=|usr=007}} | ||
+ | {{tp|p=32424886|t=2020. The management of the outbreak of acral skin manifestations in asymptomatic children during COVID-19 era.|pdf=|usr=007}} | ||
+ | {{tp|p=32418320|t=2020. Urticaria in a patient with COVID-19: Therapeutic and diagnostic difficulties.|pdf=|usr=007}} | ||
+ | {{tp|p=32406078|t=2020. COVID-19 in an elderly patient treated with secukinumab.|pdf=|usr=007}} | ||
+ | {{tp|p=32506813|t=2020. A fatal case of COVID-19 infection presenting with an erythema multiforme-like eruption and fever.|pdf=|usr=007}} | ||
+ | {{tp|p=32500647|t=2020. Dermatological Manifestation of Pediatrics Multisystem Inflammatory Syndrome Associated with COVID-19 in a 3-Year-Old Girl.|pdf=|usr=007}} | ||
+ | {{tp|p=32500589|t=2020. Superficial thrombophlebitis in a patient with COVID 19: Heparin treatment after evaluation of D - Dimer: COVID 19 and Superficial thrombophlebitis.|pdf=|usr=007}} | ||
+ | {{tp|p=32500580|t=2020. Schamberg-like purpuric eruptions and tonsillitis in mild COVID-19.|pdf=|usr=007}} | ||
+ | {{tp|p=32478942|t=2020. Covid-19 infection in psoriasis patients treated with cyclosporin.|pdf=|usr=007}} | ||
+ | {{tp|p=32430456|t=2020. Outcomes in Patients With Hyperglycemia Affected by Covid-19: Can We Do More on Glycemic Control?|pdf=|usr=007}} | ||
+ | {{tp|p=32409505|t=2020. COVID-19 in People With Diabetes: Urgently Needed Lessons From Early Reports.|pdf=|usr=007}} | ||
+ | {{tp|p=32409504|t=2020. Clinical Characteristics and Risk Factors for Mortality of COVID-19 Patients With Diabetes in Wuhan, China: A Two-Center, Retrospective Study.|pdf=|usr=007}} | ||
+ | {{tp|p=32409502|t=2020. Obesity and COVID-19 Severity in a Designated Hospital in Shenzhen, China.|pdf=|usr=007}} | ||
+ | {{tp|p=32409499|t=2020. Obesity Is a Risk Factor for Greater COVID-19 Severity.|pdf=|usr=007}} | ||
+ | {{tp|p=32409498|t=2020. Clinical Characteristics and Outcomes of Patients With Diabetes and COVID-19 in Association With Glucose-Lowering Medication.|pdf=|usr=007}} | ||
+ | {{tp|p=32496012|t=2020. Influence of diabetes mellitus on the severity and fatality of SARS-CoV-2 infection.|pdf=|usr=007}} | ||
+ | {{tp|p=32482296|t=2020. COVID-19: Perspectives from people with diabetes.|pdf=|usr=007}} | ||
+ | {{tp|p=32478675|t=2020. Headache is an important symptom in patients with coronavirus disease 2019 (COVID-19).|pdf=|usr=007}} | ||
+ | {{tp|p=32423922|t=2020. More advice on the use of ibuprofen for COVID-19.|pdf=|usr=007}} | ||
+ | {{tp|p=32468357|t=2020. An unresponsive COVID-19 patient.|pdf=|usr=007}} | ||
+ | {{tp|p=32464652|t=2020. Epicardial adipose tissue: fuel for COVID-19-induced cardiac injury?|pdf=|usr=007}} | ||
+ | {{tp|p=32464641|t=2020. Does epicardial fat contribute to COVID-19 myocardial inflammation?|pdf=|usr=007}} | ||
+ | {{tp|p=32459851|t=2020. Stress-induced cardiac arrest with mitral annulus disjunction in a physician amid the COVID-19 pandemic fight.|pdf=|usr=007}} | ||
+ | {{tp|p=32441750|t=2020. Angioedema in COVID-19.|pdf=|usr=007}} | ||
+ | {{tp|p=32432700|t=2020. Return to sports after COVID-19 infection.|pdf=|usr=007}} | ||
+ | {{tp|p=32282026|t=2020. Call to action for the cardiovascular side of COVID-19.|pdf=|usr=007}} | ||
+ | {{tp|p=32498076|t=2020. Association of hypertension and antihypertensive treatment with COVID-19 mortality: a retrospective observational study.|pdf=|usr=007}} | ||
+ | {{tp|p=32464642|t=2020. Myocardial injury in severe COVID-19 infection.|pdf=|usr=007}} | ||
+ | {{tp|p=32449762|t=2020. Acute coronary syndromes during COVID-19.|pdf=|usr=007}} | ||
+ | {{tp|p=32432723|t=2020. Renin-angiotensin system and SARS-CoV-2 infection: there is a before and after.|pdf=|usr=007}} | ||
+ | {{tp|p=32432704|t=2020. Renin-angiotensin-aldosterone system dysregulation and severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection.|pdf=|usr=007}} | ||
+ | {{tp|p=32462177|t=2020. Myocarditis detected after COVID-19 recovery.|pdf=|usr=007}} | ||
+ | {{tp|p=32464637|t=2020. The mechanistic overview of SARS-CoV-2 using angiotensin-converting enzyme 2 to enter the cell for replication: possible treatment options related to the renin-angiotensin system.|pdf=|usr=007}} | ||
+ | {{tp|p=32501480|t=2020. Continuation versus discontinuation of ACE inhibitors or angiotensin II receptor blockers in COVID-19: effects on blood pressure control and mortality.|pdf=|usr=007}} | ||
+ | {{tp|p=32501477|t=2020. Antihypertensive drugs in COVID-19 infection.|pdf=|usr=007}} | ||
+ | {{tp|p=32511752|t=2020. COVID-19 and End Stage Renal Disease.|pdf=|usr=007}} | ||
+ | {{tp|p=32511751|t=2020. SARS-CoV-2: what is known and what there is to know. Focus on coagulation and lipids.|pdf=|usr=007}} | ||
+ | {{tp|p=32469251|t=2020. The gendered impact of coronavirus disease (COVID-19): do estrogens play a role?|pdf=|usr=007}} | ||
+ | {{tp|p=32453009|t=2020. Dangerous interactions of gastrointestinal drugs with experimental treatments for COVID-19.|pdf=|usr=007}} | ||
+ | {{tp|p=32282549|t=2020. Chronic liver disease is not associated with severity or mortality in Coronavirus disease 2019 (COVID-19): a pooled analysis.|pdf=|usr=007}} | ||
+ | {{tp|p=32485082|t=2020. ACE-inhibitors and Angiotensin-2 Receptor Blockers are not associated with severe SARS-COVID19 infection in a multi-site UK acute Hospital Trust.|pdf=|usr=007}} | ||
+ | {{tp|p=32503088|t=2020. A systematic review of neurological manifestations of SARS-CoV-2 infection: the devil is hidden in the details.|pdf=|usr=007}} | ||
+ | {{tp|p=32503084|t=2020. Miller-Fisher syndrome after SARS-CoV-2 infection.|pdf=|usr=007}} | ||
+ | {{tp|p=32503080|t=2020. Concomitant brain arterial and venous thrombosis in a COVID-19 patient.|pdf=|usr=007}} | ||
+ | {{tp|p=32492256|t=2020. How to support the quality of life of people living with cognitive disorders? A (k)new challenge in the post-Covid World.|pdf=|usr=007}} | ||
+ | {{tp|p=32478936|t=2020. SARS-CoV-2 and Guillain-Barre syndrome: AIDP variant with favorable outcome.|pdf=|usr=007}} | ||
+ | {{tp|p=32450718|t=2020. Ophthalmology and SARS-CoV-2: Blind toward those who fight blindness?|pdf=|usr=007}} | ||
+ | {{tp|p=32396903|t=2020. Venous Thromboembolism Complicated with COVID-19: What Do We Know So Far?|pdf=|usr=007}} | ||
+ | {{tp|p=32238235|t=2020. Da Tuberculose ao COVID-19: Legitimidade Juridico-Constitucional do Isolamento/Tratamento Compulsivo por Doencas Contagiosas em Portugal.|pdf=|usr=007}} | ||
+ | {{tp|p=32433817|t=2020. Prolonged Confusional state as first manifestation of COVID-19.|pdf=|usr=007}} | ||
+ | {{tp|p=32498096|t=2020. Intramural Hematoma as Unexpected Complication of COVID-19 Infection.|pdf=|usr=007}} | ||
+ | {{tp|p=32470281|t=2020. La bronquiolitis en el ano del COVID-19.|pdf=|usr=007}} | ||
+ | {{tp|p=32505489|t=2020. ROLE OF REHABILITATION DEPARTMENT FOR ADULT COVID-19 PATIENTS: THE EXPERIENCE OF THE SAN RAFFAELE HOSPITAL OF MILAN.|pdf=|usr=007}} | ||
+ | {{tp|p=32401850|t=2020. Coronavirus e o Coracao | Um Relato de Caso sobre a Evolucao da COVID-19 Associado a Evolucao Cardiologica.|pdf=|usr=007}} | ||
+ | {{tp|p=32401847|t=2020. O Coracao e a COVID-19: O que o Cardiologista Precisa Saber.|pdf=|usr=007}} | ||
+ | {{tp|p=32401844|t=2020. COVID-19: Dados Atualizados e sua Relacao Com o Sistema Cardiovascular.|pdf=|usr=007}} | ||
+ | {{tp|p=32491075|t=2020. Implicacoes Cardiovasculares em Pacientes Infectados com Covid-19 e a Importancia do Isolamento Social para Reduzir a Disseminacao da Doenca.|pdf=|usr=007}} | ||
+ | {{tp|p=32491074|t=2020. COVID-19 e Estado de Hipercoagulabilidade: Uma Nova Perspectiva Terapeutica.|pdf=|usr=007}} | ||
+ | {{tp|p=32491073|t=2020. O Efeito da Doenca de Coronavirus 2019 nas Doencas Cardiovasculares.|pdf=|usr=007}} | ||
+ | {{tp|p=32386125|t=2020. Capturing patient-reported outcomes during the COVID-19 pandemic: Development of the COVID-19 Global Rheumatology Alliance Patient Experience Survey.|pdf=|usr=007}} | ||
+ | {{tp|p=32458534|t=2020. Mild course of Coronavirus disease 2019 and spontaneous severe acute respiratory syndrome coronavirus 2 clearance in a patient with depleted peripheral blood B-cells due to treatment with rituximab.|pdf=|usr=007}} | ||
+ | {{tp|p=32472827|t=2020. First Successful Treatment of Coronavirus Disease 2019 Induced Refractory Cardiogenic Plus Vasoplegic Shock by Combination of Percutaneous Ventricular Assist Device and Extracorporeal Membrane Oxygenation: A Case Report.|pdf=|usr=007}} | ||
+ | {{tp|p=32512532|t=2020. Lived experiences of the corona survivors (patients admitted in COVID wards): A narrative real-life documented summaries of internalized guilt, shame, stigma, anger.|pdf=|usr=007}} | ||
+ | {{tp|p=32453688|t=2020. COVID-19, thromboembolic risk and thromboprophylaxis: learning lessons from the bedside, awaiting evidence.|pdf=|usr=007}} | ||
+ | {{tp|p=32471884|t=2020. Characterization and clinical course of 1000 patients with coronavirus disease 2019 in New York: retrospective case series.|pdf=|usr=007}} | ||
+ | {{tp|p=32467124|t=2020. 80-year-old man with dyspnoea and bilateral groundglass infiltrates: an elusive case of COVID-19.|pdf=|usr=007}} | ||
+ | {{tp|p=32503812|t=2020. Elevation of blood glucose level predicts worse outcomes in hospitalized patients with COVID-19: a retrospective cohort study.|pdf=|usr=007}} | ||
+ | {{tp|p=32460349|t=2020. Further evidence that chilblains are a cutaneous manifestation of COVID-19 infection.|pdf=|usr=007}} | ||
+ | {{tp|p=32469077|t=2020. Covid-19 in Bone Marrow Transplant Recipients: Reflecting on a Single Centre Experience.|pdf=|usr=007}} | ||
+ | {{tp|p=32460350|t=2020. Cold Agglutinin Autoimmune Hemolytic Anemia Associated with Novel Coronavirus (COVID-19).|pdf=|usr=007}} | ||
+ | {{tp|p=32453889|t=2020. Haemoglobin Oxygen Affinity in Patients with Severe COVID-19 Infection.|pdf=|usr=007}} | ||
+ | {{tp|p=32453877|t=2020. Delayed-Phase Thrombocytopenia in Patients of Coronavirus Disease 2019 (COVID-19).|pdf=|usr=007}} | ||
+ | {{tp|p=32453861|t=2020. Is molecular mimicry the culprit in the autoimmune haemolytic anaemia affecting patients with COVID-19?|pdf=|usr=007}} | ||
+ | {{tp|p=32438482|t=2020. Real-world assessment of the clinical impact of symptomatic infection with severe acute respiratory syndrome coronavirus (COVID-19 disease) in patients with multiple myeloma receiving systemic anti-cancer therapy.|pdf=|usr=007}} | ||
+ | {{tp|p=32438458|t=2020. Molecular mechanisms for thrombosis risk in Black people: a role in excess mortality from COVID-19.|pdf=|usr=007}} | ||
+ | {{tp|p=32420629|t=2020. Evans syndrome in a patient with COVID-19.|pdf=|usr=007}} | ||
+ | {{tp|p=32420615|t=2020. Dynamic relationship between D-dimer and COVID-19 severity.|pdf=|usr=007}} | ||
+ | {{tp|p=32420614|t=2020. First COVID-19 maternal mortality in the UK associated with thrombotic complications.|pdf=|usr=007}} | ||
+ | {{tp|p=32420612|t=2020. COVID-19-associated immune thrombocytopenia.|pdf=|usr=007}} | ||
+ | {{tp|p=32420611|t=2020. More on 'Association between ABO blood groups and risk of SARS-CoV-2 pneumonia'.|pdf=|usr=007}} | ||
+ | {{tp|p=32420609|t=2020. Clinical outcome of coronavirus disease 2019 in haemato-oncology patients.|pdf=|usr=007}} | ||
+ | {{tp|p=32420608|t=2020. Patients with sickle cell disease and suspected COVID-19 in a paediatric intensive care unit.|pdf=|usr=007}} | ||
+ | {{tp|p=32452530|t=2020. Abdominal fluid samples (negative for SARS-CoV-2) from a critically unwell patient with respiratory COVID-19.|pdf=|usr=007}} | ||
+ | {{tp|p=32408910|t=2020. Interdisciplinary and Collaborative Approaches Needed to Determine Impact of COVID-19 on Older Adults and Aging: CAG/ACG and CJA/RCV Joint Statement.|pdf=|usr=007}} | ||
+ | {{tp|p=32470162|t=2020. Management of a patient presenting with anterior STEMI with concomitant COVID-19 infection early in the course of the U.S. pandemic.|pdf=|usr=007}} | ||
+ | {{tp|p=32427416|t=2020. COVID-19 complicated by acute myocardial infarction with extensive thrombus burden and cardiogenic shock.|pdf=|usr=007}} | ||
+ | {{tp|p=32506683|t=2020. D-dimer triage for COVID-19.|pdf=|usr=007}} | ||
+ | {{tp|p=32412848|t=2020. A Case of COVID-19 and Pneumocystis jirovecii Co-infection.|pdf=|usr=007}} | ||
+ | {{tp|p=32492436|t=2020. Covid-19 may be exacerbated by right-to-left interatrial shunt.|pdf=|usr=007}} | ||
+ | {{tp|p=32444450|t=2020. SARS-CoV-2 infection in ambulatory and hospitalised Spanish children.|pdf=|usr=007}} | ||
+ | {{tp|p=32422078|t=2020. Effects of SARS-CoV-2 infection on pregnant women and their infants: A retrospective study in Wuhan, China.|pdf=|usr=007}} | ||
+ | {{tp|p=32338533|t=2020. INFECTIONS IN PREGNANCY WITH COVID-19 AND OTHER RESPIRATORY RNA VIRUS DISEASES ARE RARELY, IF EVER, TRANSMITTED TO THE FETUS: EXPERIENCES WITH CORONAVIRUSES, HPIV, hMPV RSV, AND INFLUENZA.|pdf=|usr=007}} | ||
+ | {{tp|p=32320546|t=2020. Criterios para la gestion de personas especialmente vulnerables y trabajadores/as especialmente sensibles frente al SARS-CoV-2 en las empresas de Cataluna en el contexto de pandemia.|pdf=|usr=007}} | ||
+ | {{tp|p=32506699|t=2020. Incidence of COVID-19 in patients with rheumatic diseases treated with targeted immunosuppressive drugs: what can we learn from observational data?|pdf=|usr=007}} | ||
+ | {{tp|p=32475091|t=2020. Cardiovascular conditions and COVID-19.|pdf=|usr=007}} | ||
+ | {{tp|p=32427288|t=2020. ACE2 Receptor Expression in Testes: Implications in COVID-19 Pathogenesis.|pdf=|usr=007}} | ||
+ | {{tp|p=32462179|t=2020. Impact of anticoagulation prior to COVID-19 infection: a propensity score-matched cohort study.|pdf=|usr=007}} | ||
+ | {{tp|p=32492712|t=2020. COVID and Coagulation: Bleeding and Thrombotic Manifestations of SARS-CoV2 Infection.|pdf=|usr=007}} | ||
+ | {{tp|p=32376670|t=2020. Covid-19: the challenge of patient rehabilitation after intensive care.|pdf=|usr=007}} | ||
+ | {{tp|p=32366505|t=2020. Covid-19 and pregnancy.|pdf=|usr=007}} | ||
+ | {{tp|p=32439704|t=2020. Covid-19 and thrombosis: what do we know about the risks and treatment?|pdf=|usr=007}} | ||
+ | {{tp|p=32434891|t=2020. Covid-19 and cardiovascular disease.|pdf=|usr=007}} | ||
+ | {{tp|p=32398229|t=2020. Covid-19: Low skilled men have highest death rate of working age adults.|pdf=|usr=007}} | ||
+ | {{tp|p=32393504|t=2020. Covid-19: Known risk factors fail to explain the increased risk of death among people from ethnic minorities.|pdf=|usr=007}} | ||
+ | {{tp|p=32357954|t=2020. Covid-19 is no worse in immunocompromised children, says NICE.|pdf=|usr=007}} | ||
+ | {{tp|p=32217618|t=2020. Covid-19: risk factors for severe disease and death.|pdf=|usr=007}} | ||
+ | {{tp|p=32213482|t=2020. Covid-19 and long term conditions: what if you have cancer, diabetes, or chronic kidney disease?|pdf=|usr=007}} | ||
+ | {{tp|p=32209544|t=2020. Covid-19: most patients require mechanical ventilation in first 24 hours of critical care.|pdf=|usr=007}} | ||
+ | {{tp|p=32327432|t=2020. Covid-19: Doctors should be alert for signs of myocardial injury, says NICE.|pdf=|usr=007}} | ||
+ | {{tp|p=32291260|t=2020. Covid-19: Nine in 10 pregnant women with infection when admitted for delivery are asymptomatic, small study finds.|pdf=|usr=007}} | ||
+ | {{tp|p=32303575|t=2020. Case series of coronavirus (SARS-CoV-2) in a military recruit school: clinical, sanitary and logistical implications.|pdf=|usr=007}} | ||
+ | {{tp|p=32467101|t=2020. Symptom burden and clinical profile of COVID-19 deaths: a rapid systematic review and evidence summary.|pdf=|usr=007}} | ||
+ | {{tp|p=32378464|t=2020. Long-term conditions and severe acute respiratory syndrome SARS-CoV-2 (COVID-19).|pdf=|usr=007}} | ||
+ | {{tp|p=32479680|t=2020. Cutaneous manifestations in patients with COVID-19: A preliminary review of an emerging issue.|pdf=|usr=007}} | ||
+ | {{tp|p=32497248|t=2020. Pulmonary Artery Thrombectomy - A Life Saving Treatment in a Patient with Presumed COVID-19 complicated by a massive Pulmonary Embolus.|pdf=|usr=007}} | ||
+ | {{tp|p=32484907|t=2020. Prevalence of Venous Thromboembolism in Critically Ill Patients with COVID-19.|pdf=|usr=007}} | ||
+ | {{tp|p=32484906|t=2020. Prevalence and Mortality due to Outbreak of Novel Coronavirus Disease (COVID-19) in beta-Thalassemias: The Nationwide Iranian Experience.|pdf=|usr=007}} | ||
+ | {{tp|p=32484901|t=2020. Re The source of elevated plasma D-dimer levels in COVID-19 infection.|pdf=|usr=007}} | ||
+ | {{tp|p=32479664|t=2020. A Case Series of MGUS and COVID-19.|pdf=|usr=007}} | ||
+ | {{tp|p=32468862|t=2020. Licking the lungs, biting the brain: malignant MCA infarct in a patient with COVID 19 infection.|pdf=|usr=007}} | ||
+ | {{tp|p=32475821|t=2020. The Stanford Hall consensus statement for post-COVID-19 rehabilitation.|pdf=|usr=007}} | ||
+ | {{tp|p=32492174|t=2020. First case of acute pancreatitis related to SARS-CoV-2 infection.|pdf=|usr=007}} | ||
+ | {{tp|p=32311273|t=2020. Managing COVID-19-Positive Maternal-Infant Dyads: An Italian Experience.|pdf=|usr=007}} | ||
+ | {{tp|p=32468972|t=2020. Guillain-Barre syndrome with facial diplegia related to SARS-CoV-2 infection.|pdf=|usr=007}} | ||
+ | {{tp|p=32493536|t=2020. COVID-19 presenting with thalamic hemorrhage unmasking moyamoya angiopathy.|pdf=|usr=007}} | ||
+ | {{tp|p=32493522|t=2020. The impact of the Covid-19 Pandemic on Stroke Volume.|pdf=|usr=007}} | ||
+ | {{tp|p=32484130|t=2020. COVID-19 associated central nervous system vasculopathy.|pdf=|usr=007}} | ||
+ | {{tp|p=32471876|t=2020. Registries Offer Insights on COVID-19-Cancer Connection.|pdf=|usr=007}} | ||
+ | {{tp|p=32398243|t=2020. Impact of PD-1 blockade on severity of COVID-19 in patients with lung cancers.|pdf=|usr=007}} | ||
+ | {{tp|p=32427636|t=2020. ACE Inhibitors and ARBs in Patients with COVID-19: Friend or Foe?|pdf=|usr=007}} | ||
+ | {{tp|p=32496364|t=2020. Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers in Patients With Coronavirus Disease 2019: Friend or Foe?|pdf=|usr=007}} | ||
+ | {{tp|p=32427637|t=2020. The Novel Coronavirus Disease (COVID-19) and Its Impact on Cardiovascular Disease.|pdf=|usr=007}} | ||
+ | {{tp|p=32494800|t=2020. Coronavirus disease 2019 (COVID-19) and simultaneous acute anteroseptal and inferior ST-segment elevation myocardial infarction.|pdf=|usr=007}} | ||
+ | {{tp|p=32490506|t=2020. Coronavirus disease 2019 (COVID-19) and simultaneous acute anteroseptal and inferior ST-segment elevation myocardial infarction.|pdf=|usr=007}} | ||
+ | {{tp|p=32473085|t=2020. SARS-COV-2 infection presenting as ST-elevationmyocardial infarction.|pdf=|usr=007}} | ||
+ | {{tp|p=32473051|t=2020. Massive coronary thrombosis caused primary percutaneous coronary intervention to fail in a COVID-19 patient with ST-elevation myocardial infarction.|pdf=|usr=007}} | ||
+ | {{tp|p=32403983|t=2020. Neurotropic mechanisms in COVID-19 and their potential influence on neuropsychological outcomes in children.|pdf=|usr=007}} | ||
+ | {{tp|p=32209890|t=2020. Clinical characteristics of fatal and recovered cases of coronavirus disease 2019 in Wuhan, China: a retrospective study.|pdf=|usr=007}} | ||
+ | {{tp|p=32432519|t=2020. Does the compromised sleep and circadian disruption of night and shiftworkers make them highly vulnerable to 2019 coronavirus disease (COVID-19)?|pdf=|usr=007}} | ||
+ | {{tp|p=32511019|t=2020. COVID-19 infection at nighttime.|pdf=|usr=007}} | ||
+ | {{tp|p=32498625|t=2020. SARS-CoV-2/COVID-19 and physical distancing: risk for circadian rhythm dysregulation, advice to alleviate it, and natural experiment research opportunities.|pdf=|usr=007}} | ||
+ | {{tp|p=32434385|t=2020. Cardiac Arrhythmias in COVID-19 Infection.|pdf=|usr=007}} | ||
+ | {{tp|p=32397816|t=2020. Diffuse Myocardial Inflammation in COVID-19 Associated Myocarditis Detected by Multiparametric Cardiac Magnetic Resonance Imaging.|pdf=|usr=007}} | ||
+ | {{tp|p=32474587|t=2020. COVID-19: Possible reasons for the increased prevalence of Olfactory and Gustatory dysfunction observed in European studies.|pdf=|usr=007}} | ||
+ | {{tp|p=32473009|t=2020. Age-dependent gender differences of COVID-19 in mainland China: comparative study.|pdf=|usr=007}} | ||
+ | {{tp|p=32472683|t=2020. Detectable severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in human breast milk of a mildly symptomatic patient with coronavirus disease 2019 (COVID-19).|pdf=|usr=007}} | ||
+ | {{tp|p=32472676|t=2020. Predictors for Severe COVID-19 Infection.|pdf=|usr=007}} | ||
+ | {{tp|p=32472138|t=2020. Clinical characteristics and outcomes in people living with HIV hospitalized for COVID-19.|pdf=|usr=007}} | ||
+ | {{tp|p=32463454|t=2020. Alterations in smell or taste - Classic COVID-19?|pdf=|usr=007}} | ||
+ | {{tp|p=32459833|t=2020. Hospitalized patients with COVID-19 and HIV: a case series.|pdf=|usr=007}} | ||
+ | {{tp|p=32444880|t=2020. Clinical Features and Outcomes of 105 Hospitalized patients with COVID-19 in Seattle, Washington.|pdf=|usr=007}} | ||
+ | {{tp|p=32442294|t=2020. Therapy with agents acting on the renin-angiotensin system and risk of SARS-CoV-2 infection.|pdf=|usr=007}} | ||
+ | {{tp|p=32442285|t=2020. Association of renin-angiotensin-aldosterone system inhibitors with COVID-19-related outcomes in Korea: a nationwide population-based cohort study.|pdf=|usr=007}} | ||
+ | {{tp|p=32442265|t=2020. Characterization of an asymptomatic cohort of SARS-COV-2 infected individuals outside of Wuhan, China.|pdf=|usr=007}} | ||
+ | {{tp|p=32442259|t=2020. Renin-angiotensin-aldosterone system inhibitors impact on COVID-19 mortality: What's next for ACE2?|pdf=|usr=007}} | ||
+ | {{tp|p=32433729|t=2020. Symptomatic Infants have Higher Nasopharyngeal SARS-CoV-2 Viral Loads but Less Severe Disease than Older Children.|pdf=|usr=007}} | ||
+ | {{tp|p=32211755|t=2020. Epidemiological and Clinical Predictors of COVID-19.|pdf=|usr=007}} | ||
+ | {{tp|p=32502247|t=2020. Inverse association between chronic hepatitis B infection and COVID-19: immune-exhaustion or coincidence?|pdf=|usr=007}} | ||
+ | {{tp|p=32444393|t=2020. Clinical Features of Maintenance Hemodialysis Patients with 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China.|pdf=|usr=007}} | ||
+ | |||
+ | {{tp|p=32441332|t=2020. Clinical course of coronavirus disease-2019 in pregnancy.|pdf=|usr=007}} | ||
+ | {{tp|p=32436625|t=2020. Low risk of SARS-CoV-2 transmission through the ocular surface.|pdf=|usr=007}} | ||
+ | {{tp|p=32421258|t=2020. Ocular manifestations and clinical characteristics of 535 cases of COVID-19 in Wuhan, China: a cross-sectional study.|pdf=|usr=007}} | ||
+ | {{tp|p=32470948|t=2020. Why does COVID-19 disproportionately affect older people?|pdf=|usr=007}} | ||
+ | {{tp|p=32499448|t=2020. Comparison of clinical characteristics and outcomes of patients with coronavirus disease 2019 at different ages.|pdf=|usr=007}} | ||
+ | {{tp|p=32507570|t=2020. Acute myocarditis associated with COVID-19 infection.|pdf=|usr=007}} | ||
+ | {{tp|p=32496339|t=2020. Lipase Elevation in Patients With COVID-19.|pdf=|usr=007}} | ||
+ | {{tp|p=32483005|t=2020. Liver Enzyme Elevation in Coronavirus Disease 2019: A Multicenter, Retrospective, Cross-Sectional Study.|pdf=|usr=007}} | ||
+ | {{tp|p=32445584|t=2020. Immune thrombocytopenia due to COVID-19 during pregnancy.|pdf=|usr=007}} | ||
+ | {{tp|p=32512038|t=2020. IgG Antibody Response to SARS-CoV-2 Infection and Viral RNA Persistence in Patients on Maintenance Hemodialysis.|pdf=|usr=007}} | ||
+ | {{tp|p=32459524|t=2020. Obesity and COVID-19: Immune and metabolic derangement as a possible link to adverse clinical outcomes.|pdf=|usr=007}} | ||
+ | {{tp|p=32421367|t=2020. Is there an impact of the COVID-19 pandemic on male fertility? The ACE2 connection.|pdf=|usr=007}} | ||
+ | {{tp|p=32396497|t=2020. COVID-19-associated SIADH: a clue in the times of pandemic!|pdf=|usr=007}} | ||
+ | {{tp|p=32491949|t=2020. Understanding the age divide in COVID-19: Why are children overwhelmingly spared?|pdf=|usr=007}} | ||
+ | {{tp|p=32432918|t=2020. Estrogen regulates the expression of SARS-CoV-2 receptor ACE2 in differentiated airway epithelial cells.|pdf=|usr=007}} | ||
+ | {{tp|p=32401670|t=2020. Treatment of COVID-19-exacerbated asthma: should systemic corticosteroids be used?|pdf=|usr=007}} | ||
+ | {{tp|p=32412303|t=2020. Is the kidney a target of SARS-CoV-2?|pdf=|usr=007}} | ||
+ | {{tp|p=32436646|t=2020. Clinical outcome in solid organ transplant recipients with COVID-19: A single-center experience.|pdf=|usr=007}} | ||
+ | {{tp|p=32503857|t=2020. Clinical features and outcomes of COVID-19 in patients with rheumatic diseases treated with biological and synthetic targeted therapies.|pdf=|usr=007}} | ||
+ | {{tp|p=32469504|t=2020. Heralding Healthcare Professionals: Recognition of Neurological Deficits in COVID-19.|pdf=|usr=007}} | ||
+ | {{tp|p=32491829|t=2020. SARS-CoV-2 more than a respiratory virus: Its potential role in neuropathogenesis.|pdf=|usr=007}} | ||
+ | {{tp|p=32420961|t=2020. Report of a series of healthy term newborns from convalescent mothers with COVID-19.|pdf=|usr=007}} | ||
+ | {{tp|p=32420955|t=2020. Preliminary epidemiological analysis on children and adolescents with novel coronavirus disease (2019-nCoV) in a central area of Calabria region.|pdf=|usr=007}} | ||
+ | {{tp|p=32420954|t=2020. Smell and taste dysfunction during the COVID-19 outbreak: a preliminary report.|pdf=|usr=007}} | ||
+ | {{tp|p=32420950|t=2020. The medical concerns of patients with thalassemias at the time of COVID-19 outbreak: The personal experience and the international recommendations.|pdf=|usr=007}} | ||
+ | {{tp|p=32420949|t=2020. Rare Anaemias, Sickle-Cell Disease and COVID-19.|pdf=|usr=007}} | ||
+ | {{tp|p=32420948|t=2020. SARS-CoV-2 infection in children in Parma.|pdf=|usr=007}} | ||
+ | {{tp|p=32420942|t=2020. COVID19: potential cardiovascular issues in pediatric patients.|pdf=|usr=007}} | ||
+ | {{tp|p=32420941|t=2020. Novel coronavirus infection and children.|pdf=|usr=007}} | ||
+ | {{tp|p=32420939|t=2020. Assessment and treatment of older individuals with COVID 19 multi-system disease: Clinical and ethical implications.|pdf=|usr=007}} | ||
+ | {{tp|p=32420934|t=2020. Tobacco smoking and COVID-19 pandemic: old and new issues. A summary of the evidence from the scientific literature.|pdf=|usr=007}} | ||
+ | {{tp|p=32420930|t=2020. Primum non nocere. The SARS-CoV-2 pandemic course in oldest.|pdf=|usr=007}} | ||
+ | {{tp|p=32420925|t=2020. Implications of SARSr-CoV 2 infection in thalassemias: Do patients fall into the "high clinical risk" category?|pdf=|usr=007}} | ||
+ | {{tp|p=32474914|t=2020. Anxiety and depression levels among pregnant women with COVID-19.|pdf=|usr=007}} | ||
+ | {{tp|p=32473022|t=2020. Coronavirus disease-2019 in pregnancy with neurological manifestations versus pregnancy with eclampsia: Need for liberal testing to rule out the masquerades.|pdf=|usr=007}} | ||
+ | {{tp|p=32483943|t=2020. Episcleritis as an ocular manifestation in a patient with COVID-19.|pdf=|usr=007}} | ||
+ | {{tp|p=32470131|t=2020. The COVID-19 Rehabilitation Pandemic.|pdf=|usr=007}} | ||
+ | {{tp|p=32449420|t=2020. Interpretation of arrhythmogenic effects of COVID-19 disease through ECG.|pdf=|usr=007}} | ||
+ | {{tp|p=32508193|t=2020. Risk factors for mortality in patients with Coronavirus disease 2019 (COVID-19) infection: a systematic review and meta-analysis of observational studies.|pdf=|usr=007}} | ||
+ | {{tp|p=32501851|t=2020. SARS-CoV-2 infection in a highly experienced person living with HIV.|pdf=|usr=007}} | ||
+ | {{tp|p=32501850|t=2020. Potential impact of COVID-19 in people living with HIV: experience from previous 21st century coronaviruses epidemics.|pdf=|usr=007}} | ||
+ | {{tp|p=32469614|t=2020. A Case Series of Five People Living with HIV Hospitalized with COVID-19 in Chicago, Illinois.|pdf=|usr=007}} | ||
+ | {{tp|p=32407127|t=2020. Why Aren't People Living with HIV at Higher Risk for Developing Severe Coronavirus Disease 2019 (COVID-19)?|pdf=|usr=007}} | ||
+ | {{tp|p=32467191|t=2020. Brain Imaging Use and Findings in COVID-19: A Single Academic Center Experience in the Epicenter of Disease in the United States.|pdf=|usr=007}} | ||
+ | {{tp|p=32467190|t=2020. COVID-19-Associated Miller Fisher Syndrome: MRI Findings.|pdf=|usr=007}} | ||
+ | {{tp|p=32467189|t=2020. Surprise Diagnosis of COVID-19 following Neuroimaging Evaluation for Unrelated Reasons during the Pandemic in Hot Spots.|pdf=|usr=007}} | ||
+ | {{tp|p=32439646|t=2020. Hemorrhagic Posterior Reversible Encephalopathy Syndrome as a Manifestation of COVID-19 Infection.|pdf=|usr=007}} | ||
+ | {{tp|p=32409316|t=2020. Cerebrovascular Disease in COVID-19.|pdf=|usr=007}} | ||
+ | {{tp|p=32354715|t=2020. Neuroradiologists, Be Mindful of the Neuroinvasive Potential of COVID-19.|pdf=|usr=007}} | ||
+ | {{tp|p=32383969|t=2020. Segmental Pulmonary Vascular Changes in COVID-19 Pneumonia.|pdf=|usr=007}} | ||
+ | {{tp|p=32478611|t=2020. Reply to "Segmental Pulmonary Vascular Changes in COVID-19 Pneumonia".|pdf=|usr=007}} | ||
+ | {{tp|p=32470238|t=2020. Taste and smell as chemosensory dysfunctions in COVID-19 infection.|pdf=|usr=007}} | ||
+ | {{tp|p=32511678|t=2020. Use of RAAS inhibitors and risk of clinical deterioration in COVID-19: results from an Italian cohort of 133 hypertensives.|pdf=|usr=007}} | ||
+ | {{tp|p=32380565|t=2020. COVID-19 in Newborns and Infants-Low Risk of Severe Disease: Silver Lining or Dark Cloud?|pdf=|usr=007}} | ||
+ | {{tp|p=32438425|t=2020. COVID-19 in Pregnant Women: Case Series from One Large New York City Obstetrical Practice.|pdf=|usr=007}} | ||
+ | {{tp|p=32428964|t=2020. The Relationship between Status at Presentation and Outcomes among Pregnant Women with COVID-19.|pdf=|usr=007}} | ||
+ | {{tp|p=32403141|t=2020. Vertical Transmission of Severe Acute Respiratory Syndrome Coronavirus 2: A Systematic Review.|pdf=|usr=007}} | ||
+ | {{tp|p=32503058|t=2020. Vertical Transmission of SARS-CoV-2: What is the Optimal Definition?|pdf=|usr=007}} | ||
+ | {{tp|p=32467494|t=2020. In response to: Simpson R and Robinson L: Rehabilitation following critical illness in people with COVID-19 infection.|pdf=|usr=007}} | ||
+ | {{tp|p=32467490|t=2020. The place of early rehabilitation in ICU for Covid-19.|pdf=|usr=007}} | ||
+ | {{tp|p=32396381|t=2020. COVID-19 Associated Pulmonary Aspergillosis.|pdf=|usr=007}} | ||
+ | {{tp|p=32510975|t=2020. Thromboprophylaxis in COVID-19: Anti-FXa - The Missing Factor?|pdf=|usr=007}} | ||
+ | {{tp|p=32471004|t=2020. Early COVID-19 infection after lung transplantation.|pdf=|usr=007}} | ||
+ | {{tp|p=32471001|t=2020. COVID-19 in elderly kidney transplant recipients.|pdf=|usr=007}} | ||
+ | {{tp|p=32492753|t=2020. Recovery from COVID-19 following Hepatitis C, Human Immunodeficiency Virus Infection and Liver Transplantation.|pdf=|usr=007}} | ||
+ | {{tp|p=32483909|t=2020. Renal Infarct in a COVID-19 Positive Kidney-Pancreas Transplant Recipient.|pdf=|usr=007}} | ||
+ | {{tp|p=32476258|t=2020. Clinical Outcomes and Serologic Response in Solid Organ Transplant Recipients with COVID-19: A Case Series from the United States.|pdf=|usr=007}} | ||
+ | {{tp|p=32431287|t=2020. Critical Care Management of Patients with COVID-19: Early Experience in Thailand.|pdf=|usr=007}} | ||
+ | {{tp|p=32419694|t=2020. Case Report: COVID-19 Presenting as Acute Undifferentiated Febrile Illness-A Tropical World Threat.|pdf=|usr=007}} | ||
+ | {{tp|p=32500854|t=2020. Primary Respiratory Bacterial Coinfections in Patients with COVID-19.|pdf=|usr=007}} | ||
+ | {{tp|p=32503849|t=2020. Severe COVID-19-associated pneumonia in 3 patients with systemic sclerosis treated with rituximab.|pdf=|usr=007}} | ||
+ | {{tp|p=32503848|t=2020. Response to: 'Severe COVID-19 associated pneumonia in 3 patients with systemic sclerosis treated with rituximab' by Avouac et al.|pdf=|usr=007}} | ||
+ | {{tp|p=32205336|t=2020. Are my patients with rheumatic diseases at higher risk of COVID-19?|pdf=|usr=007}} | ||
+ | {{tp|p=32354774|t=2020. Non-steroidal anti-inflammatory treatment during covid-19: friend or foe? Response to: 'Coronavirus disease 19 (Covid-19) and non-steroidal anti-inflammatory drugs (NSAID)' by Giollo et al.|pdf=|usr=007}} | ||
+ | {{tp|p=32354773|t=2020. Diagnostic and therapeutic challenges for patients with ANCA-associated vasculitides at the time of COVID-19. Response to: 'Rituximab for granulomatosis with polyangiitis in the pandemic of COVID-19: lessons from a case with severe pneumonia' by Guilpain et al.|pdf=|usr=007}} | ||
+ | {{tp|p=32321723|t=2020. What is the true incidence of COVID-19 in patients with rheumatic diseases?|pdf=|usr=007}} | ||
+ | |||
+ | '''others''' | ||
{{tp|p=32276139|t=2020. COVID-19 in a patient with long-term use of glucocorticoids: A study of a familial cluster |pdf=|usr=}} | {{tp|p=32276139|t=2020. COVID-19 in a patient with long-term use of glucocorticoids: A study of a familial cluster |pdf=|usr=}} | ||
{{tp|p=32276140|t=2020. Epigenetic dysregulation of ACE2 and interferon-regulated genes might suggest increased COVID-19 susceptibility and severity in lupus patients |pdf=|usr=}} | {{tp|p=32276140|t=2020. Epigenetic dysregulation of ACE2 and interferon-regulated genes might suggest increased COVID-19 susceptibility and severity in lupus patients |pdf=|usr=}} |
Version vom 22. Juni 2020, 10:44 Uhr
coviki.org collects the really good Ideas and the scientific Record on Covid-19 Virus.
which risk factors make covid worse/better/no effect
RSP - identifying risk factors
which characteristics has covid in a diseased patient with underlying disorder/state
===007=== rsp and secondary d
32310612 2020. Cardiac Manifestations Of Coronavirus (COVID-19)
32490972 2020. COVID-19 and the eye: how much do we really know? A best evidence review.
32380787 2020. Acute Kidney Injury in SARS-CoV-2 Infection: Direct Effect of Virus on Kidney Proximal Tubule Cells.
32486196 2020. Cerebrovascular and Neurological Dysfunction under the Threat of COVID-19: Is There a Comorbid Role for Smoking and Vaping?
32455539 2020. Smoking-Mediated Upregulation of the Androgen Pathway Leads to Increased SARS-CoV-2 Susceptibility.
32423094 2020. COVID-19 and Individual Genetic Susceptibility/Receptivity: Role of ACE1/ACE2 Genes, Immunity, Inflammation and Coagulation. Might the Double X-chromosome in Females Be Protective against SARS-CoV-2 Compared to the Single X-Chromosome in Males?
32393136 2020. COVID-19 and the Cerebro-Cardiovascular Systems: What do we Know so Far?
32472662 2020. COVID-19 and diabetes: Is there enough evidence?
32397558 2020. Impact of COVID-19 on the Cardiovascular System: A Review.
32392741 2020. Clotting Factors in COVID-19: Epidemiological Association and Prognostic Values in Different Clinical Presentations in an Italian Cohort.
32443899 2020. Early Predictors of Clinical Deterioration in a Cohort of 239 Patients Hospitalized for Covid-19 Infection in Lombardy, Italy.
32443834 2020. Specific EEG Encephalopathy Pattern in SARS-CoV-2 Patients.
32403255 2020. COVID-19, MERS and SARS with Concomitant Liver Injury-Systematic Review of the Existing Literature.
32503180 2020. Fatal Outcomes of COVID-19 in Patients with Severe Acute Kidney Injury.
32498262 2020. Outcomes of COVID-19 among Patients on In-Center Hemodialysis: An Experience from the Epicenter in South Korea.
32498230 2020. Acute Coronary Syndromes and Covid-19: Exploring the Uncertainties.
32496205 2020. Why African Americans Are a Potential Target for COVID-19 Infection in the United States.
32449782 2020. Long-term clinical outcomes in survivors of severe acute respiratory syndrome and Middle East respiratory syndrome coronavirus outbreaks after hospitalisation or ICU admission: A systematic review and meta-analysis.
32271393 2020. Medical Rehabilitation in Pandemics: Towards a New Perspective.
32482654 2020. Dr. Favalli, et al reply.
32469410 2020. Venous Thrombosis Among Critically Ill Patients With Coronavirus Disease 2019 (COVID-19).
32475878 2020. The first pediatric patients with coronavirus disease 2019 (COVID-19) in Japan; The risk of co-infection with other respiratory viruses.
32475104 2020. Coronavirus Disease 2019 Presenting as Conjunctivitis.
32314329 2020. ACE-2 och coronavirus - en fraga om balans och dynamik?
32471831 2020. Reply to Siniorakis et al., "COVID-19 Interference with Renin-Angiotensin System in the Context of Heart Failure".
32444383 2020. COVID-19 Interference with Renin-Angiotensin System in the Context of Heart Failure.
32467553 2020. Smoking amidst the COVID-19 Pandemic - the invisible threat?
32478706 2020. Severe COVID-19 Cases: Is Respiratory Distress Partially Explained by Central Nervous System Involvement?
32442932 2020. Experiencia COVID-19 en un sanatorio privado de Buenos Aires durante el primer mes de la pandemia: 26 casos.
32481381 2020. A case report with COVID-19 during perioperative period of lobectomy.
32443345 2020. SARS-CoV-2 pneumonia with subcutaneous emphysema, mediastinal emphysema, and pneumothorax: A case report.
32384516 2020. Novel coronavirus 2019 (COVID-19): A case report and review of treatments.
32502054 2020. A 3-month-old child with COVID-19: A case report.
32502034 2020. The epidemiological characteristics of 2019 novel coronavirus diseases (COVID-19) in Jingmen, Hubei, China.
32397692 2020. A case of Covid19 infection manifesting itself with only abdominal symptoms.
32408731 2020. Covid-19 infection in kidney transplant recipients: endocrine and metabolic issues.
32380802 2020. Cardiovascular system and COVID-19: perspectives from a developing country.
32449614 2020. Gender differences in patients with COVID-19: a narrative review.
32447949 2020. Extrapolation of mortality in COVID-19: Exploring the role of age, sex, co-morbidities and health-care related occupation.
32432433 2020. Severity of COVID-19: The importance of being hypertensive.
32425013 2020. COVID-19 and coagulative axis: review of emerging aspects in a novel disease.
32415003 2020. Do SARS-CoV2 viral proteins have neuromodulatory properties?
32457227 2020. COVID-19-related acute necrotizing encephalopathy with brain stem involvement in a patient with aplastic anemia.
32457226 2020. COVID-19 in MS: Initial observations from the Pacific Northwest.
32482781 2020. Acute disseminated encephalomyelitis after SARS-CoV-2 infection.
32461235 2020. Guillain-Barre syndrome related to SARS-CoV-2 infection.
32444427 2020. COVID-19-White matter and globus pallidum lesions: Demyelination or small-vessel vasculitis?
32414755 2020. COVID-19 and MS disease-modifying therapies.
32432445 2020. The kidney in COVID-19: protagonist or figurant?
32486188 2020. SARS-CoV-2 Infection and the Liver.
32503140 2020. Human T leukaemia Type 1 and COVID-19.
32384078 2020. Clinical findings of patients with coronavirus disease 2019 in Jiangsu province, China: A retrospective, multi-center study.
32497090 2020. Maternal and neonatal outcomes associated with COVID-19 infection: A systematic review.
32420710 2020. Clinical characteristics and short-term outcomes of patients with coronavirus disease 2019: a retrospective single-center experience of a designated hospital in Poland.
32385979 2020. Diagnosis and recovery from severe acute respiratory syndrome coronavirus 2 infection is challenging in kidney patients: tests are an issue.
32491298 2020. Gender differences in the frequency of gastrointestinal symptoms and olfactory or taste disorders among 1,942 non-hospitalized patients with COVID-19.
32469263 2020. Nierensonomorphologie bei COVID-19 mit akuter Niereninsuffizienz.
32458823 2020. Infeccion por coronavirus Covid-19 y lactancia materna: una revision exploratoria.
32390132 2020. Trombosis venosa cerebral e infeccion por SARS-CoV-2.
32491116 2020. A brief-review of the risk factors for covid-19 severity.
32491091 2020. Adults at high-risk of severe coronavirus disease-2019 (Covid-19) in Brazil.
32491053 2020. Diabetes and covid-19: more than the sum of two morbidities.
32507709 2020. Sindrome de DRESS simulando enfermedad por coronavirus 2019-NcoV.
32512263 2020. COVID-19 in rheumatic disease patients on immunosuppressive agents.
32460453 2020. COVID-19 in Singapore - a case series from primary care.
32466735 2020. Clinical Characteristics and Outcomes of COVID-19 Patients With a History of Stroke in Wuhan, China.
32459857 2020. D-dimer and mortality in COVID-19: a self-fulfilling prophecy or a pathophysiological clue?
32506344 2020. Acute intestinal ischemia in a patient with COVID-19.
32463186 2020. Lungeembolisme ved covid-19.
32460390 2020. Covid-19 in solid organ transplant recipients: A single center experience.
32429038 2020. Prognosis of COVID-19 in Patients with Liver and Kidney Diseases: An Early Systematic Review and Meta-Analysis.
32395790 2020. COVID-19 and Cardiovascular diseases. Scoping review study.
32395788 2020. Features of patients with 2019 novel coronavirus admitted in a pneumology department: The first retrospective Tunisian case series.
32395787 2020. First case of imported and confirmed COVID-19 in Tunisia.
32394689 2020. COVID-19, Renin-angiotensin System and Hematopoiesis.
32490641 2020. Characteristics of the initial patients hospitalized for COVID-19: a single-center report.
32430957 2020. Effects of coronavirus disease 2019 (COVID-19) on maternal, perinatal and neonatal outcomes: a systematic review.
32450787 2020. Liver injury in COVID-19: The current evidence.
32450785 2020. COVID-19 and digestive health.
32501145 2020. Venous thromboembolism in patients with COVID-19 (SARS-CoV-2 infection) - a position paper of the German Society of Angiology (DGA).
32456286 2020. Antiviral Effects of Hydroxychloroquine and Type I Interferon on In Vitro Fatal Feline Coronavirus Infection.
32403242 2020. Prognostic Value of Cardiovascular Biomarkers in COVID-19: A Review.
32463395 2020. The involvement of the central nervous system in patients with COVID-19.
32493200 2020. Prevention of COVID-19 infection in the medical population: a possible help from anosmia?.
32386285 2020. Anosmia as a presenting symptom of SARS-CoV-2 infection in healthcare workers - A systematic review of the literature, case series, and recommendations for clinical assessment and management.
32352450 2020. Sniffing out the evidence; It's now time for public health bodies recognize the link between COVID-19 and smell and taste disturbance.
32396143 2020. Clinical and laboratory findings from patients with COVID-19 pneumonia in Babol North of Iran: a retrospective cohort study.
32435811 2020. COVID-19 Infection May Cause Clozapine Intoxication: Case Report and Discussion.
32355007 2020. The mystery of the pandemic's 'happy hypoxia'.
32396963 2020. SARS-2 Coronavirus-Associated Hemostatic Lung Abnormality in COVID-19: Is It Pulmonary Thrombosis or Pulmonary Embolism?
32512587 2020. Bleeding and Bleeding Risk in COVID-19.
32512586 2020. Confronting COVID-19: Issues in Hemophilia and Congenital Bleeding Disorders.
32447301 2020. Coexistent COVID-19 pneumonia and pulmonary embolism: challenges in identifying dual pathology.
32455440 2020. Sars-CoV-2 Induced Coagulopathy and Prognosis in Hospitalized Patients: A Snapshot from Italy.
32510876 2020. Differences in Clinical Characteristics of Covid-19 in Hispanic/Latino Population.
32510771 2020. COVID-19 In Lung Transplant Recipients: A Case Series From Milan, Italy.
32510756 2020. Hyponatremia: A Possible Immuno-Neuroendocrine Interface with COVID-19 in a Kidney Transplant Recipient.
32500942 2020. Outcome of COVID-19 in liver transplant recipients: A preliminary report from Northwestern Italy.
32500922 2020. Failed antibody response in a renal transplant recipient with SARS-CoV-2 infected.
32500666 2020. Coronavirus Disease 2019 in an Orthotopic Liver Transplant Recipient Living with Human Immunodeficiency Virus.
32492485 2020. Comparison of clinical and epidemiological characteristics of asymptomatic and symptomatic SARS-CoV-2 infection: A multi-center study in Sichuan Province, China.
32400381 2020. [De forste kliniske data fra RASi-behandlede indlagte patienter med COVID-19 kommer nu, og vi skal ikke aendre medicinering].
32400371 2020. [Anosmia and ageusia as primary symptoms of COVID-19].
32286214 2020. [Possible unregistered SARS-CoV-2 infection in a young man with anosmia and ageusia].
32462990 2020. COVID-19 complicated by pulmonary embolism treated with catheter directed thrombectomy.
32314950 2020. Society for Vascular Medicine (SVM) Leaders Respond to the COVID-19 Crisis.
32476394 2020. Otorinolaringologicheskie aspekty techeniya zabolevaniya u detei, infitsirovannykh virusom SARS-CoV-2.
32223839 2020. [Epidemiology and clinical features of highly pathogenic human coronavirus infection in children].
32065520 2020. [First case of neonate infected with novel coronavirus pneumonia in China].
32294814 2020. [Recommendations for respiratory rehabilitation of coronavirus disease 2019 in adult].
32447934 2020. [Clinical and coagulation characteristics in 7 patients with critical COVID-2019 pneumonia and acro-ischemia].
32418377 2020. [Clinical analysis of kidney injury in patients with COVID-19].
32496259 2020. COVID-19-Hospitalized Patients in Karnataka: Survival and Stay Characteristics.
32393678 2020. COVID-19: Important Issues for Pediatricians.
32412915 2020. Managing Children with Renal Diseases during COVID-19 Pandemic.
32487797 2020. The seXY side of COVID-19: what is behind female protection?
32487793 2020. Severe respiratory failure in an immunocompetent host with invasive pulmonary aspergillosis and H1N1 influenza.
32487789 2020. Risk factors for mortality in patients with Coronavirus Disease 2019 (COVID-19) in Bolivia: An analysis of the first 107 confirmed cases.
32468632 2020. Olfactory dysfunction in recovered COVID-19 patients.
32449528 2020. Effects of COVID-19 on Parkinson's Disease Clinical Features: A Community-Based Case-Control Study.
32470210 2020. Obesity is associated with worse outcomes in COVID-19: Analysis of Early Data From New York City.
32463562 2020. Possible Role of Adipose Tissue and Endocannabinoid System in COVID-19 Pathogenesis: Can Rimonabant Return?
32463545 2020. Obesity and COVID-19: an Italian snapshot.
32445512 2020. Morbid Obesity as an Independent Risk Factor for COVID-19 Mortality in Hospitalized Patients Younger than 50.
32445496 2020. Body Mass Index, Weight Discrimination, and Psychological, Behavioral, and Interpersonal Responses to the Coronavirus Pandemic.
32428380 2020. Increased ACE2 Expression in the Bronchial Epithelium of COPD Patients who are Overweight.
32505551 2020. Oral submucous fibrosis and COVID-19: Perspective on comorbidity.
32507368 2020. SARS-COV-2 associated acute pancreatitis: Cause, consequence or epiphenomenon?
32469426 2020. African American children are at higher risk of COVID-19 infection.
32453902 2020. Chilblains-like lesions and COVID-19.
32445583 2020. Erythema multiforme-like lesions in children and COVID-19.
32437077 2020. Clinical characteristics of COVID-19 in children: Are they similar to those of SARS?
32501190 2020. Angiotensin converting enzyme 2 (ACE2) and COVID-19: using antihypertensive medications, pharmacogenetic considerations.
32461198 2020. COVID-19, hypertension and cardiovascular diseases: Should we change the therapy?
32505834 2020. Would ACEIs/ARBs be beneficial for COVID-19 patients without hypertension?
32512122 2020. Acute myocardial injury in patients hospitalized with COVID-19 infection: A review.
32512352 2020. Affective psychosis after COVID-19 infection in a previously healthy patient: a case report.
32454268 2020. D-dimer in patients infected with COVID-19 and suspected pulmonary embolism.
32507399 2020. Tromboembolismo pulmonar y COVID-19: un cambio de paradigma.
32463446 2020. Familial cluster of SARS-CoV-2 infection associated with a railway journey.
32250460 2020. Impact of the COVID-19 Pandemic on Parkinson's Disease and Movement Disorders.
32502296 2020. SARS-CoV2 as a potential trigger of neurodegenerative diseases.
32502289 2020. SARS-CoV-2 as a trigger of neurodegeneration: thinking ahead.
32484584 2020. COVID-19 in Parkinson's Disease Patients Living in Lombardy, Italy.
32479103 2020. Special report: Prevalence of selected underlying health conditions among active component Army service members with coronavirus disease 2019, 11 February-6 April 2020.
32467603 2020. Resistance of children to Covid-19. How?
32463329 2020. Alemtuzumab in multiple sclerosis during the COVID-19 pandemic: A mild uncomplicated infection despite intense immunosuppression.
32391998 2020. De eerste 29 COVID-19-patienten in de kliniek.
32391997 2020. De eerste honderd opgenomen COVID-19-patienten in het Elisabeth-Tweesteden Ziekenhuis.
32395964 2020. Do's-and-don'ts bij COVID-19-coagulopathie.
32498065 2020. Neonates Hospitalized with Community-Acquired SARS-CoV-2 in a Colorado Neonatal Intensive Care Unit.
32468450 2020. New clinical manifestation of COVID-19 related Guillain-Barre syndrome highly responsive to intravenous immunoglobulins: two Italian cases.
32444493 2020. Clinical characteristics and outcomes of inpatients with neurologic disease and COVID-19 in Brescia, Lombardy, Italy.
32444492 2020. Bilateral transient olfactory bulbs edema during COVID-19-related anosmia.
32439822 2020. Pearls and Oy-sters: Facial nerve palsy as a neurological manifestation of Covid-19 infection.
32439821 2020. Generalized myoclonus in COVID-19.
32487714 2020. Cranial Neuropathies and COVID-19: Neurotropism and Autoimmunity.
32482845 2020. Neurologic manifestations in hospitalized patients with COVID-19: The ALBACOVID registry.
32424429 2020. Neurologically Devastating Intraparenchymal Hemorrhage in COVID-19 Patients on Extracorporeal Membrane Oxygenation: A Case Series.
32496534 2020. Letter: Thrombotic Neurovascular Disease in COVID-19 Patients.
32490520 2020. Letter: Hemorrhagic Conditions Affecting the Central Nervous System in COVID-19 Patients.
32237206 2020. Obesity and its Implications for COVID-19 Mortality.
32384387 2020. A Postpartum Death Due to Coronavirus Disease 2019 (COVID-19) in the United States.
32384385 2020. Acute Respiratory Distress Syndrome in a Preterm Pregnant Patient With Coronavirus Disease 2019 (COVID-19).
32459701 2020. Symptoms and Critical Illness Among Obstetric Patients With Coronavirus Disease 2019 (COVID-19) Infection.
32433453 2020. Clinical Findings and Disease Severity in Hospitalized Pregnant Women With Coronavirus Disease 2019 (COVID-19).
32433451 2020. Lymphopenia and Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection Among Hospitalized Obstetric Patients.
32496337 2020. Prevalence and Severity of Coronavirus Disease 2019 (COVID-19) Illness in Symptomatic Pregnant and Postpartum Women Stratified by Hispanic Ethnicity.
32510821 2020. Oral cavity lesions as a manifestation of the novel virus (COVID-19): a letter-to-editor.
32506730 2020. Oral Manifestations in Coronavirus Disease 2019 (COVID-19).
32506662 2020. Necrotizing periodontal disease: oral manifestation of COVID-19.
32419568 2020. Orbital cellulitis, sinusitis and intracranial abnormalities in two adolescents with COVID-19.
32453702 2020. Procoagulatio, hypercoagulatio es fibrinolysis "shut down" kimutatasa ClotPro(R) viszkoelasztikus tesztek segitsegevel COVID-19-betegekben.
32423359 2020. Subjective Changes in Smell and Taste During the COVID-19 Pandemic: A National Survey-Preliminary Results.
32423285 2020. Aggregate Prevalence of Chemosensory and Sinonasal Dysfunction in SARS-CoV-2 and Related Coronaviruses.
32482123 2020. SARS-CoV-2 Infection in Health Care Workers: Cross-sectional Analysis of an Otolaryngology Unit.
32501861 2020. Considering the potential for an increase in chronic pain following the COVID-19 pandemic.
32413201 2020. Symptoms and immunoglobulin development in hospital staff exposed to a SARS-CoV-2 outbreak.
32495391 2020. COVID-19 presenting with autoimmune hemolytic anemia in the setting of underlying immune dysregulation.
32467457 2020. Severe SARS-CoV-2 Infection in Children With Suspected Acute Abdomen: A Case Series From a Tertiary Hospital in Spain.
32467452 2020. ORCHIEPIDIDYMITIS IN A BOY WITH COVID-19.
32404789 2020. Neonatal Early-Onset Infection With SARS-CoV-2 in a Newborn Presenting With Encephalitic Symptoms.
32404786 2020. Clinical Analysis of 25 Novel Coronavirus Infections in Children.
32502128 2020. COVID-19-Associated Myocarditis in an Adolescent.
32398569 2020. COVID-19 in Children, Pregnancy and Neonates: A Review of Epidemiologic and Clinical Features.
32433226 2020. The Role of Human Coronavirus Infection in Pediatric Acute Gastroenteritis.
32433225 2020. Acute Inflammation and Elevated Cardiac Markers in a Two-Month-Old Infant with Severe Acute Respiratory Syndrome Coronavirus 2 Infection Presenting with Cardiac Symptoms.
32427645 2020. Pediatric Life-Threatening Coronavirus Disease 2019 With Myocarditis.
32404791 2020. COVID-19 in the Pediatric Population Admitted to a Tertiary Referral Hospital in Northern Italy: Preliminary Clinical Data.
32404780 2020. First Case of Coronavirus Disease 2019 in Childhood Leukemia in China.
32384398 2020. COVID-19 in Neonates and Infants: Progression and Recovery.
32384397 2020. Children Hospitalized With Severe COVID-19 in Wuhan.
32384396 2020. Hematuria Associated With SARS-CoV-2 Infection in a Child.
32492251 2020. Clinical manifestations of children with COVID-19: A systematic review.
32483934 2020. Overview: The history and pediatric perspectives of severe acute respiratory syndromes: Novel or just like SARS.
32392382 2020. COVID-19: A message of hope from a young girl with severe cystic fibrosis.
32439817 2020. Immune Thrombocytopenia (ITP) in a SARS-CoV-2 Positive Pediatric Patient.
32409480 2020. Caring for Newborns Born to Mothers with COVID-19: More Questions than Answers.
32404431 2020. A Case Series of the 2019 Novel Coronavirus (SARS-CoV-2) in Three Febrile Infants in New York.
32380898 2020. The "venous perspective" in Lombardia (Italy) during the first weeks of the COVID-19 epidemic.
32419564 2020. Consideration of prevention and management of long-term consequences of post-acute respiratory distress syndrome in patients with COVID-19.
32449876 2020. COVID-19: an unprecedented pandemia with a potential arrhythmic undertone.
32434874 2020. Elevated N-terminal pro-brain natriuretic peptide is associated with increased mortality in patients with COVID-19: systematic review and meta-analysis.
32338566 2020. Experiences and Insights from the Early US COVID-19 Epicenter: A Rapid Assessment Procedure Informed Clinical Ethnography Case Series.
32286091 2020. Mental health burden for the public affected by the COVID-19 outbreak in China: Who will be the high-risk group?
32442308 2020. The Clinical Features and Outcomes of Discharged Coronavirus Disease 2019 PatientsA Prospective Cohort Study.
32442268 2020. Stroke in a young COVID -19 patient.
32437314 2020. COVID-19 -associated Diffuse Leukoencephalopathy and Microhemorrhages.
32437313 2020. Imaging in Neurological Disease of Hospitalized COVID-19 Patients: An Italian Multicenter Retrospective Observational Study.
32407258 2020. COVID-19-Associated Leukoencephalopathy.
32391742 2020. Abdominal Imaging Findings in COVID-19: Preliminary Observations.
32484418 2020. Focal Cerebral Arteriopathy in a COVID-19 Pediatric Patient.
32374550 2020. Covid-19: la troublante decouverte des possibles vertus de la nicotine.
32374540 2020. Prise en charge de l'asthme et de la BPCO en situation de pandemie de COVID-19.
32374539 2020. Pandemie de COVID-19 : aspects cardiologiques.
32462846 2020. COVID-19: differences de symptomatologie entre la Chine et l'Europe.
32462841 2020. Obesite et risque de COVID-19 severe.
32432429 2020. COVID-19: elements de connaissances concernant les enfants.
32401442 2020. Les bloqueurs du systeme renine-angiotensine-aldosterone en temps de pandemie Covid-19 : amis ou ennemis ?
32496707 2020. La rehabilitation: indispensable pour les survivants d'un COVID-19 severe.
32348058 2020. Les complications cardiaques de la maladie COVID-19 sont-elles associees a une mortalite plus elevee ?
32348051 2020. Anosmie et COVID-19.
32348050 2020. Prise en charge des patients avec maladies digestives et hepatiques durant la pandemie COVID-19.
32348048 2020. COVID-19 : impact pediatrique.
32490966 2020. Neurological complications in patients with SARS-CoV-2 infection: a systematic review.
32469246 2020. Psychophysical Olfactory Tests and Detection of COVID-19 in Patients With Sudden Onset Olfactory Dysfunction: A Prospective Study.
32436441 2020. Anosmia Is a Key Symptom of COVID-19 Infection and Should Be Used as a Diagnostic Tool.
32490886 2020. Is there a rationale for heparin use among severe COVID-19 patients?
32453917 2020. SARS-CoV-2, bacterial co-infections, and AMR: the deadly trio in COVID-19?
32453685 2020. Acute Cerebral Stroke with Multiple Infarctions and COVID-19, France, 2020.
32441243 2020. Clostridioides difficile in COVID-19 Patients, Detroit, Michigan, USA, March-April 2020.
32487282 2020. Encephalopathy and Encephalitis Associated with Cerebrospinal Fluid Cytokine Alterations and Coronavirus Disease, Atlanta, Georgia, USA, 2020.
32458742 2020. Nurse infected with Covid-19 from a provisional dengue patient.
32395943 2020. Pericarditis aguda secundaria a COVID-19.
32392566 2020. The Hidden Face of Fear in the COVID-19 Era: The Amygdala Hijack.
32467096 2020. Clinicopathological characteristics of 8697 patients with COVID-19 in China: meta-analysis.
32429041 2020. COVID-19 and Gastrointestinal Symptoms-A Case Report.
32474561 2020. Clinical Characteristics of Elderly Patients with COVID-19 in Hunan Province, China: A Multicenter, Retrospective Study.
32482915 2020. Expression of Receptors for SARS-CoV-2 in the Gut of Patients with Inflammatory Bowel Disease.
32436996 2020. The value of clinical parameters in predicting the severity of COVID-19.
32427361 2020. Four cases: Human immunodeficiency virus and novel coronavirus 2019 Co-infection in patients from Long Island, New York.
32427357 2020. Encephalopathy in patients with COVID-19: 'Causality or coincidence?'
32418237 2020. Hypoxemia in COVID-19; Comment on: "The neuroinvasive potential of SARS - CoV2 may play a role in the respiratory failure of COVID-19 patients".
32418216 2020. Children with coronavirus disease 2019: A review of demographic, clinical, laboratory, and imaging features in pediatric patients.
32503883 2020. Defining causality in COVID-19 and neurological disorders.
32507577 2020. COVID-19 and Cerebral Hemorrhage: Proposed Mechanisms.
32510106 2020. Clinical Presentation of COVID19 in Dementia Patients.
32418199 2020. Angiotensin-converting enzyme 2 (ACE2), SARS-CoV-2 and the pathophysiology of coronavirus disease 2019 (COVID-19).
32470213 2020. All those D-dimers in COVID-19.
32470207 2020. Frequency of lupus anticoagulant in Covid-19 patients.
32470198 2020. Clinical differentiation of anticoagulant and non-anticoagulant properties of heparin.
32470154 2020. Reply to 'Ibuprofen and thromboembolism in SARS-COV2'.
32464707 2020. Macrothrombosis and stroke in patients with mild Covid-19 infection.
32459046 2020. Scientific and Standardization Committee Communication: Clinical Guidance on the Diagnosis, Prevention and Treatment of Venous Thromboembolism in Hospitalized Patients with COVID-19.
32426897 2020. Heparin - an old drug with multiple potential targets in Covid-19 therapy.
32415902 2020. Ibuprofen and thromboembolism in SARS-COV2.
32506364 2020. Hyperacute multi-organ thromboembolic storm in COVID-19: a case report.
32504449 2020. Diagnosis of venous and arterial thromboembolic events in COVID-19 virus-infected patients.
32492092 2020. Epidemiology, Clinical Features, and Disease Severity in Patients With Coronavirus Disease 2019 (COVID-19) in a Children's Hospital in New York City, New York.
32505466 2020. Cyclosporine as preferred calcineurin inhibitor in renal allograft recipients with COVID-19 infection.
32505222 2020. Early evidence of pronounced brain involvement in fatal COVID-19 outcomes.
32436600 2020. SARS-CoV-2 as an extrahepatic precipitator of acute-on-chronic liver failure.
32505846 2020. The use of ibuprofen to treat fever in COVID-19: A possible indirect association with worse outcome?
32512494 2020. Could nutritional and functional status serve as prognostic factors for COVID-19 in the elderly?
32441063 2020. Coronavirus disease 2019 (COVID-19): angiotensin-converting enzyme inhibitors, angiotensin II receptor blockers and cardiovascular disease.
32507110 2020. Pattern of liver injury in adult patients with COVID-19: a retrospective analysis of 105 patients.
32472989 2020. Relationship between ACE-inhibitors, ARBs and SARS-CoV-2 infection: where are we?
32508078 2020. SARS-CoV-2 infection in pregnant women: are there long-term effects in offspring's brain development?
32480326 2020. Are type 1 interferons treatment in Multiple Sclerosis as a potential therapy against COVID-19?
32480327 2020. Benign course of COVID-19 in a multiple sclerosis patient treated with Ocrelizumab.
32460086 2020. B-cell depleting therapies may affect susceptibility to acute respiratory illness among patients with multiple sclerosis during the early COVID-19 epidemic in Iran.
32445201 2020. SARS-CoV-2-associated Guillain-Barre syndrome with dysautonomia.
32510173 2020. Clinical characteristics and outcomes of COVID-19 patients with gastrointestinal symptoms admitted to Jianghan Fangcang Shelter Hospital in Wuhan, China.
32497344 2020. COVID-19 presenting with immune thrombocytopenia: a case report and review of the literature.
32497334 2020. A missing link between SARS-CoV-2 and the eye?: ACE2 expression on the ocular surface.
32497298 2020. Pancreatic injury in the course of coronavirus disease 2019 (COVID-19): a not-so-rare occurrence.
32497297 2020. Gendered effects on inflammation reaction and outcome of COVID-19 patients in Wuhan.
32497290 2020. Epidemiological evidence for association between higher influenza vaccine uptake in the elderly and lower COVID-19 deaths in Italy.
32497288 2020. COVID-19 polyradiculitis in 24 patients without SARS-CoV-2 in the cerebro-spinal fluid.
32508329 2020. COVID-19 in Refractory Myasthenia Gravis- A Case Report of Successful Outcome.
32500549 2020. Clinical update on COVID-19 in pregnancy: A review article.
32423324 2020. Clinical course of COVID-19 infection in elderly patient with melanoma on nivolumab.
32427809 2020. Inflammatory and Coagulative Considerations for the Management of Orthopaedic Trauma Patients with COVID-19: A Review of the Current Evidence and Our Surgical Experience.
32390643 2020. COVID-19 and Parkinson's Disease: Are We Dealing with Short-term Impacts or Something Worse?
32441753 2020. Clinical and Epidemiological Features of a Family Cluster of Symptomatic and Asymptomatic SARS-CoV-2 Infection.
32441743 2020. A Case Report of Neonatal Acute Respiratory Failure Due to SARS-CoV-2.
32504532 2020. Coronavirus Disease 2019 in Children Cared for at Texas Children's Hospital: Initial Clinical Characteristics and Outcomes.
32479632 2020. Characteristics of Hospitalized Pediatric COVID-19 Cases - Chicago, Illinois, March - April 2020.
32401228 2020. Are Covid-19-positive mothers dangerous for their term and well newborn babies? Is there an answer?
32404798 2020. Long-term Pulmonary Consequences of Coronavirus Disease 2019 (COVID-19): What We Know and What to Expect.
32495985 2020. The association between D-dimers in COVID-19 patients and mortality remains beset of uncertainties.
32348627 2020. Hereditary Haemorrhagic Telangiectasia: a disease not to be forgotten during the COVID-19 pandemic.
32432682 2020. Olfactory Dysfunction in COVID-19: Diagnosis and Management.
32432681 2020. Nasal ACE2 Levels and COVID-19 in Children.
32391864 2020. COVID-19 and Racial/Ethnic Disparities.
32215579 2020. Can SARS-CoV-2 Infection Be Acquired In Utero?: More Definitive Evidence Is Needed.
32511673 2020. Association Between Mode of Delivery Among Pregnant Women With COVID-19 and Maternal and Neonatal Outcomes in Spain.
32250408 2020. Critical Illness in Patients With COVID-19: Mounting an Effective Clinical and Research Response.
32293639 2020. COVID-19 and African Americans.
32469387 2020. Neuropathogenesis and Neurologic Manifestations of the Coronaviruses in the Age of Coronavirus Disease 2019: A Review.
32401283 2020. Low-Income Children and Coronavirus Disease 2019 (COVID-19) in the US.
32392288 2020. Characteristics and Outcomes of Children With Coronavirus Disease 2019 (COVID-19) Infection Admitted to US and Canadian Pediatric Intensive Care Units.
32511066 2020. Effect of Cancer on Clinical Outcomes of Patients With COVID-19: A Meta-Analysis of Patient Data.
32369410 2020. Management of Febrile Neutropenia Associated With SARS-CoV-2 Infection in a Patient With Cancer.
32394850 2020. [Role of age, comorbidity and renin- angiotensin-aldosterone system in COVID-19. Effects of ACE inhibitors and angiotensin receptor blockers].
32392591 2020. SARS CoV-2 und Influenza A-Ko-Infektion bei einem padiatrischen Patienten in Deutschland.
32471013 2020. Low prevalence and disease severity of COVID-19 in post liver transplant recipients - a single centre experience.
32495496 2020. Abnormal liver tests in patients hospitalized with Coronavirus disease 2019: should we worry?
32502316 2020. COVID-19 Infection in Early Post-Operative Period after Liver Transplantation.
32485314 2020. Persistent SARS-CoV-2 infection and the risk for cancer.
32512287 2020. Evaluation of COVID-19 infection in patients with Neuromyelitis optica spectrum disorder (NMOSD): A report from Iran.
32497292 2020. Guillain-Barre Syndrome in a Patient with Minimal Symptoms of COVID-19 Infection.
32320565 2020. First Case of Covid-19 in the United States. Reply.
32320563 2020. First Case of Covid-19 in the United States.
32320562 2020. First Case of Covid-19 in the United States.
32320561 2020. First Case of Covid-19 in the United States.
32320560 2020. First Case of Covid-19 in the United States.
32320559 2020. First Case of Covid-19 in the United States.
32220206 2020. Clinical Characteristics of Covid-19 in China. Reply.
32220205 2020. Clinical Characteristics of Covid-19 in China.
32220204 2020. Clinical Characteristics of Covid-19 in China.
32220203 2020. Clinical Characteristics of Covid-19 in China.
32220202 2020. Clinical Characteristics of Covid-19 in China.
32402156 2020. Case 17-2020: A 68-Year-Old Man with Covid-19 and Acute Kidney Injury.
32453517 2020. More on Neurologic Features in Severe SARS-CoV-2 Infection. Reply.
32453516 2020. More on Neurologic Features in Severe SARS-CoV-2 Infection.
32453515 2020. More on Neurologic Features in Severe SARS-CoV-2 Infection.
32427431 2020. Renin-Angiotensin-Aldosterone System Inhibitors in Covid-19. Reply.
32427430 2020. Renin-Angiotensin-Aldosterone System Inhibitors in Covid-19.
32427429 2020. Renin-Angiotensin-Aldosterone System Inhibitors in Covid-19.
32427428 2020. Renin-Angiotensin-Aldosterone System Inhibitors in Covid-19.
32329974 2020. Mild or Moderate Covid-19.
32427903 2020. How to address the coronavirus's outsized toll on people of colour.
32393875 2020. Coronavirus blood-clot mystery intensifies.
32265541 2020. Why measles deaths are surging - and coronavirus could make it worse.
32395965 2020. Een man met dyspneu na een COVID-19-pneumonie.
32503617 2020. Clinical characteristics of invasive pulmonary aspergillosis in patients with COVID-19 in Zhejiang, China: a retrospective case series.
32403153 2020. COVID-19-assoziierte Pneumonie trotz persistierend negativen PCR-Tests aus oropharyngealen Abstrichen.
32449179 2020. Mortality in Older Patients with COVID-19.
32441771 2020. COVID-SAFER: Deprescribing Guidance for Hydroxychloroquine Drug Interactions in Older Adults.
32445276 2020. Prosthetic aortic valve endocarditis complicated by COVID-19 and hemorrhage.
32452050 2020. The outlook for diagnostic purposes of the 2019-novel coronavirus disease.
32459882 2020. Comment on "Is the type of diabetes treatment relevant to outcome of COVID-19?"
32455499 2020. Late onset of acral necrosis after SARS-CoV-2 infection resolution.
32455485 2020. The COVID-19 outbreak in dermatologic surgery: resetting clinical priorities.
32455475 2020. COVID-19 in a melanoma patient under treatment with checkpoint-inhibition.
32453865 2020. Cutaneous small-vessel vasculitis associated with novel 2019 coronavirus SARS-CoV-2 infection (COVID-19).
32452545 2020. Are chilblain-like acral skin lesions really indicative of COVID-19? A prospective study and literature review.
32452542 2020. COVID-19 Presenting with Atypical Sweet's Syndrome.
32441876 2020. Cutaneous small vessel vasculitis secondary to COVID-19 infection: A case report.
32441830 2020. Diversity of clinical appearance of cutaneous manifestations in the course of COVID-19.
32434277 2020. Acral purpuric lesions (erythema multiforme type) associated with thrombotic vasculopathy in a child during the COVID-19 pandemic.
32428303 2020. COVID-19 and dermatology: a comprehensive guide for dermatologists.
32428291 2020. Fever with Rash in COVID-19: Viral Exanthema or Secondary Lesions?
32426877 2020. Metastatic melanoma treatment with checkpoint inhibitors in the COVID-19 era: experience from an Italian Skin Cancer Unit.
32426864 2020. A clinicopathological study of 8 patients with COVID-19 pneumonia and a late-onset exanthema.
32421877 2020. A late-onset widespread skin rash in a previous COVID-19-infected patient: viral or multidrug effect?
32421876 2020. Chilblain acral lesions in the COVID-19 era. Are they marker of infection in asymptomatic patients?
32450607 2020. Gastrointestinal: Bowel ischemia in a suspected coronavirus disease (COVID-19) patient.
32436622 2020. Metabolic associated fatty liver disease increases coronavirus disease 2019 disease severity in nondiabetic patients.
32512022 2020. Early administered antibiotics do not impact mortality in critically ill patients with COVID-19.
32512021 2020. Anormal pulmonary function and residual CT abnormalities in rehabilitating COVID-19 patients after discharge.
32504736 2020. Tumor biomarkers predict clinical outcome of COVID-19 patients.
32458565 2020. Mortality of people with intellectual disabilities during the 2017/2018 influenza epidemic in the Netherlands: potential implications for the COVID-19 pandemic.
32459372 2020. COVID-19 and renin-angiotensin system inhibition: role of angiotensin converting enzyme 2 (ACE2) - Is there any scientific evidence for controversy?
32500773 2020. COVID-19 and Acute Lupus Pneumonitis: Diagnostic and Treatment Dilemma.
32470212 2020. Letter to the Editor: Are severe COVID-19 patients more susceptible to conjunctivitis?
32470211 2020. Are we now observing an increasing number of coinfections between SARS-CoV-2 and other respiratory pathogens?
32470186 2020. Correlation between the variables collected at admission and progression to severe cases during hospitalization among patients with COVID-19 in Chongqing.
32470174 2020. Higher prevalence of asymptomatic or mild COVID-19 in children, claims and clues.
32470167 2020. Early risk factors of the exacerbation of Coronavirus disease 2019 pneumonia.
32470156 2020. The novel coronavirus disease (COVID-19) complicated by pulmonary embolism and acute respiratory distress syndrome.
32462695 2020. Coinfection with SARS-CoV-2 and other respiratory pathogens in COVID-19 patients in Guangzhou, China.
32462689 2020. Features of enteric disease from human coronaviruses: Implications for COVID-19.
32462663 2020. Clinical features and outcome of HIV/SARS-CoV-2 coinfected patients in The Bronx, New York city.
32458578 2020. COVID-19 encephalopathy masquerading as substance withdrawal.
32449972 2020. Presenting characteristics, comorbidities, and outcomes of patients coinfected with COVID-19 and Mycoplasma pneumoniae in the USA.
32449792 2020. Severe SARS-CoV-2 pneumonia in a 58-year-old patient with HIV: a clinical case report from the Republic of Cyprus.
32445489 2020. COVID-19 and Liver Dysfunction: a systematic review and meta-analysis of retrospective studies.
32441816 2020. Systematic analysis of ACE2 and TMPRSS2 expression in salivary glands reveals underlying transmission mechanism caused by SARS-CoV-2.
32441789 2020. Predictors of mortality in hospitalized COVID-19 patients: A systematic review and meta-analysis.
32441787 2020. A Rare Case of Immune Thrombocytopenic Purpura Secondary to COVID-19.
32441773 2020. COVID-19 in a patient with HIV infection.
32437017 2020. Epidemiological and clinical characteristics of discharged patients infected with SARS-CoV-2 on the Qinghai plateau.
32437016 2020. Obesity predisposes to the risk of higher mortality in young COVID-19 patients.
32437004 2020. Hepatic complications of COVID-19 and its treatment.
32437000 2020. HIV and SARS-CoV-2 coinfection: A case report from Uganda.
32436998 2020. Lack of viral transmission to preterm newborn from a COVID-19 positive breastfeeding mother at 11 days postpartum.
32505530 2020. Co-infection with an atypical pathogen of COVID-19 in a young.
32505438 2020. The Association Between Symptom Onset and Length of Hospital Stay in 2019 Novel Coronavirus Pneumonia Cases Without Epidemiological Trace.
32505908 2020. Immunologic characterization of a immunosuppressed multiple sclerosis patient that recovered from SARS-CoV-2 infection.
32385130 2020. Clinical Characteristics of and Medical Interventions for COVID-19 in Hemodialysis Patients in Wuhan, China.
32467113 2020. Presentation and Outcomes of Patients with ESKD and COVID-19.
32484893 2020. Elevated Cardiac Troponin I Is Associated with Poor Outcomes in COVID-19 Patients at an Academic Medical Center in Midwestern USA.
32448041 2020. Covid-19 induced superimposed bacterial infection.
32453074 2020. Atrial Fibrillation in COVID-19: From epidemiological association to pharmacological implications.
32510598 2020. Single-cell RNA analysis on ACE2 expression provides insights into SARS-CoV-2 potential entry into the bloodstream and heart injury.
32433344 2020. Judicious Use of Sodium-Glucose Cotransporter 2 Inhibitors in Patients with Diabetes on Coronavirus-19 Pandemic.
32433342 2020. Cardiovascular Manifestation and Treatment in COVID-19.
32502117 2020. Coronavirus disease 2019 in children: Current status.
32474598 2020. Predicting mortality due to SARS-CoV-2: A mechanistic score relating obesity and diabetes to COVID-19 outcomes in Mexico.
32436948 2020. Subacute Thyroiditis After Sars-COV-2 Infection.
32488958 2020. Analysis of clinical features and outcomes of 161 patients with severe and critical COVID-19: A multicenter descriptive study.
32488888 2020. Elevated serum aspartate aminotransferase level identifies patients with coronavirus disease 2019 and predicts the length of hospital stay.
32479133 2020. TMPRSS2 and ACE2 Coexpression in SARS-CoV-2 Salivary Glands Infection.
32406283 2020. A survey of psoriasis patients on biologics during COVID-19: a single centre experience.
32363967 2020. A challenging case of psoriasis flare-up after COVID-19 infection.
32433220 2020. When life is put on hold, how do we hold on to life? - Challenges and Opportunities in Developmental and Behavioral Pediatrics during COVID-19.
32394639 2020. COVID-19 and comorbidities: A role for dipeptidyl peptidase 4 (DPP4) in disease severity?
32389027 2020. Glycemic Characteristics and Clinical Outcomes of COVID-19 Patients Hospitalized in the United States.
32506937 2020. Why Do People With Diabetes Have a High Risk for Severe COVID-19 Disease?-A Dental Hypothesis and Possible Prevention Strategy.
32484624 2020. COVID-19 Pandemic: Are There Unique Cutaneous Manifestations in Patients Infected With SARS-CoV-2?
32468512 2020. COVID-19 may affect the endocrine pancreas by activating Na(+)/H(+) exchanger 2 and increasing lactate levels.
32474947 2020. A clinical, histopathological and laboratory study of 19 consecutive Italian paediatric patients with chilblain-like lesions: lights and shadows on the relationship with COVID-19 infection.
32510648 2020. Urticarial vasculitis in COVID-19 infection: a vasculopathy-related symptom?
32500642 2020. Histology of skin lesions establishes that the vesicular rash associated with COVID-19 is not "varicella-like".
32495400 2020. Exanthema and eosinophilia in Covid-19 patients: has viral infection a role in drug induced exanthemas?
32495368 2020. Clinical and histological characterization of late appearance maculopapular eruptions in association with the coronavirus disease 2019. A case series of seven patients.
32491234 2020. Retiform purpura as a dermatological sign of covid-19 coagulopathy.
32491223 2020. COVID-19: how it can look on the skin. Clinical and pathological features in twenty COVID-19 patients observed in Bologna, northeastern Italy.
32488946 2020. No antibody response in acral cutaneous manifestations associated with COVID-19 ?
32488910 2020. Acro-ischemia and COVID-19 infection: clinical and histopathological features.
32506122 2020. Clinical Characteristics of Hospitalized Individuals Dying with COVID-19 by Age Group in Italy.
32490807 2020. Clinical Progress Note: Point-of-Care Ultrasound Applications in COVID-19.
32502097 2020. Angiotensin-converting enzyme inhibitors, angiotensin II type 1 receptor blockers and risk of COVID 19: information from Bartter's and Gitelman's syndromes patients.
32502096 2020. Are COVID-19 patients with hypertension at higher risk in China?
32504747 2020. Cardiovascular complications in COVID-19: A systematic review and meta-analysis.
32504746 2020. SARS-CoV-2 RNA detection in tears and conjunctival secretions of COVID-19 patients with conjunctivitis.
32504741 2020. Does type of immunosupression influence the course of Covid-19 infection?
32490559 2020. Supporting individuals with intellectual and developmental disability during the first 100 days of the COVID-19 outbreak in the USA.
32462792 2020. Sex-based dimorphism in the SARS-CoV2 virulence.
32452046 2020. Racial disparities in COVID-19 deaths reveal harsh truths about structural inequality in America.
32498135 2020. Older age and comorbidity are independent mortality predictors in a large cohort of 1305 COVID-19 patients in Michigan, United States.
32406374 2020. Olfactory dysfunction in the COVID-19 outbreak.
32498581 2020. Relationship between pregnancy and coronavirus: what we know.
32223477 2020. Pregnant women in the exposure to COVID-19 infection outbreak: the unseen risk factors and preventive healthcare patterns.
32369209 2020. Clinical characteristics and outcomes of cancer patients with COVID-19.
32497287 2020. Anticardiolipin antibodies and COVID-19-A case report from America.
32497283 2020. Influenza and COVID-19 Co-infection: Report of 6 cases and review of the Literature.
32492209 2020. Determining Host Factors Contributing to Disease Severity in a Family Cluster of 29 Hospitalized SARS-CoV-2 Patients: Could Genetic Factors Be Relevant in the Clinical Course of COVID-19?.
32492199 2020. Direct endothelial damage and vasculitis due to SARS-CoV-2 in small bowel submucosa of CoViD-19 patient with diarrhea.
32492193 2020. Potential Neuroinvasive Pathways of SARS-CoV-2: Deciphering the Spectrum of Neurological Deficit Seen in Coronavirus Disease 2019 (COVID-19).
32492188 2020. A case of SARS-CoV-2 infection in an untreated HIV patient in Tokyo, Japan.
32484990 2020. First Case of Focal Epilepsy Associated with SARS-Coronavirus-2.
32484975 2020. Myocardial injury characterized by elevated cardiac troponin and in-hospital mortality of COVID-19: an insight from a meta-analysis.
32314808 2020. Comment on Li et al: COVID-19 patients' clinical characteristics, discharge rate, and fatality rate of meta-analysis.
32335609 2020. Clinical Profile of Cases of COVID-19 in Far Western Province of Nepal.
32451359 2020. Stroke and mechanical thrombectomy in patients with COVID-19: technical observations and patient characteristics.
32409442 2020. Skin manifestations of COVID-19.
32409440 2020. The role of cardiac imaging in hospitalized COVID-19-positive patients.
32409438 2020. Treating acute anxiety in patients with COVID-19.
32409436 2020. Patients with interstitial lung disease and pulmonary sarcoidosis are at high risk for severe illness related to COVID-19.
32409434 2020. Renin-angiotensin system inhibitors in COVID-19.
32393596 2020. COVID-19 and pulmonary hypertension.
32393593 2020. Recognition and management of respiratory coinfection and secondary bacterial pneumonia in patients with COVID-19.
32409435 2020. Coagulopathy in COVID-19.
32452350 2020. Understanding immune effects of oestrogens to explain the reduced morbidity and mortality in female versus male COVID-19 patients. Comparisons with autoimmunity and vaccination.
32461326 2020. Baseline characteristics and outcomes of patients with COVID-19 admitted to intensive care units in Vancouver, Canada: a case series.
32461325 2020. Anosmia and dysgeusia associated with SARS-CoV-2 infection: an age-matched case-control study.
32409520 2020. Probable congenital SARS-CoV-2 infection in a neonate born to a woman with active SARS-CoV-2 infection.
32504100 2020. Ocular manifestations of coronavirus disease 2019.
32437033 2020. Objective olfactory evaluation of self-reported loss of smell in a case series of 86 COVID-19 patients.
32437022 2020. Olfactory and gustatory function impairment in COVID-19 patients: Italian objective multicenter-study.
32507468 2020. Measuring grip strength in COVID-19: A simple way to predict overall frailty/impairment.
32456720 2020. COVID-19 infections among HCWs exposed to a patient with a delayed diagnosis of COVID-19.
32460395 2020. Focus on kidney disease among the coronavirus disease 2019 patients: A comparative perspective between China, Italy and the United States.
32447761 2020. Dermatological findings in COVID-19 patients: Mexican experience.
32505878 2020. Patients with COVID-19 and neurological manifestations show undetectable SARS-CoV-2 RNA levels in the cerebrospinal fluid.
32505779 2020. Could antiphospholipid antibodies contribute to coagulopathy in COVID-19?
32505431 2020. Neuroimmune correlates of the nervous system involvement of COVID-19: A commentary.
32505432 2020. Does COVID-19 cause axonal GBS?
32449224 2020. Analysis of the clinical characteristics, drug treatments and prognoses of 136 patients with coronavirus disease 2019.
32398625 2020. Coincidence of COVID-19 Infection and Smell: Taste Perception Disorders.
32512349 2020. Clinically significant anticardiolipin antibodies associated with COVID-19.
32242895 2020. Experiences and lesson strategies for cardiology from the COVID-19 outbreak in Wuhan, China, by 'on the scene' cardiologists.
32498078 2020. Renin-angiotensin system inhibitors in the COVID-19 pandemic: consequences of antihypertensive drugs.
32423251 2020. Comparison of cardiovascular metabolic characteristics and impact on COVID-19 and MERS.
32423249 2020. Physical activity/inactivity and COVID-19.
32397803 2020. Les liaisons dangereuses and the danger of deductions: The interplay between cardiovascular disease and COVID-19.
32475157 2020. Exercise in the Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) era: A Question and Answer session with the experts Endorsed by the section of Sports Cardiology & Exercise of the European Association of Preventive Cardiology (EAPC).
32270698 2020. Physical inactivity and cardiovascular disease at the time of coronavirus disease 2019 (COVID-19).
32233671 2020. Have a heart during the COVID-19 crisis: Making the case for cardiac rehabilitation in the face of an ongoing pandemic.
32495914 2020. No infectious risk of COVID-19 patients with long-term fecal 2019-nCoV nucleic acid positive.
32495913 2020. Severe acute dried gangrene in COVID-19 infection: a case report.
32495849 2020. Gender differences in COVID-19 infection. The estrogen effect on upper and lower airways. Can it help to figure out a treatment?
32441761 2020. COVID-19 and QT interval prolongation: more than just drug toxicity?
32441223 2020. COVID-19 and obesity: links and risks.
32511033 2020. COVID-19 and diabetes mellitus: implications for prognosis and clinical management.
32425184 2020. Sindrome Takotsubo in corso di polmonite da SARS-CoV-2: una possibile complicanza cardiovascolare.
32412510 2020. Neurological manifestations of COVID-19.
32420884 2020. Pathologies cardiovasculaires et Covid-19 : particularites chez les personnes agees.
32434831 2020. Clinical course and risk factors for mortality of COVID-19 patients with pre-existing cirrhosis: a multicentre cohort study.
32430348 2020. Comparative study of the clinical characteristics and epidemiological trend of 244 COVID-19 infected children with or without GI symptoms.
32414813 2020. Risk of severe illness from COVID-19 in patients with metabolic dysfunction-associated fatty liver disease and increased fibrosis scores.
32493828 2020. Prevalence, risk factors and clinical outcomes of COVID-19 in patients with a history of pancreatitis in Northern California.
32464676 2020. Haemostasis in Times of COVID-19.
32498097 2020. Coagulopathy in COVID-19 and Its Implication for Safe and Efficacious Thromboprophylaxis.
32431118 2020. [CURRENT KNOWLEDGE ON COVID-19 IN CHILDREN - CAUTIOUS OPTIMISM].
32437224 2020. Disparities In Outcomes Among COVID-19 Patients In A Large Health Care System In California.
32461330 2020. Impact of cardiovascular disease and cardiac injury on in-hospital mortality in patients with COVID-19: a systematic review and meta-analysis.
32461328 2020. Getting to the heart of the matter of COVID-19.
32451360 2020. Cardiovascular disease and COVID-19: implications for prevention, surveillance and treatment.
32499236 2020. COVID-19 pandemic and troponin: indirect myocardial injury, myocardial inflammation or myocarditis?
32364920 2020. A Case of Postoperative Covid-19 Infection After Cardiac Surgery: Lessons Learned.
32473607 2020. Acute Liver Injury in COVID-19: Prevalence and Association with Clinical Outcomes in a Large US Cohort.
32415860 2020. Liver Biochemistries in Hospitalized Patients With COVID-19.
32512611 2020. Endocrine Conditions and COVID-19.
32429774 2020. Anti-coagulant and anti-platelet therapy in the COVID-19 patient: a best practices quality initiative across a large health system.
32456489 2020. Complications and outcomes of SARS-CoV-2 in pregnancy: where and what is the evidence?
32383626 2020. RAAs inhibitors and outcome in patients with SARS-CoV-2 pneumonia. A case series study.
32383624 2020. Controversial Relationship between Renin-Angiotensin System Inhibitors and Severity of COVID-19: Announcing a Large Multicentre Case-Control Study in Italy.
32458694 2020. Decreased Mortality of COVID-19 with Renin-Angiotensin-Aldosterone System Inhibitors Therapy in Patients with Hypertension: A Meta-Analysis.
32493070 2020. Comparative impacts of angiotensin converting enzyme inhibitors versus angiotensin II receptor blockers on the risk of COVID-19 mortality.
32476472 2020. COVID-19: ACE2centric infective disease?
32503820 2020. Ocular Manifestations of COVID-19 (SARS-CoV-2): A Critical Review of Current Literature.
32389131 2020. A case of COVID-19 with an ultralong incubation period.
32427018 2020. Several neonates reported positive for COVID-19.
32476551 2020. Challenges in COVID-19: is pulmonary thromboembolism related to overall severity?
32476537 2020. Early experience with COVID-19 patients at academic hospital in Southwestern United States.
32436835 2020. Isolated Anosmia as a Presentation of COVID-19: An Experience in a Referral Hospital.
32418532 2020. Counter-regulatory 'Renin-Angiotensin' System-based Candidate Drugs to Treat COVID-19 Diseases in SARS-CoV-2-infected patients.
32389117 2020. A Viewpoint on Angiotensin-Converting Enzyme 2, Anti-Hypertensives and Coronavirus Disease 2019 (COVID-19).
32348232 2020. A Patient with COVID-19 Disease in a Referral Hospital in Iran: A Typical Case.
32440692 2020. Temporal Correlation Between Neurological and Gastrointestinal Symptoms of SARS-CoV-2.
32497397 2020. Psychophysical olfactory testing in COVID-19: is smell function really impaired in nearly all patients?
32496658 2020. Reply to: Psychophysical olfactory testing in COVID-19: Is smell function really impaired in nearly all patients?
32505331 2020. COVID-19 and cardiovascular injury: A role for oxidative stress and antioxidant treatment?
32506768 2020. Clinical features and outcomes of COVID-19 patients with benign prostatic hyperplasia in aging male: A retrospective study of 18 cases.
32506743 2020. No current evidence supporting risk of using Ibuprofen in patients with COVID-19.
32496583 2020. Chilblain-like lesions during the COVID-19 pandemic: should we really worry?
32496578 2020. Chilblains-like dermatologic manifestation of COVID-19 diagnosed by serology via multidisciplinary virtual care.
32363628 2020. Management of older people during the COVID-19 outbreak: Recommendations from an Italian experience.
32473603 2020. Maternal mortality from COVID-19 in Mexico.
32438521 2020. Update on clinical outcomes of women with COVID-19 during pregnancy.
32428290 2020. Severe COVID-19 in a pregnant patient admitted to hospital in Wuhan.
32510581 2020. Clinical characteristics and laboratory results of pregnant women with COVID-19 in Wuhan, China.
32330289 2020. Be aware of misdiagnosis-Influenza A H1N1 in a pregnant patient with suspected COVID-19.
32510283 2020. EXPRESS: COVID-19 and stroke in Iran; a case series, and effects on stroke admissions.
32501751 2020. EXPRESS: Brain ischemic and hemorrhagic complications of COVID-19.
32468166 2020. Acute kidney injury associated with COVID-19: another extrapulmonary manifestation.
32408926 2020. Fallout from the Covid-19 pandemic - should we prepare for a tsunami of post viral depression?
32267662 2020. Pregnancy and Sars-Cov-2: A Novel Virus in a Unique Population
32483000 2020. COVID-19 pneumonia in patients with HIV - A Case Series.
32404716 2020. A case of HIV and SARS-CoV-2 co-infection in Singapore.
32418475 2020. Who are the Most At-Risk Older Adults in the COVID-19 Era? It's Not Just Those in Nursing Homes.
32250655 2020. Call to Action: Announcing the Traditional, Complementary and Integrative Health and Medicine COVID-19 Support Registry.
32497704 2020. Comment on: "Characterization of acute acro-ischemic lesions in non-hospitalized patients: a case series of 132 patients during the COVID-19 outbreak".
32482887 2020. Haemorrhagic enteritis and COVID-19: causality or coincidence.
32511148 2020. COVID-19 and Its Potential Effect on Patients With Rheumatic Diseases in Latin America.
32364930 2020. Circadian rhythm sleep-wake disorders and the COVID-19 pandemic.
32364928 2020. Dental sleep medicine perspectives post-COVID-19: interprofessional adaptation and directions.
32441248 2020. The impact of SARS-CoV-2 on sleep.
32441246 2020. Does obstructive sleep apnea lead to increased risk of COVID-19 infection and severity?
32356516 2020. Potential influences of obstructive sleep apnea and obesity on COVID-19 severity.
32484776 2020. COVID-19 and obstructive sleep apnea.
32347205 2020. Narcolepsy and COVID-19: sleeping on an opportunity?
32449619 2020. Preliminary Data Suggests That Biologics in Dermatology Are Not Associated With Adverse COVID-19 Outcomes.
32436736 2020. Visual Dermatology: Acral Erythemato-purpuric Lesions During COVID-19 Pandemic.
32391713 2020. Cutaneous Manifestations of Coronavirus Disease 2019 (COVID-19) Infection-What Do We Know So Far?
32464084 2020. The first two months of COVID-19 pandemic in Bosnia and Herzegovina: Single-center experience.
32415815 2020. Lessons Learned from COVID-19 Pandemic in Italy.
32468942 2020. A matter of time: duration and choice of venous thromboprophylaxis in patients diagnosed with COVID-19.
32454503 2020. Stroke in COVID-19 and SARS-CoV-1.
32438476 2020. Reply to "Clinical and histological characterization of vesicular COVID-19 rashes: a prospective study in a tertiary care hospital": Pseudoherpetic Grover disease seems to appear in patients with COVID-19 infection.
32421857 2020. Novel outbreak of acral lesions in times of COVID-19: A description of 74 cases from a tertiary university hospital in Spain.
32505730 2020. Uncommon presentation of COVID-19: Gastrointestinal bleeding.
32508062 2020. COVID-19 critical illness pathophysiology driven by diffuse pulmonary thrombi and pulmonary endothelial dysfunction responsive to thrombolysis.
32508037 2020. Mental health status and related influencing factors of COVID-19 survivors in Wuhan, China.
32508034 2020. Predicted value of coagulation function for prognosis and admission time to negative RT-PCR detection in non-critical COVID-19 patients.
32508024 2020. Clinical characteristics and risk factors for mortality among inpatients with COVID-19 in Wuhan, China.
32508041 2020. Significance of clinical phenomes of patients with COVID-19 infection: A learning from 3795 patients in 80 reports.
32507407 2020. COVID 19-An eye on the virus.
32505211 2020. Lung ventilation function characteristics of survivors from severe COVID-19: a prospective study.
32467423 2020. Potential mechanisms of cardiac injury and common pathways of inflammation in patients with COVID-19.
32458546 2020. Cutaneous manifestations of COVID-19: A review of the published literature.
32447798 2020. Are erythema multiforme and urticaria related to a better outcome of COVID-19?
32505652 2020. Detrimental effects of metabolic dysfunction-associated fatty liver disease and increased neutrophil-to-lymphocyte ratio on severity of COVID-19.
32505980 2020. Relationship between COVID-19 and obesity.
32469464 2020. Newly diagnosed diabetes is associated with a higher risk of mortality than known diabetes in hospitalized patients with COVID-19.
32463179 2020. Exposure to DPP-4 inhibitors and COVID-19 among people with type 2 diabetes. A case-control study.
32463166 2020. Why is hyperglycemia worsening COVID-19 and its prognosis?
32451317 2020. The contribution of diabetic micro-angiopathy to adverse outcomes in COVID-19.
32506222 2020. COVID-19: Impact of and on Diabetes.
32507692 2020. Clinical characteristics of coronavirus disease (COVID-19) patients with gastrointestinal symptoms: A report of 164 cases.
32463538 2020. Excess out-of-hospital deaths during COVID-19 outbreak: evidence of pulmonary embolism as a main determinant.
32438449 2020. The Dilemma of Renin Angiotensin System Blockers in Coronavirus Disease (Covid-19): Insights on the Lung Fluid Handling and Gas Exchange in Heart Failure Patients.
32430971 2020. SARS-CoV2-related myocarditis-like syndroms: Shakespeare s question: What s in a name?
32507518 2020. Does active smoking worsen Covid-19?
32460417 2020. COVID-19 - neurologists stay aware!
32460415 2020. Dysphagia in COVID-19 -multilevel damage to the swallowing network?
32449247 2020. Reply to letter: Acute-onset smell and taste disorders in the context of Covid-19: a pilot multicenter PCR-based case-control study.
32449248 2020. COVID-19 and herpes zoster co-infection presenting with trigeminal neuropathy.
32443166 2020. Letter to the Editor about the Beltran-Corbellini et al. publication :"Acute-onset smell and taste disorders in the context of Covid-19: a pilot multicenter PCR-based case-control study" (Eur J Neurol. 2020. doi: 10.1111/ene.14273.).
32416028 2020. Neurological manifestations and neuro-invasive mechanisms of the severe acute respiratory syndrome coronavirus type 2.
32505514 2020. COVID-19 infection during the third trimester of pregnancy: Current clinical dilemmas.
32504135 2020. Point-of-care lung ultrasound in three neonates with COVID-19.
32339038 2020. ST-Segment-Elevation Myocardial Infarction Care and COVID-19: The Value Proposition of Fibrinolytic Therapy and the Pharmacoinvasive Strategy.
32500721 2020. Approach to Acute Cardiovascular Complications in COVID-19 Infection.
32482087 2020. Incidence of New-Onset and Worsening Heart Failure Before and After the COVID-19 Epidemic Lockdown in Denmark: A Nationwide Cohort Study.
32508261 2020. Hypoalbuminemia, Coagulopathy and Vascular Disease in Covid-19.
32469253 2020. The Spectrum of Cardiac Manifestations in Coronavirus Disease 2019 (COVID-19) - a Systematic Echocardiographic Study.
32421381 2020. Deep Vein Thrombosis in Hospitalized Patients with Coronavirus Disease 2019 (COVID-19) in Wuhan, China: Prevalence, Risk Factors, and Outcome.
32412320 2020. Extremely High Incidence of Lower Extremity Deep Venous Thrombosis in 48 Patients with Severe COVID-19 in Wuhan.
32507123 2020. Self-reported anosmia and dysgeusia as key symptoms of COVID-19.
32386189 2020. ACE Ins/Del genetic polymorphism and epidemiological findings in COVID-19.
32386188 2020. No significant correlation between ACE Ins/Del genetic polymorphism and COVID-19 infection.
32432563 2020. Reporting of D-dimer data in COVID-19: some confusion and potential for misinformation.
32406381 2020. COVID-19: progression of disease and intravascular coagulation - present status and future perspectives.
32423908 2020. Early Outcomes of Outpatient Management of Kidney Transplant Recipients with Coronavirus Disease 2019.
32390405 2020. COVID-19 Viral Load of an Infected Family in China.
32423903 2020. Thrombotic risk in COVID-19: a case series and case-control study.
32414711 2020. The renin-angiotensin system - a therapeutic target in COVID-19?
32503799 2020. Abrupt deterioration and pulmonary embolism in COVID-19: a case report.
32452757 2020. Vascular injury and COVID-19-related mortality: What lies below the tip of the iceberg?
32512408 2020. The choice of intravenous thrombolysis for Acute Ischemic Stroke under COVID-19 infection.
32462940 2020. Characteristics of Children With Reactivation of SARS-CoV-2 Infection After Hospital Discharge.
32468411 2020. COVID-19 and Asthma: Reflection During the Pandemic.
32507883 2020. Covid-19: the renin-angiotensin system imbalance hypothesis.
32459672 2020. Routine Venous Thromboembolism Prophylaxis May Be Inadequate in the Hypercoagulable State of Severe Coronavirus Disease 2019.
32463005 2020. The COVID-19 Pandemic: A Challenge for the Cardiovascular Health.
32442082 2020. Severe acute respiratory syndrome coronavirus 2 is penetrating to dementia research.
32448405 2020. Characteristics of patients with COVID-19 pneumonia at Hvidovre Hospital, March-April 2020.
32475056 2020. Psoriasis, COVID-19 and acute respiratory distress syndrome: focusing on the risk of concomitant biological treatment.
32475035 2020. Contributions of dermatologists to COVID-19 research: a brief systematic review.
32474988 2020. Non-complicated evolution of COVID-19 infection in a patient with psoriasis and psoriatic arthritis during treatment with adalimumab.
32424886 2020. The management of the outbreak of acral skin manifestations in asymptomatic children during COVID-19 era.
32418320 2020. Urticaria in a patient with COVID-19: Therapeutic and diagnostic difficulties.
32406078 2020. COVID-19 in an elderly patient treated with secukinumab.
32506813 2020. A fatal case of COVID-19 infection presenting with an erythema multiforme-like eruption and fever.
32500647 2020. Dermatological Manifestation of Pediatrics Multisystem Inflammatory Syndrome Associated with COVID-19 in a 3-Year-Old Girl.
32500589 2020. Superficial thrombophlebitis in a patient with COVID 19: Heparin treatment after evaluation of D - Dimer: COVID 19 and Superficial thrombophlebitis.
32500580 2020. Schamberg-like purpuric eruptions and tonsillitis in mild COVID-19.
32478942 2020. Covid-19 infection in psoriasis patients treated with cyclosporin.
32430456 2020. Outcomes in Patients With Hyperglycemia Affected by Covid-19: Can We Do More on Glycemic Control?
32409505 2020. COVID-19 in People With Diabetes: Urgently Needed Lessons From Early Reports.
32409504 2020. Clinical Characteristics and Risk Factors for Mortality of COVID-19 Patients With Diabetes in Wuhan, China: A Two-Center, Retrospective Study.
32409502 2020. Obesity and COVID-19 Severity in a Designated Hospital in Shenzhen, China.
32409499 2020. Obesity Is a Risk Factor for Greater COVID-19 Severity.
32409498 2020. Clinical Characteristics and Outcomes of Patients With Diabetes and COVID-19 in Association With Glucose-Lowering Medication.
32496012 2020. Influence of diabetes mellitus on the severity and fatality of SARS-CoV-2 infection.
32482296 2020. COVID-19: Perspectives from people with diabetes.
32478675 2020. Headache is an important symptom in patients with coronavirus disease 2019 (COVID-19).
32423922 2020. More advice on the use of ibuprofen for COVID-19.
32468357 2020. An unresponsive COVID-19 patient.
32464652 2020. Epicardial adipose tissue: fuel for COVID-19-induced cardiac injury?
32464641 2020. Does epicardial fat contribute to COVID-19 myocardial inflammation?
32459851 2020. Stress-induced cardiac arrest with mitral annulus disjunction in a physician amid the COVID-19 pandemic fight.
32441750 2020. Angioedema in COVID-19.
32432700 2020. Return to sports after COVID-19 infection.
32282026 2020. Call to action for the cardiovascular side of COVID-19.
32498076 2020. Association of hypertension and antihypertensive treatment with COVID-19 mortality: a retrospective observational study.
32464642 2020. Myocardial injury in severe COVID-19 infection.
32449762 2020. Acute coronary syndromes during COVID-19.
32432723 2020. Renin-angiotensin system and SARS-CoV-2 infection: there is a before and after.
32432704 2020. Renin-angiotensin-aldosterone system dysregulation and severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection.
32462177 2020. Myocarditis detected after COVID-19 recovery.
32464637 2020. The mechanistic overview of SARS-CoV-2 using angiotensin-converting enzyme 2 to enter the cell for replication: possible treatment options related to the renin-angiotensin system.
32501480 2020. Continuation versus discontinuation of ACE inhibitors or angiotensin II receptor blockers in COVID-19: effects on blood pressure control and mortality.
32501477 2020. Antihypertensive drugs in COVID-19 infection.
32511752 2020. COVID-19 and End Stage Renal Disease.
32511751 2020. SARS-CoV-2: what is known and what there is to know. Focus on coagulation and lipids.
32469251 2020. The gendered impact of coronavirus disease (COVID-19): do estrogens play a role?
32453009 2020. Dangerous interactions of gastrointestinal drugs with experimental treatments for COVID-19.
32282549 2020. Chronic liver disease is not associated with severity or mortality in Coronavirus disease 2019 (COVID-19): a pooled analysis.
32485082 2020. ACE-inhibitors and Angiotensin-2 Receptor Blockers are not associated with severe SARS-COVID19 infection in a multi-site UK acute Hospital Trust.
32503088 2020. A systematic review of neurological manifestations of SARS-CoV-2 infection: the devil is hidden in the details.
32503084 2020. Miller-Fisher syndrome after SARS-CoV-2 infection.
32503080 2020. Concomitant brain arterial and venous thrombosis in a COVID-19 patient.
32492256 2020. How to support the quality of life of people living with cognitive disorders? A (k)new challenge in the post-Covid World.
32478936 2020. SARS-CoV-2 and Guillain-Barre syndrome: AIDP variant with favorable outcome.
32450718 2020. Ophthalmology and SARS-CoV-2: Blind toward those who fight blindness?
32396903 2020. Venous Thromboembolism Complicated with COVID-19: What Do We Know So Far?
32238235 2020. Da Tuberculose ao COVID-19: Legitimidade Juridico-Constitucional do Isolamento/Tratamento Compulsivo por Doencas Contagiosas em Portugal.
32433817 2020. Prolonged Confusional state as first manifestation of COVID-19.
32498096 2020. Intramural Hematoma as Unexpected Complication of COVID-19 Infection.
32470281 2020. La bronquiolitis en el ano del COVID-19.
32505489 2020. ROLE OF REHABILITATION DEPARTMENT FOR ADULT COVID-19 PATIENTS: THE EXPERIENCE OF THE SAN RAFFAELE HOSPITAL OF MILAN.
32401850 2020. Coronavirus e o Coracao
32401847 2020. O Coracao e a COVID-19: O que o Cardiologista Precisa Saber.
32401844 2020. COVID-19: Dados Atualizados e sua Relacao Com o Sistema Cardiovascular.
32491075 2020. Implicacoes Cardiovasculares em Pacientes Infectados com Covid-19 e a Importancia do Isolamento Social para Reduzir a Disseminacao da Doenca.
32491074 2020. COVID-19 e Estado de Hipercoagulabilidade: Uma Nova Perspectiva Terapeutica.
32491073 2020. O Efeito da Doenca de Coronavirus 2019 nas Doencas Cardiovasculares.
32386125 2020. Capturing patient-reported outcomes during the COVID-19 pandemic: Development of the COVID-19 Global Rheumatology Alliance Patient Experience Survey.
32458534 2020. Mild course of Coronavirus disease 2019 and spontaneous severe acute respiratory syndrome coronavirus 2 clearance in a patient with depleted peripheral blood B-cells due to treatment with rituximab.
32472827 2020. First Successful Treatment of Coronavirus Disease 2019 Induced Refractory Cardiogenic Plus Vasoplegic Shock by Combination of Percutaneous Ventricular Assist Device and Extracorporeal Membrane Oxygenation: A Case Report.
32512532 2020. Lived experiences of the corona survivors (patients admitted in COVID wards): A narrative real-life documented summaries of internalized guilt, shame, stigma, anger.
32453688 2020. COVID-19, thromboembolic risk and thromboprophylaxis: learning lessons from the bedside, awaiting evidence.
32471884 2020. Characterization and clinical course of 1000 patients with coronavirus disease 2019 in New York: retrospective case series.
32467124 2020. 80-year-old man with dyspnoea and bilateral groundglass infiltrates: an elusive case of COVID-19.
32503812 2020. Elevation of blood glucose level predicts worse outcomes in hospitalized patients with COVID-19: a retrospective cohort study.
32460349 2020. Further evidence that chilblains are a cutaneous manifestation of COVID-19 infection.
32469077 2020. Covid-19 in Bone Marrow Transplant Recipients: Reflecting on a Single Centre Experience.
32460350 2020. Cold Agglutinin Autoimmune Hemolytic Anemia Associated with Novel Coronavirus (COVID-19).
32453889 2020. Haemoglobin Oxygen Affinity in Patients with Severe COVID-19 Infection.
32453877 2020. Delayed-Phase Thrombocytopenia in Patients of Coronavirus Disease 2019 (COVID-19).
32453861 2020. Is molecular mimicry the culprit in the autoimmune haemolytic anaemia affecting patients with COVID-19?
32438482 2020. Real-world assessment of the clinical impact of symptomatic infection with severe acute respiratory syndrome coronavirus (COVID-19 disease) in patients with multiple myeloma receiving systemic anti-cancer therapy.
32438458 2020. Molecular mechanisms for thrombosis risk in Black people: a role in excess mortality from COVID-19.
32420629 2020. Evans syndrome in a patient with COVID-19.
32420615 2020. Dynamic relationship between D-dimer and COVID-19 severity.
32420614 2020. First COVID-19 maternal mortality in the UK associated with thrombotic complications.
32420612 2020. COVID-19-associated immune thrombocytopenia.
32420611 2020. More on 'Association between ABO blood groups and risk of SARS-CoV-2 pneumonia'.
32420609 2020. Clinical outcome of coronavirus disease 2019 in haemato-oncology patients.
32420608 2020. Patients with sickle cell disease and suspected COVID-19 in a paediatric intensive care unit.
32452530 2020. Abdominal fluid samples (negative for SARS-CoV-2) from a critically unwell patient with respiratory COVID-19.
32408910 2020. Interdisciplinary and Collaborative Approaches Needed to Determine Impact of COVID-19 on Older Adults and Aging: CAG/ACG and CJA/RCV Joint Statement.
32470162 2020. Management of a patient presenting with anterior STEMI with concomitant COVID-19 infection early in the course of the U.S. pandemic.
32427416 2020. COVID-19 complicated by acute myocardial infarction with extensive thrombus burden and cardiogenic shock.
32506683 2020. D-dimer triage for COVID-19.
32412848 2020. A Case of COVID-19 and Pneumocystis jirovecii Co-infection.
32492436 2020. Covid-19 may be exacerbated by right-to-left interatrial shunt.
32444450 2020. SARS-CoV-2 infection in ambulatory and hospitalised Spanish children.
32422078 2020. Effects of SARS-CoV-2 infection on pregnant women and their infants: A retrospective study in Wuhan, China.
32338533 2020. INFECTIONS IN PREGNANCY WITH COVID-19 AND OTHER RESPIRATORY RNA VIRUS DISEASES ARE RARELY, IF EVER, TRANSMITTED TO THE FETUS: EXPERIENCES WITH CORONAVIRUSES, HPIV, hMPV RSV, AND INFLUENZA.
32320546 2020. Criterios para la gestion de personas especialmente vulnerables y trabajadores/as especialmente sensibles frente al SARS-CoV-2 en las empresas de Cataluna en el contexto de pandemia.
32506699 2020. Incidence of COVID-19 in patients with rheumatic diseases treated with targeted immunosuppressive drugs: what can we learn from observational data?
32475091 2020. Cardiovascular conditions and COVID-19.
32427288 2020. ACE2 Receptor Expression in Testes: Implications in COVID-19 Pathogenesis.
32462179 2020. Impact of anticoagulation prior to COVID-19 infection: a propensity score-matched cohort study.
32492712 2020. COVID and Coagulation: Bleeding and Thrombotic Manifestations of SARS-CoV2 Infection.
32376670 2020. Covid-19: the challenge of patient rehabilitation after intensive care.
32366505 2020. Covid-19 and pregnancy.
32439704 2020. Covid-19 and thrombosis: what do we know about the risks and treatment?
32434891 2020. Covid-19 and cardiovascular disease.
32398229 2020. Covid-19: Low skilled men have highest death rate of working age adults.
32393504 2020. Covid-19: Known risk factors fail to explain the increased risk of death among people from ethnic minorities.
32357954 2020. Covid-19 is no worse in immunocompromised children, says NICE.
32217618 2020. Covid-19: risk factors for severe disease and death.
32213482 2020. Covid-19 and long term conditions: what if you have cancer, diabetes, or chronic kidney disease?
32209544 2020. Covid-19: most patients require mechanical ventilation in first 24 hours of critical care.
32327432 2020. Covid-19: Doctors should be alert for signs of myocardial injury, says NICE.
32291260 2020. Covid-19: Nine in 10 pregnant women with infection when admitted for delivery are asymptomatic, small study finds.
32303575 2020. Case series of coronavirus (SARS-CoV-2) in a military recruit school: clinical, sanitary and logistical implications.
32467101 2020. Symptom burden and clinical profile of COVID-19 deaths: a rapid systematic review and evidence summary.
32378464 2020. Long-term conditions and severe acute respiratory syndrome SARS-CoV-2 (COVID-19).
32479680 2020. Cutaneous manifestations in patients with COVID-19: A preliminary review of an emerging issue.
32497248 2020. Pulmonary Artery Thrombectomy - A Life Saving Treatment in a Patient with Presumed COVID-19 complicated by a massive Pulmonary Embolus.
32484907 2020. Prevalence of Venous Thromboembolism in Critically Ill Patients with COVID-19.
32484906 2020. Prevalence and Mortality due to Outbreak of Novel Coronavirus Disease (COVID-19) in beta-Thalassemias: The Nationwide Iranian Experience.
32484901 2020. Re The source of elevated plasma D-dimer levels in COVID-19 infection.
32479664 2020. A Case Series of MGUS and COVID-19.
32468862 2020. Licking the lungs, biting the brain: malignant MCA infarct in a patient with COVID 19 infection.
32475821 2020. The Stanford Hall consensus statement for post-COVID-19 rehabilitation.
32492174 2020. First case of acute pancreatitis related to SARS-CoV-2 infection.
32311273 2020. Managing COVID-19-Positive Maternal-Infant Dyads: An Italian Experience.
32468972 2020. Guillain-Barre syndrome with facial diplegia related to SARS-CoV-2 infection.
32493536 2020. COVID-19 presenting with thalamic hemorrhage unmasking moyamoya angiopathy.
32493522 2020. The impact of the Covid-19 Pandemic on Stroke Volume.
32484130 2020. COVID-19 associated central nervous system vasculopathy.
32471876 2020. Registries Offer Insights on COVID-19-Cancer Connection.
32398243 2020. Impact of PD-1 blockade on severity of COVID-19 in patients with lung cancers.
32427636 2020. ACE Inhibitors and ARBs in Patients with COVID-19: Friend or Foe?
32496364 2020. Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers in Patients With Coronavirus Disease 2019: Friend or Foe?
32427637 2020. The Novel Coronavirus Disease (COVID-19) and Its Impact on Cardiovascular Disease.
32494800 2020. Coronavirus disease 2019 (COVID-19) and simultaneous acute anteroseptal and inferior ST-segment elevation myocardial infarction.
32490506 2020. Coronavirus disease 2019 (COVID-19) and simultaneous acute anteroseptal and inferior ST-segment elevation myocardial infarction.
32473085 2020. SARS-COV-2 infection presenting as ST-elevationmyocardial infarction.
32473051 2020. Massive coronary thrombosis caused primary percutaneous coronary intervention to fail in a COVID-19 patient with ST-elevation myocardial infarction.
32403983 2020. Neurotropic mechanisms in COVID-19 and their potential influence on neuropsychological outcomes in children.
32209890 2020. Clinical characteristics of fatal and recovered cases of coronavirus disease 2019 in Wuhan, China: a retrospective study.
32432519 2020. Does the compromised sleep and circadian disruption of night and shiftworkers make them highly vulnerable to 2019 coronavirus disease (COVID-19)?
32511019 2020. COVID-19 infection at nighttime.
32498625 2020. SARS-CoV-2/COVID-19 and physical distancing: risk for circadian rhythm dysregulation, advice to alleviate it, and natural experiment research opportunities.
32434385 2020. Cardiac Arrhythmias in COVID-19 Infection.
32397816 2020. Diffuse Myocardial Inflammation in COVID-19 Associated Myocarditis Detected by Multiparametric Cardiac Magnetic Resonance Imaging.
32474587 2020. COVID-19: Possible reasons for the increased prevalence of Olfactory and Gustatory dysfunction observed in European studies.
32473009 2020. Age-dependent gender differences of COVID-19 in mainland China: comparative study.
32472683 2020. Detectable severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in human breast milk of a mildly symptomatic patient with coronavirus disease 2019 (COVID-19).
32472676 2020. Predictors for Severe COVID-19 Infection.
32472138 2020. Clinical characteristics and outcomes in people living with HIV hospitalized for COVID-19.
32463454 2020. Alterations in smell or taste - Classic COVID-19?
32459833 2020. Hospitalized patients with COVID-19 and HIV: a case series.
32444880 2020. Clinical Features and Outcomes of 105 Hospitalized patients with COVID-19 in Seattle, Washington.
32442294 2020. Therapy with agents acting on the renin-angiotensin system and risk of SARS-CoV-2 infection.
32442285 2020. Association of renin-angiotensin-aldosterone system inhibitors with COVID-19-related outcomes in Korea: a nationwide population-based cohort study.
32442265 2020. Characterization of an asymptomatic cohort of SARS-COV-2 infected individuals outside of Wuhan, China.
32442259 2020. Renin-angiotensin-aldosterone system inhibitors impact on COVID-19 mortality: What's next for ACE2?
32433729 2020. Symptomatic Infants have Higher Nasopharyngeal SARS-CoV-2 Viral Loads but Less Severe Disease than Older Children.
32211755 2020. Epidemiological and Clinical Predictors of COVID-19.
32502247 2020. Inverse association between chronic hepatitis B infection and COVID-19: immune-exhaustion or coincidence?
32444393 2020. Clinical Features of Maintenance Hemodialysis Patients with 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China.
32441332 2020. Clinical course of coronavirus disease-2019 in pregnancy.
32436625 2020. Low risk of SARS-CoV-2 transmission through the ocular surface.
32421258 2020. Ocular manifestations and clinical characteristics of 535 cases of COVID-19 in Wuhan, China: a cross-sectional study.
32470948 2020. Why does COVID-19 disproportionately affect older people?
32499448 2020. Comparison of clinical characteristics and outcomes of patients with coronavirus disease 2019 at different ages.
32507570 2020. Acute myocarditis associated with COVID-19 infection.
32496339 2020. Lipase Elevation in Patients With COVID-19.
32483005 2020. Liver Enzyme Elevation in Coronavirus Disease 2019: A Multicenter, Retrospective, Cross-Sectional Study.
32445584 2020. Immune thrombocytopenia due to COVID-19 during pregnancy.
32512038 2020. IgG Antibody Response to SARS-CoV-2 Infection and Viral RNA Persistence in Patients on Maintenance Hemodialysis.
32459524 2020. Obesity and COVID-19: Immune and metabolic derangement as a possible link to adverse clinical outcomes.
32421367 2020. Is there an impact of the COVID-19 pandemic on male fertility? The ACE2 connection.
32396497 2020. COVID-19-associated SIADH: a clue in the times of pandemic!
32491949 2020. Understanding the age divide in COVID-19: Why are children overwhelmingly spared?
32432918 2020. Estrogen regulates the expression of SARS-CoV-2 receptor ACE2 in differentiated airway epithelial cells.
32401670 2020. Treatment of COVID-19-exacerbated asthma: should systemic corticosteroids be used?
32412303 2020. Is the kidney a target of SARS-CoV-2?
32436646 2020. Clinical outcome in solid organ transplant recipients with COVID-19: A single-center experience.
32503857 2020. Clinical features and outcomes of COVID-19 in patients with rheumatic diseases treated with biological and synthetic targeted therapies.
32469504 2020. Heralding Healthcare Professionals: Recognition of Neurological Deficits in COVID-19.
32491829 2020. SARS-CoV-2 more than a respiratory virus: Its potential role in neuropathogenesis.
32420961 2020. Report of a series of healthy term newborns from convalescent mothers with COVID-19.
32420955 2020. Preliminary epidemiological analysis on children and adolescents with novel coronavirus disease (2019-nCoV) in a central area of Calabria region.
32420954 2020. Smell and taste dysfunction during the COVID-19 outbreak: a preliminary report.
32420950 2020. The medical concerns of patients with thalassemias at the time of COVID-19 outbreak: The personal experience and the international recommendations.
32420949 2020. Rare Anaemias, Sickle-Cell Disease and COVID-19.
32420948 2020. SARS-CoV-2 infection in children in Parma.
32420942 2020. COVID19: potential cardiovascular issues in pediatric patients.
32420941 2020. Novel coronavirus infection and children.
32420939 2020. Assessment and treatment of older individuals with COVID 19 multi-system disease: Clinical and ethical implications.
32420934 2020. Tobacco smoking and COVID-19 pandemic: old and new issues. A summary of the evidence from the scientific literature.
32420930 2020. Primum non nocere. The SARS-CoV-2 pandemic course in oldest.
32420925 2020. Implications of SARSr-CoV 2 infection in thalassemias: Do patients fall into the "high clinical risk" category?
32474914 2020. Anxiety and depression levels among pregnant women with COVID-19.
32473022 2020. Coronavirus disease-2019 in pregnancy with neurological manifestations versus pregnancy with eclampsia: Need for liberal testing to rule out the masquerades.
32483943 2020. Episcleritis as an ocular manifestation in a patient with COVID-19.
32470131 2020. The COVID-19 Rehabilitation Pandemic.
32449420 2020. Interpretation of arrhythmogenic effects of COVID-19 disease through ECG.
32508193 2020. Risk factors for mortality in patients with Coronavirus disease 2019 (COVID-19) infection: a systematic review and meta-analysis of observational studies.
32501851 2020. SARS-CoV-2 infection in a highly experienced person living with HIV.
32501850 2020. Potential impact of COVID-19 in people living with HIV: experience from previous 21st century coronaviruses epidemics.
32469614 2020. A Case Series of Five People Living with HIV Hospitalized with COVID-19 in Chicago, Illinois.
32407127 2020. Why Aren't People Living with HIV at Higher Risk for Developing Severe Coronavirus Disease 2019 (COVID-19)?
32467191 2020. Brain Imaging Use and Findings in COVID-19: A Single Academic Center Experience in the Epicenter of Disease in the United States.
32467190 2020. COVID-19-Associated Miller Fisher Syndrome: MRI Findings.
32467189 2020. Surprise Diagnosis of COVID-19 following Neuroimaging Evaluation for Unrelated Reasons during the Pandemic in Hot Spots.
32439646 2020. Hemorrhagic Posterior Reversible Encephalopathy Syndrome as a Manifestation of COVID-19 Infection.
32409316 2020. Cerebrovascular Disease in COVID-19.
32354715 2020. Neuroradiologists, Be Mindful of the Neuroinvasive Potential of COVID-19.
32383969 2020. Segmental Pulmonary Vascular Changes in COVID-19 Pneumonia.
32478611 2020. Reply to "Segmental Pulmonary Vascular Changes in COVID-19 Pneumonia".
32470238 2020. Taste and smell as chemosensory dysfunctions in COVID-19 infection.
32511678 2020. Use of RAAS inhibitors and risk of clinical deterioration in COVID-19: results from an Italian cohort of 133 hypertensives.
32380565 2020. COVID-19 in Newborns and Infants-Low Risk of Severe Disease: Silver Lining or Dark Cloud?
32438425 2020. COVID-19 in Pregnant Women: Case Series from One Large New York City Obstetrical Practice.
32428964 2020. The Relationship between Status at Presentation and Outcomes among Pregnant Women with COVID-19.
32403141 2020. Vertical Transmission of Severe Acute Respiratory Syndrome Coronavirus 2: A Systematic Review.
32503058 2020. Vertical Transmission of SARS-CoV-2: What is the Optimal Definition?
32467494 2020. In response to: Simpson R and Robinson L: Rehabilitation following critical illness in people with COVID-19 infection.
32467490 2020. The place of early rehabilitation in ICU for Covid-19.
32396381 2020. COVID-19 Associated Pulmonary Aspergillosis.
32510975 2020. Thromboprophylaxis in COVID-19: Anti-FXa - The Missing Factor?
32471004 2020. Early COVID-19 infection after lung transplantation.
32471001 2020. COVID-19 in elderly kidney transplant recipients.
32492753 2020. Recovery from COVID-19 following Hepatitis C, Human Immunodeficiency Virus Infection and Liver Transplantation.
32483909 2020. Renal Infarct in a COVID-19 Positive Kidney-Pancreas Transplant Recipient.
32476258 2020. Clinical Outcomes and Serologic Response in Solid Organ Transplant Recipients with COVID-19: A Case Series from the United States.
32431287 2020. Critical Care Management of Patients with COVID-19: Early Experience in Thailand.
32419694 2020. Case Report: COVID-19 Presenting as Acute Undifferentiated Febrile Illness-A Tropical World Threat.
32500854 2020. Primary Respiratory Bacterial Coinfections in Patients with COVID-19.
32503849 2020. Severe COVID-19-associated pneumonia in 3 patients with systemic sclerosis treated with rituximab.
32503848 2020. Response to: 'Severe COVID-19 associated pneumonia in 3 patients with systemic sclerosis treated with rituximab' by Avouac et al.
32205336 2020. Are my patients with rheumatic diseases at higher risk of COVID-19?
32354774 2020. Non-steroidal anti-inflammatory treatment during covid-19: friend or foe? Response to: 'Coronavirus disease 19 (Covid-19) and non-steroidal anti-inflammatory drugs (NSAID)' by Giollo et al.
32354773 2020. Diagnostic and therapeutic challenges for patients with ANCA-associated vasculitides at the time of COVID-19. Response to: 'Rituximab for granulomatosis with polyangiitis in the pandemic of COVID-19: lessons from a case with severe pneumonia' by Guilpain et al.
32321723 2020. What is the true incidence of COVID-19 in patients with rheumatic diseases?
others
32276139 2020. COVID-19 in a patient with long-term use of glucocorticoids: A study of a familial cluster
32276140 2020. Epigenetic dysregulation of ACE2 and interferon-regulated genes might suggest increased COVID-19 susceptibility and severity in lupus patients
32283499 2020. Comorbidities in COVID-19: Outcomes in hypertensive cohort and controversies with renin angiotensin system blockers
32228738 ä. Mortality Rate of Infection With COVID-19 in Korea From the Perspective of Underlying Disease
32256706 2020. COVID-19 and treatment with NSAIDs and corticosteroids: should we be limiting their use in the clinical setting?
32134381 2020. Lack of Vertical Transmission of Severe Acute Respiratory Syndrome Coronavirus 2, China
C7141546 ä. Is low sodium intake a risk factor for severe and fatal COVID-19 infection?
32269089 2020. ACE-2 expression in the small airway epithelia of smokers and COPD patients: implications for COVID-19
32307025 ä. Could COVID-19 represent a negative prognostic factor in patients with stroke?
32355869 ä. The Dermatologist?s Perspective: Why is COVID-19 mortality lower in females than males?
32253068 2020. Recommendations for coronavirus infection in rheumatic diseases treated with biologic therapy
32335513 2020. Incidence and Clinical Course of COVID-19 in Patients with Connective Tissue Diseases: A Descriptive Observational Analysis
32334645 2020. Use of glucocorticoids in patients with adrenal insufficiency and COVID-19 infection
32332856 ä. COVID-19 in persons with haematological cancers
32303807 ä. Electronic cigarette and vaping should be discouraged during the new coronavirus SARS-CoV-2 pandemic
32339776 2020. Covid-19, TMPRSS2, and whether android regulation affects pandemic virus gender incidence and age distribution of disease
32320740 ä. Low-density lipoprotein is a potential predictor of poor prognosis in patients with coronavirus disease 2019
32302077 ä. Clinical Characteristics of Pregnant Women with Covid-19 in Wuhan, China
32289171 ä. Cardiac drugs and outcome in COVID-19: Reply
32289168 ä. Cardiac drugs and outcome in COVID - 19
32379903 2020. Outcome of a patient with refractory Hodgkin lymphoma on pembrolizumab, infected with SARS-CoV-2
32369615 2020. Favourable outcome of coronavirus disease 2019 in a 1-year-old girl with acute myeloid leukaemia and severe treatment-induced immunosuppression
32266501 ä. Double Jeopardy: Methamphetamine Use and HIV as Risk Factors for COVID-19
32352633 2020. Insights for increased risk of failed fibrinolytic therapy and stent thrombosis associated with COVID-19 in ST-segment elevation myocardial infarction patients
32339025 2020. Why Fibrinolytic Therapy for STEMI in The COVID-19 Pandemic is Not Your New Best Friend
32320270 2020. Obesity a Risk Factor for Severe COVID-19 Infection: Multiple Potential Mechanisms
32259878 ä. A case of exacerbation of psoriasis after oseltamivir and hydroxychloroquine in a patient with COVID?19: Will cases of psoriasis increase after COVID?19 pandemic?
32369240 2020. Cutaneous manifestations of a 21st century worldwide fungal epidemic possibly complicating the COVID-19 pandemic to jointly menace mankind
32367558 2020. Dermatological diseases presented before COVID-19: Are patients with psoriasis and superficial fungal infections more vulnerable to the COVID-19?
32310015 2020. Cerebrovascular disease is associated with an increased disease severity in patients with Coronavirus Disease 2019 (COVID-19): A pooled analysis of published literature
32347572 2020. Outcome of Parkinson s Disease Patients Affected by COVID-19
32360210 2020. Letter to the Editor: Fasting plasma glucose associated with mortality rate in T2DM patients with COVID-19 infection
32386796 ä. Children are at risk from COVID-19
32324968 2020. Does high cardiorespiratory fitness confer some protection against pro-inflammatory responses after infection by SARS-CoV-2?
32413819 2020. Vitamin D concentrations and COVID-19 infection in UK Biobank
32291196 2020. Is low sodium intake a risk factor for severe and fatal COVID-19 infection?